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CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation. 
Babu D, Motterlini R, Lefebvre RA. 
Br J Pharmacol. 2015, 172, 1557-1573 
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Chapter I   Literature survey 
 
I. 1 The gastrointestinal tract 
I.1.1 Anatomy and histology 
The human gastrointestinal (GI) tract consists of a 6-9 m long canal from mouth to 
anus, and the associated organs that empty their content into the canal (Fig. I.1). The GI 
canal consists of the mouth (the pharynx), esophagus (involving upper and lower esophageal 
sphincters), the stomach (comprising the cardia, fundus, corpus and antrum leading to the 
pyloric sphincter), the small intestine (composed of the duodenum, jejunum and ileum), the 
large intestine (composed of the cecum, colon and rectum) and the anus (comprising the 
internal and external anal sphincters). 
 
Fig. I.1 Schematic illustration of the anatomy of the gastrointestinal tract (adapted from Boron & Boulpaep, 
2009). 
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Motility, digestion, secretion, absorption and elimination are the major physiological 
processes occurring in the GI tract. These processes are well coordinated by the organs of 
the GI tract to efficiently digest food for taking in nutrients and eliminating waste. The 
interplay of several humoral and neuronal mechanisms regulates the different processes of 
the GI tract. Apart from those major functions described above, the GI tract also plays a vital 
role in the immune defense. 
The basic structural organization of the GI tract is relatively similar resembling a 
hollow cylindrical tube consisting of four concentric layers from inside to outside of the 
lumen (Fig. I.2): 
 The mucosa is the innermost layer enclosing the intestinal lumen; it consists of three 
sublayers, namely, the epithelium, the lamina propria (a layer of loose connective 
tissue containing the mucosal capillaries) and the muscularis mucosae (comprising a 
thin smooth muscle layer). 
 The submucosa is the second layer, also consisting of loose connective tissue along 
with the submucosal nerve plexus and blood vessels. 
 The muscularis externa is the third layer, consisting of inner circular and outer 
longitudinal smooth muscle layers, with the myenteric nerve plexus in between. 
 The adventitia is the outermost layer comprising loose connective tissue; when 
covered by the visceral peritoneum, it is called the serosa. 
 
Fig. I.2 Schematic representation of the different layers of the gastrointestinal tract (adapted from Marieb et 
al., 2004). 
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I.1.2 The mucosal epithelial cell layer 
The surface epithelium in the mucosa forms the border between the luminal content 
and the body. In the oral cavity, pharynx and esophagus, it consists of non-keratinized 
stratified squamous epithelium; in the stomach, the small intestine and almost the entire 
length of the large intestine, it consists of simple columnar epithelium; in the rectum and 
anus, it consists of stratified columnar epithelium followed by non-keratinized stratified 
squamous epithelium, and finally keratinized stratified squamous epithelium towards the 
end of the anal canal. Starch and lipid digestion start in the oral cavity via salivary amylase 
and lipase, and protein digestion starts in the stomach via pepsin. But digestion is mainly 
covered in the small intestine via the pancreatic enzymes, entering the duodenum via the 
ductus pancreaticus, and via the intestinal enzymes provided by the epithelial lining of the 
duodenum and jejunum. All digested nutrients and the majority of water, daily passing 
through the GI tract via oral intake and GI secretions, are absorbed in the jejunum and 
ileum. The epithelial surface of the small intestine is multiplied by 600 via three mechanisms: 
1) the valvulae conniventes hanging in the lumen (x 3); 2) the presence of finger-like 
projections, called intestinal villi, alternating with crypts in between (x 10); 3) the presence 
of numerous very small projections at the apical side of the epithelial cells, called microvilli  
(x 20) (Fig. I.3). This yields an estimated surface of 200 m2 allowing the absorptive function of 
the small intestine but also meaning that there is a great mucosal surface in contact with 
luminal contents and in danger of damage. The large intestine consists of a smooth surface 
interspersed with crypts; a last part of water is absorbed here to maintain the water balance 
and indigestible material is stored till defecation occurs. 
Unlike other mucosal sites, the intestinal epithelium is normally exposed to 
commensal bacteria and their products. The small intestine is only sparsely populated with 
bacteria while the large intestine contains around 1013 microorganisms. Thus, intestinal 
epithelial cells are the initial site of contact between the host and the gut microbiome. This 
epithelial layer prevents the uncontrolled passage of luminal contents to subepithelial 
tissues by forming a physical barrier between the luminal contents and the body (Karrasch & 
Jobin, 2009). 
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Fig. I.3 Illustration of a cross section through the small intestine with valvulae conniventes (A), villi (B) and 
epithelial cells featuring microvilli at the apical side (C) (from Pearson education). 
 
The intestinal epithelium is composed of different types of cells, each of them having 
a specialized function. The stem cells located near (small intestine) or in (large intestine) 
each crypt bottom continuously produce proliferating progenitor cells, which finally result in 
differentiated cells along the crypt-villus axis (Sancho et al., 2004; van der Flier & Clevers, 
2009). These differentiated epithelial cells can be further divided into cells of the absorptive 
and secretory lineages (Fig. I.4A). 
In the small intestine, the progenitor cells migrate to the crypt bottom to 
differentiate to Paneth cells or along the crypt-villus axis to proliferate several times and 
finally differentiate into absorptive epithelial cells, enteroendocrine cells or goblet cells (Fig. 
I.4B). The absorptive epithelial cells are called enterocytes in the small intestine and 
colonocytes in the large intestine; they represent the most numerous cell type in the 
intestinal epithelium contributing to the physical barrier (Sancho et al., 2003; van der Flier & 
Clevers, 2009). In the literature, the term "intestinal epithelial cells (abbreviated as IECs)" is 
used to describe the absorptive epithelial cells, and hence this description will be followed 
from now on in this thesis. The main function of IECs is efficient absorption and transport of 
nutrients from the luminal side towards the circulation. The Paneth cells, goblet cells and 
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Fig. I.4 (A) Scheme depicting intestinal stem cells, progenitor cells and the two differentiated branches of cell 
lineages, viz., the absorptive lineage (absorptive epithelial cells) and secretary lineage (Paneth, goblet and 
enteroendocrine cells). (B) Different cell types along the crypt-villus axis in the small intestinal epithelium 
(adapted from Radtke & Clevers, 2005). 
 
enteroendocrine cells are of secretory lineage developing from the same epithelial 
progenitor cells but differ from absorptive epithelial cells both in morphology and function. 
Paneth cells are restricted to the crypt in the small intestine and are located together with 
intestinal stem cells at the crypt base. They express antimicrobial peptides (AMPs) like  
α-defensins, lysozyme or phospholipase A, which along with the secretory immunoglobulin A 
(sIgA), contribute to host defence against a broad spectrum of pathogens like bacteria, fungi 
and viruses (Fig. I.5). Goblet cells secrete high molecular weight glycoproteins called mucins. 
These mucins result in the formation of a gel-like matrix covering the intestinal epithelium, 
which provides a protective function against physical and chemical injury. The mucin forms 
an IEC-adherent inner mucus layer that is largely impervious to bacterial penetration or 
colonization and a less densely cross-linked outer mucus layer, which is highly colonized by 
constituents of the microbiota. The mucus layer is thicker in the large intestine than in the 
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small intestine, which accounts for its effective protection against the large number of 
bacteria in large intestine (Fig. I.5). Finally, enteroendocrine cells coordinate the gut function 
by secreting specific gut hormones and are mainly found in the upper part of the small 
intestine. 
 
 
Fig. I.5 Distinct subpopulations of intestinal epithelial cells are integrated into a continuous, single cell layer 
that is divided into apical and basolateral regions by tight junctions to form an intact barrier in small (left) and 
large (right) intestine. AMPs: antimicrobial peptides; sIgA: secretory immunoglobulin A (adapted from Maynard 
et al., 2012). 
 
I.1.3 Intestinal epithelial homeostasis 
Since the IECs (enterocytes and colonocytes) are the major targets of invasive 
enterobacteria to induce mucosal damage, they have several crucial functions to maintain 
intestinal homeostasis apart from absorption. Connected by tight junctions, they form a 
physical barrier separating the sterile underlying gut layer from the non-sterile contents of 
the lumen (Fig. I.6). Additionally, they secrete regulatory cytokines (e.g. transforming growth 
factor-β) and electrolytes (e.g. chlorides and bicarbonates) to influence microbial 
colonization, they sense differences between beneficial (commensal) and harmful 
(pathogenic) microbes, and they initiate immune responses when necessary to maintain 
epithelial barrier integrity. In order to achieve this, they work in concerted action with the  
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Fig. I.6 Four components of the intestinal barrier (adapted from Anderson et al., 2012). 
 
other epithelial cell types of secretory lineage and with immune cells, together with the 
signals provided by the gut residing commensal microbiota. The gastrointestinal microbiota 
is composed of several species including bacteria and eukarya. The human body benefits 
from the commensal microbiota as many of them live in a homeostatic symbiosis with the 
host. The commensal bacteria help in water and electrolyte retention, and could even 
modulate tissue development and repair (Leser & Molbak, 2009). However, upon ingestion 
of food, potential pathogens can enter the intestinal lumen. Therefore, the intestinal 
epithelium is constantly challenged with the discrimination between beneficial and 
pathogenic organisms. The mucus layer above the IECs acts as a chemical barrier to 
undesired invasion of foreign organisms and toxins, and thus plays a crucial role in intestinal 
homeostasis. The gut has a mucosal immune system called the gut-associated lymphoid 
tissue (GALT); this consists of both organized (e.g. Peyer’s patches and M-cells) and diffuse 
structures (e.g. intraepithelial lymphocytes and gut-draining mesenteric lymph nodes) to 
maintain homeostasis. Upon exposure to bacteria, phagocytic cells like macrophages (mɸ) 
and dendritic cells (DCs) detect the antigens resulting in activation of lymphocytes (like  
B-cells) to trigger the immune response. The GALT forms the largest immune system in the 
body. The two main functions of GALT are to enable protective immunity against harmful 
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pathogens (like bacteria, viruses and protozoans) and to ensure immunological tolerance to 
harmless materials (like dietary components and commensal bacteria). Additionally, non-
immunogenic mechanisms like gastric acid secretion, intestinal mucin and gut motility are 
also important to protect against the pathogens and maintain a healthy intestinal microflora 
(Boron & Boulpaep, 2009). 
Taken together, a tightly regulated cross-talk exists between IECs, commensal 
bacteria and immune cells in order to maintain intestinal homeostasis. It is now clear that 
the intestinal barrier comprises microbiological, chemical, physical and immunological 
components (Fig. I.6). 
One unique feature of IECs is thus that they are constantly exposed to high 
concentrations of nutrients, microbes and xenobiotics. The regulation of the function of IECs 
is controlled by both external substances through food components and microbes, and 
factors like hormones and cytokines (Shimizu, 2010). IECs were once considered as an inert 
physical barrier, but over the last few decades it has been increasingly realized that they 
express a cadre of surface receptors (like pattern recognition receptors; PRRs) that allows 
direct communication between the human body and the intestinal microbiota. Apparently, 
IECs can manage the numbers and types of microbes present in the gut microbiota through 
regulation of their colonization and penetration of the epithelium. This is effectively 
achieved by secretion of AMPs by the enterocytes themselves together with the Paneth 
cells. This epithelial sensing of microbes is critical as the alterations in the composition of the 
microbiota are now believed to predispose to chronic diseases like inflammatory bowel 
disease (IBD) (Asquith & Powrie, 2010). 
The intestinal homeostasis is primarily regulated by a delicate balance of the life and 
death of IECs. The intestinal epithelium has an enormous self-renewing capacity, the life 
span of a normal epithelial cell being four to five days. Undifferentiated stem cells proliferate 
within the crypt base, undergo a few rounds of cell division before they differentiate and 
migrate upwards along the crypt-villus axis. After three to four days, these terminally 
differentiated cells reach the tip of the villi (in the small intestine) or the surface epithelium 
(in the colon), followed by cell shedding as depicted in Fig. I.7 (Ramachandran et al., 2000; 
Sancho et al., 2004; Sato et al., 2009). Minor breaks in epithelial layer continuity are rapidly 
resealed by a cell proliferation-independent process called epithelial restitution; however, 
major damage by exaggerated epithelial cell death leads to barrier impairment. 
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Fig. I.7 Schematic intestinal construction with crypts and villi representing the small intestine (A), and the 
colon (B) solely exhibiting crypts. Dendritic cells (DCs) and macrophages (mɸ) are resident in the lamina propria. 
 
In order to maintain an efficient intestinal barrier, the rates of epithelial cell 
proliferation and cell death have to be tightly regulated. During normal conditions, aged 
epithelial cells in the villus tip (of small intestine) or the surface epithelial cuff (of colon) are 
believed to die by apoptosis. Among the various ways by which cells could die, apoptosis is a 
programmed cell death pathway which is physiologically relevant in the intestinal epithelium 
(Hall et al., 1994; Bullen et al., 2006). The main mechanism is usually thought to be 
activation of caspases, which are a class of cleavage enzymes involved in the breakdown of 
cells into apoptotic bodies. Under normal conditions, induction of apoptosis has been 
observed before shedding of human IECs without compromising epithelial barrier and the 
rate of IEC apoptosis varies significantly across the different sections of the intestinal tract 
(Grossmann et al., 2002). Apart from the villus tip, apoptosis also occurs at the crypt level to 
remove excess or unwanted stem cells (Leedham et al., 2005). 
Because of the complex structure and organization of the intestinal epithelium, the 
various processes of cell proliferation, differentiation, migration and cell death have to be 
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tightly controlled. Excessive cell death might result in barrier dysfunction and “leaky gut” 
allowing uncontrolled access of bacteria and their components to the gut wall (Fig. I.8). 
Increase in the rate of apoptotic cell death can create leaks contributing to barrier 
dysfunction. The subsequent entry of bacteria and luminal contents into the lamina propria 
leads to secretion of cytokines and chemokines by IECs and inflammatory cells (like 
macrophages, neutrophils and mast cells) to initiate an inflammatory cascade (Peterson & 
Artis, 2014). The accumulation of neutrophils with the release of enzymes and reactive 
oxygen species (ROS) enhances the inflammatory reaction. The study of Nenci et al., (2007) 
showed an essential role for nuclear factor-κB (NF-κB) essential modulator (NEMO) in the 
control of IEC apoptosis. In this study, mice deficient in the gene NEMO specifically in IECs 
were used; NEMO deficiency in IECs led to excessive tumor necrosis factor (TNF)-dependent 
apoptosis within the epithelium, followed by a barrier breakdown and the translocation of 
bacteria into the bowel wall driving inflammation. Apoptotic cells are rapidly phagocytized 
by macrophages, a process that represents a critical step in tissue remodeling, immune 
responses and the resolution of inflammation (Henson & Bratton, 2013). Apoptotic cell 
death plays thus an important role in inflammatory processes and in the resolution of 
inflammatory reactions. However, dysregulation of cell proliferation or resistance to cell 
death may result in tumor development in the gut (Mehlen & Puisieux, 2006; Maloy & 
Powrie, 2011). 
 
I. 2 Acute gastrointestinal inflammation 
 
I.2.1 The role of enterocytes in the immune responses of the GI tract 
Under normal situations, the immune responses maintain the intestinal mucosa in a 
state of 'controlled' inflammation, regulated by a delicate balance of pro-inflammatory and 
anti-inflammatory cytokines, to maintain intestinal homeostasis (Fiocchi, 2003). This is not 
surprising due to the fact that the intestinal mucosa is constantly exposed to limitless 
number of foreign antigens (e.g. commensal microbes, pathogenic bacteria, viruses and 
food-derived materials). Directly below the epithelium, numerous immune cells create a 
homeostasis between the commensal flora of the intestine and the host immune system.  
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Fig. I.8 Intact versus leaky intestinal barrier: When the intestinal barrier is functioning correctly, luminal 
bacteria and antigens are unlikely to pass across the epithelium into the lamina propria. In contrast, disruption 
of the intestinal barrier due to cell death leads to increased epithelial permeability (AMPs: antimicrobial 
peptides; adapted from Coskun, 2014). 
 
The innate immune system is well orchestrated by various pattern recognition receptors 
(PRRs) and immune cells. The Toll-like receptors (TLRs) and nucleotide-binding 
oligomerization domain (NOD)-like receptors (NLRs) play a key role in the innate gut 
immunity as they recognize the common structures on microorganisms called the pathogen-
associated molecular patterns (PAMPs). TLRs are widely present on the epithelial cells, 
Paneth cells, mɸ and DCs (Taniguchi et al., 2009; Garrett et al., 2010; Wells et al., 2010). The 
responsiveness of these cells to PRR ligands is tightly regulated in order to avoid exceeding 
response to commensal products. Polymorphonuclear leukocytes (PMNs; neutrophils), mɸ, 
DCs, T-cells and mast cells are the important team players in maintaining immunological 
homeostasis and host defense in the gut. The highly regulated immune responses by 
different epithelial and immune cells result in the induction and maintenance of intestinal 
homeostasis. However, defects in this equilibrium can disrupt the homeostatic mechanisms 
and lead to pathogenic intestinal inflammation. Damage and death of the epithelial cells lead 
to the breakdown of the intact barrier function resulting in access of luminal content to the 
immune components of the intestinal wall leading to a state of “uncontrolled” inflammation. 
The innate immune system of the intestine plays a vital role in initiating and perpetuating 
this “uncontrolled” inflammation (Fig. I.9). 
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Fig. I.9 The intestinal immune reaction to epithelial barrier disruption. Epithelial cell death in barrier tissues 
can cause barrier disruption, allowing commensal or environmental microbes to invade the tissue. Recognition 
of microbial pathogen-associated molecular patterns (PAMPs) by Toll-like receptors (TLRs) on IECs, and pattern 
recognition receptors on dendritic cells and macrophages induces the expression of cytokines and chemokines 
that attract and activate immune cells resulting in inflammation. The cytokine tumor necrosis factor (TNF) 
binds to its receptor TNFR to initiate inflammatory signaling. 
 
In order to fight invading pathogens, epithelial cells can recognize PAMPs by means 
of TLRs. Binding of PAMP to TLR can activate several downstream inflammatory signals such 
as NF-κB, leading to an upregulation of inflammatory cytokines like TNF-α and interleukin 
(IL)-6, and chemokines like IL-8 and monocyte chemoattractant protein (MCP)-1 (Medzhitov 
et al., 1997). Thus, the redox-dependent transcription factor NF-κB in IECs plays a pivotal 
role as a regulator of pro-inflammatory genes involved in the onset of the mucosal 
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inflammatory response following microbial infection (Savkovic et al., 1997; Elewaut et al., 
1999). Amongst others, TNF-α is a master orchestrator of inflammation in the intestine 
binding to its receptor TNFR to initiate inflammatory signaling (Dagenais et al., 2014). Upon 
cytokine secretion, neutrophils circulating in the capillaries of the lamina propria can 
become activated and migrate towards the site of inflammation. Simultaneously, neutrophil 
production is upregulated and neutrophil lifetime increases. The neutrophilic cytosol 
contains granules that are filled with a variety of proteins, such as defensins, 
bactericidal/permeability-increasing protein, proteases (e.g. elastase, cathepsins) and 
myeloperoxidase (MPO). Neutrophils are well known for their bactericidal role with 
formation of superoxide anion radicals (O2) as one of the main bactericidal mechanisms 
(Klebanoff, 1967; Babior et al., 1973; Klebanoff & Rosen, 1978). Neutrophils can cause 
pathogen destruction upon the so-called “oxidative burst”, marked by an increased 
consumption of molecular oxygen (O2) and production of ROS and reactive nitrogen species 
(RNS) (Babior, 2000). O2 generation by neutrophils is catalyzed by nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase (NOX), a membrane-bound enzyme complex 
(Suzuki & Lehrer, 1980). O2 are dismutated into hydrogen peroxide (H2O2) by superoxide 
dismutase (SOD). MPO consumes H2O2 and generates hypochlorous acid (HOCl), the most 
bactericidal oxidant that is produced by neutrophils (Hampton et al., 1998; Nauseef, 2007; 
Freitas et al., 2009). 
In addition to the barrier dysfunction resulting in aberrant recognition of microbial 
products by the immune cells, death of IECs in the absence of pathogens can trigger 
intestinal inflammation. Inflammation as a result of trauma, burn, ischemia/reperfusion (I/R) 
injury or chemically induced injury typically occurs in the absence of any microorganisms and 
has therefore been termed “sterile inflammation”. In such a “sterile” setting, any stressed or 
injured cells release or expose certain molecules and cellular components into the 
extracellular environment that act as danger signals to alert the immune system to directly 
trigger inflammation. Such released factors are collectively called as damage-associated 
molecular patterns (DAMPs). DAMPs include, amongst others, cytokines (mainly of the 
interleukin family like IL-1β), heat-shock proteins, mitochondrial deoxyribonucleic acid 
(DNA), formyl peptides, cytochrome c and extracellular adenosine triphosphate (ATP). 
DAMPs are usually detected by PRRs that activate immune responses by inducing the 
expression of cytokines and chemokines by epithelial cells like IECs. Thus, apart from a 
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pathogen-triggered immunogenic response, in the absence of pathogens, cells can trigger 
inflammation through release of DAMPs. 
 
I.2.2 Oxidative stress 
 
I.2.2.1 ROS 
Oxidative stress is described as an imbalance between oxidants and antioxidants in 
favor of the oxidants, which can result in cell or tissue damage (Sies, 1997). In healthy 
conditions, formation of oxidants is balanced by the presence of a variety of antioxidants. 
Oxidants can be generated by the reduction of O2 to water (H2O), leading to the formation of 
ROS. ROS are intracellular chemical species that are formed upon partial reduction of O2, 
which include O2, H2O2 and the hydroxyl radical (OH). Furthermore, free radicals, in 
general, are also considered as oxidants. Free radicals are molecules or molecular fragments 
that possess one or more unpaired electrons, which are responsible for the high reactivity of 
the radical. Free radicals can be charged positively or negatively or be electrically neutral. 
They are formed from a normal molecule by either homolytic cleavage of a covalent bond, 
requiring high energy input (e.g. ultrasound, ultraviolet radiation), or addition or loss of a 
single electron. In biological processes, the electron transfer plays a major role in the 
generation of free radicals, as it can be initiated by enzymatic reactions (Slater, 1984; 
Cheeseman & Slater, 1993). In healthy conditions, oxidant formation is scavenged by various 
antioxidant mechanisms in the cell. The main antioxidant enzymes are SOD, catalase and 
glutathione peroxidase (GPx). Moreover, reduced glutathione (GSH; L-γ-glutamyl-L-cysteinyl-
glycine), a tripeptide containing a thiol group, is an important intracellular antioxidant. 
O2 is a primary ROS generated by the one-electron reduction of O2 and is a short-
living radical (Fig. I.10). 
Either spontaneously or through catalysis by SOD, O2 are dismutated into H2O2, which is 
relatively stable, less toxic and capable of diffusion across membranes: 
2O2
− + 2H+ → O2 + H2O2 
O2 in the cytosolic and mitochondrial matrix are dismutated by Cu/Zn-SOD (SOD1) and Mn-
SOD (SOD2), respectively. 
The formed H2O2 leads to the generation of hydroxyl radicals (OH) in the presence of 
ferrous iron (Fe2+) through the Fenton reaction: 
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Fe2+ +  H2O2 →  Fe
3+ +  OH +  OH− 
OH is a very short-lived and highly reactive radical which attacks the fatty acid side chains of 
the membrane phospholipids (called lipid peroxidation) to cause cell disruption. The risk of 
formation of OH from H2O2 is reduced by GPx and catalase. 
GPx are a class of enzymes involved in the catalytic degradation of H2O2 using GSH as a 
substrate where it is oxidized to glutathione disulfide (GSSG), resulting in the formation of 
water: 
H2O2 + 2GSH → 2H2O + GSSG 
Subsequently, GSH is recovered by GSSG reductase (Sies, 1997, 1999). Determination of the 
changes in intracellular GSH content and the GSH/GSSG ratio is a widely used marker for 
cellular response to oxidative stress. 
Additionally, H2O2 can also be degraded into water and molecular oxygen by catalase: 
2H2O2 → O2 + 2H2O 
A considerable part of H2O2 formed is consumed by MPO in the neutrophils, for the 
formation of HOCl, a highly bactericidal oxidant, used for the phagocytic defense: 
Cl− + H2O2 → HOCl + OH
− 
Furthermore, neutrophils and, more importantly macrophages, are capable of producing 
RNS, especially nitric oxide (NO), via the inducible nitric oxide synthase (iNOS) by 
consumption of NADPH and conversion of L-arginine to L-citrulline: 
L­arginine + O2 + NADPH → NO
 + L­citrulline + NADP+ 
The resulting NO can further react with O2 to generate the highly mutagenic and cytotoxic 
peroxynitrite anion (ONOO): 
NO + O2
− → ONOO− 
Once considered as a deleterious by-product of respiration in mitochondria and cell 
metabolism, ROS are now increasingly realized to be essential “second messengers” for a 
myriad of biological responses like cell growth, differentiation and host defense (Forman et 
al., 2010; Vara & Pula, 2014). The distinct biological properties of each ROS like their 
chemical reactivity, stability and lipid diffusion capabilities determine specificity of their 
signaling (Reczek & Chandel, 2015). ROS could contribute to cell-survival or cell-death 
pathways, depending on both the site and the amount of ROS generation (Azad et al., 2009). 
However, increased levels of ROS with compromised antioxidant defense (and hence  
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Fig. I.10   Enzymes involved in the generation and inactivation of reactive oxygen species (ROS). The superoxide 
anion (O2) can be produced by NADPH oxidase (NOX), xanthine oxidase, uncoupled endothelial nitric oxide 
synthase (eNOS), and the leakage of activated oxygen (O2) from mitochondria during respiration. O2 can be 
converted to hydrogen peroxide (H2O2) by the enzyme superoxide dismutase (SOD). H2O2 can undergo 
spontaneous conversion to the hydroxyl radical (OH) via the Fenton reaction. H2O2 can be detoxified by 
glutathione (GSH) peroxidase and catalase to H2O and O2. Myeloperoxidase (MPO) can use H2O2 to oxidize 
chloride to the strong oxidizing agent hypochlorous acid (HOCl). 
 
oxidative stress) are often associated with many pathological conditions of all organ systems 
(including GI) and aging. 
Indeed, higher levels of ROS damage almost all components of the cells including 
lipids, proteins and DNA resulting in lipid peroxidation, protein oxidation and nucleic acid 
oxidation with DNA damage, respectively. At the cellular level, the transcriptional factor 
nuclear factor erythroid 2-related factor 2 (Nrf2) is considered as a master regulator of 
antioxidant genes and hence of antioxidant status (Copple, 2012). 
The major sources of ROS in a cell include the NOXs and the mitochondrial electron 
transport chain (ETC) where O2 is formed as the main product and by-product, 
respectively. Other enzyme systems that generate ROS are xanthine-xanthine oxidase (XO), 
uncoupled endothelial nitric oxide synthase (eNOS), cyclo-oxygenase (COX), lipoxygenase, 
glucose oxidase and cytochrome P450 oxidases. 
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I.2.2.2 NOXs 
NOXs are a family of enzymes solely devoted to the production of O2 in cells and tissues. 
There are seven members in the NOX family – NOX1-5 and dual oxidase (DUOX)1-2 (Bedard 
& Krause, 2007). The first member, now known as NOX2, was initially discovered in 
neutrophils, but NOXs are now known to be present in many other cell types including 
epithelial cells (Bedard & Krause, 2007). NOX1 and DUOX2 are the NOX isozymes expressed 
in the IECs (Lambeth, 2004). They are multi-subunit membrane-bound enzyme complexes 
that, upon assembly in activated cells, catalyze the reduction of O2 to O2 using NADPH. 
NOX are present in the plasma membrane and in the membranes of intracellular vesicles and 
organelles. Various subunits that are located in the cytosol and in the membrane assemble 
to form the active NOX enzyme. The catalytic subunit of the predominantly expressed NOX2 
is gp91phox, a 91-kDa glycoprotein subunit; the active enzyme complex is formed by the 
association of the regulatory subunit p22phox with the four other cytosolic subunits: 
p40phox, p47phox, p67phox and the guanosine triphosphate hydrolase (GTPase) Rac (Fig. 
I.11). The small G-protein Rac, in its GDP-bound form, is stabilized by Rho GDP dissociation 
inhibitor (RhoGDI) in the resting state. Binding of ligands to the membrane-bound receptors 
adjacent to NOX enzyme generally initiates the activation cascade of complexes; the ligands 
include lipopolysaccharide (LPS), cytokines like TNF, growth factors, increased glucose and 
free fatty acids. Upon activation, the cytosolic subunits migrate towards the membrane-
bound subunits to bind and configure the active enzyme complex. NOX-derived ROS has 
been implicated in a wide array of cellular and molecular functions like cell proliferation, 
migration, angiogenesis and apoptosis. 
 
I.2.2.3 Mitochondria as cellular sources of ROS 
Mitochondria produce O2 as an unavoidable byproduct of aerobic respiration when 
electron transfer occurs through the different ETC complexes I through V (Fig. I.12). At least 
seven distinct sites of mitochondrial O2 production have been described in the 
mitochondria (Brand, 2010), but only the major sites are shown in Fig. I.12. During normal 
physiological conditions, complexes I and III are the major sites of O2 production (Turrens & 
Boveris, 1980). During pathological conditions, complex II can also participate in O2 
production by reverse electron transfer (Drose, 2013). Except for complex II, all other ETC 
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Fig. I.11   Diagrammatic representation of the resting and activated forms of NADPH oxidase2 (NOX2) upon 
exposure to ligands from microbes (e.g. LPS) and inflammatory mediators (e.g. TNF). Activation involves 
translocation of the cytosolic subunits p47phox, p67phox, p40phox and Rac to the membrane where they bind 
to p22phox and gp91phox subunits. The Rac protein bound to Rho GDP dissociation inhibitor (RhoGDI) in the 
resting state translocates to the membrane upon activation. When assembled, the enzyme generates 
superoxide anion (O2) by accepting electrons (e−) from cytoplasmic NADPH and donating them to molecular 
oxygen (O2). (Adapted from McCann & Roulston, 2013). 
 
complexes pump protons from the matrix into the intermembrane space, resulting in a 
proton gradient generating the mitochondrial membrane potential (Ψm). Ψm is utilized by 
complex V (ATP synthase) to synthesize ATP from ADP and phosphate, through the backflow 
of protons from the mitochondrial intermembrane space to the matrix. ROS production from 
mitochondria depends upon the availability of the substrates, type of tissue, redox state of 
the cells, animal species and age (Kudin et al., 2008). 
Recent reports suggest that activation of NOXs may increase production of mitochondrial 
ROS and vice versa, i.e., increase of mitochondrial ROS may activate NOXs (Daiber, 2010; 
Dikalov, 2011). Accordingly, NOX derived O2 and H2O2 were reported to trigger 
mitochondrial dysfunction and ROS formation in angiotensin-II treated endothelial cells 
(Doughan et al., 2008). Mitochondria are not only a target for ROS produced by NOXs but 
also a significant source of ROS, which under certain conditions (like serum withdrawal)  
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Fig. I.12   The mitochondrial respiratory chain (which carries out oxidative phosphorylation) with its five multi-
subunit protein complexes (I-V) localized at the inner mitochondrial membrane. Electrons are prematurely 
leaked from the electron transport chain and are aberrantly transferred to molecular oxygen (O2) resulting in 
mitochondrial O2 generation, occurring at complexes I, II and III. Complex III can generate O2 in the 
intermembrane space as well as into the matrix. O2 can escape from the intermembrane space into the 
cytoplasm via voltage dependent anion channels (VDAC); in the cytoplasm O2 are subsequently dismutated to 
H2O2 by SOD1. O2 generated into the matrix are dismutated by SOD2 (adapted from West et al., 2011). 
 
 
may stimulate NOXs (Kimura et al., 2005; Lee et al., 2006). This crosstalk between 
mitochondria and NOXs, therefore, may represent a feed-forward vicious cycle of ROS 
production which can be pharmacologically targeted under conditions of oxidative stress. 
Indeed, a mitochondria-targeted antioxidant has been demonstrated to break this vicious 
cycle, inhibiting ROS production by mitochondria, in this way reducing NOX activity (Dikalov 
et al., 2010). 
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I.2.3 Pathogenesis of acute GI inflammation: role of IEC dysfunction 
Epithelial barrier dysfunction is a common phenomenon observed during several 
acute GI inflammatory conditions. Acute GI inflammatory conditions include, amongst 
others, acute gastroenteritis (of bacterial and viral origin), postoperative ileus (POI), sepsis 
and septic ileus, necrotizing enterocolitis (NEC), appendicitis, pancreatitis and ischemic 
bowel disease. Two of these conditions are considered in detail. 1) POI as the occurrence of 
an inflammatory process in the GI wall in the first hours after intestinal manipulation is the 
main trigger for sustained suppression of GI motility; oxidative stress, also in the mucosal 
layer, might contribute to the pathogenesis. 2) Sepsis, where inflammation and oxidative 
stress are important pathogenetic factors and the intestine can have a triggering role, also 
leading to septic ileus. As intestinal I/R injury is involved in the triggering role of the intestine 
during sepsis, this pathogenetic complex is also discussed. 
 
I.2.3.1 POI 
POI is defined as a transient impairment of gastrointestinal motility after major 
abdominal surgery; it lasts 2 to 4 days until the first passage of flatus or stool combined with 
adequate oral intake during 24 h. Patients suffer from abdominal discomfort, nausea and 
vomiting. POI can delay postoperative recovery, increase the length of hospital stay and can 
induce morbidity; the economic impact of POI has been estimated at $750 million per year 
(Doorly & Senagore, 2012). The pathogenesis of POI is multifactorial; neurogenic inhibitory 
reflexes, inflammatory responses and pharmacological factors are three main mechanisms 
known to contribute to POI (Bauer & Boeckxstaens, 2004). In the first hours after surgery, 
inhibition of GI motility is mainly due to activation of reflex inhibitory nervous pathways 
(Bauer & Boeckxstaens, 2004; Boeckxstaens & de Jonge, 2009). The prolongation of GI 
motility suppression during POI is due to a complex immune-regulated inflammatory process 
in the intestinal muscularis, with a critical role for activation of the resident muscularis 
macrophage network (Kalff et al., 1999). The kinetically active substances NO (via iNOS) and 
prostaglandins (via COX-2) are released, as well as pro-inflammatory cytokines such as IL-1β, 
IL-6 and TNF-α, chemokines (MCP-1) and adhesion molecules like intercellular adhesion 
molecule (ICAM)-1. This leads to additional recruitment of circulating leukocytes and further 
release of inflammatory mediators (Boeckxstaens & de Jonge, 2009). Interestingly, oxidative 
stress might also contribute to POI. Surgical manipulation of the rat intestine resulted in 
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increased levels of oxidative stress in the mucosa with a significant increase in xanthine 
oxidase activity in the enterocytes (Anup et al., 1999). In addition, in a mouse model of POI, 
our group previously reported an increase in oxidative stress levels, measured as 
malondialdehyde (MDA; a by-product of lipid peroxidation) in both mucosa and muscularis 
of small intestine starting shortly after intestinal manipulation; the increase at 1 h after 
manipulation was more pronounced in the mucosa than in the muscular layer (De Backer et 
al., 2009). 
 
I.2.3.2 Sepsis and septic ileus 
Sepsis is defined as a systemic inflammatory response to infection (systemic 
inflammatory response syndrome; SIRS), which can progress to severe sepsis with multiple 
organ failure (MOF) and further to septic shock with acute circulatory failure and refractory 
hypotension. It is a frequent cause of mortality in intensive care. Sepsis is driven by a 
complex cascade of events, initiated by bacteria-derived molecules such as LPS or 
endotoxins with subsequent formation of inflammatory cytokines, ROS and RNS, I/R and 
mitochondrial dysfunction (Cinel & Opal, 2009). The intestine is very vulnerable during 
systemic inflammation and can trigger and perpetuate sepsis (Clark & Coopersmith, 2007). 
Conditions such as major trauma, extensive burns and hypovolemia lead to I/R of the 
intestine, triggering an intestinal inflammatory reaction and intestinal epithelial barrier 
dysfunction (Magnotti et al., 1998; de Haan et al., 2009; Flessas et al., 2011). Pro-
inflammatory mediators produced in the intestine also reach the systemic circulation, 
promoting systemic inflammation. Dysfunction of the epithelial barrier allows translocation 
of live bacteria and/or their components such as LPS through the intestinal mucosa, further 
reaching the circulation via the intestinal lymph nodes. The intestinal events are 
accompanied by severe impairment of intestinal motility (septic ileus), promoting bacterial 
colonization of the normally sterile small intestine and stomach; this will facilitate bacterial 
translocation and predisposes to pneumonia by aspiration of gastric content (Hassoun et al., 
2001; Deitch, 2002; Balzan et al., 2007). Animal models of sepsis consist of administration of 
LPS or bacteria, or cecal ligation and puncture (CLP) (De Winter & De Man, 2010). The 
mechanism of sepsis-induced ileus, as assessed by injecting LPS, shows similarity with that of 
the inflammatory phase of POI (Eskandari et al., 1997), although differences in the degree of 
particular responses were observed when comparing animals with a similar degree of transit 
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retardation, induced either by surgical intestinal manipulation or by intraperitoneal injection 
of LPS. The POI model induced a greater inflammatory response and a greater degree of 
leukocyte infiltration (Schmidt et al., 2012). IEC apoptosis is reported to increase following 
sepsis and overexpression of the anti-apoptotic protein Bcl-2 improved survival in multiple 
animal models of sepsis by prevention of intestinal apoptosis (Coopersmith et al., 2002a; 
Coopersmith et al., 2002b). 
 
I.2.3.3 Acute I/R injury of the gut 
I/R injury occurs due to the re-entry of the blood flow after interrupted blood supply 
for a time period, where the delivery of oxygen to the tissue was insufficient to support its 
metabolic demand. The reintroduction of blood flow with simultaneous re-oxygenation of 
the tissue after an ischemic episode initiates a cascade of events that can potentially worsen 
the original injury. The intestinal mucosa is extremely sensitive to I/R resulting in tissue 
edema and fluid movement into the intestinal lumen. Intestinal oxygen delivery can be 
impaired by both systemic and local vascular conditions. I/R injury of the gut is a significant 
problem in a variety of clinical conditions such as SIRS and MOF, small bowel 
transplantation, abdominal aortic aneurysm surgery, mesenteric artery occlusion, 
cardiopulmonary bypass, trauma and hemorrhagic shock (Collard & Gelman, 2001); this is 
associated with substantial morbidity and mortality (Grootjans et al., 2010). Intestinal I/R 
injury is a complex, multifactorial pathophysiological process; primary microcirculatory flow 
disturbances, caused by ROS production, lead to a subsequent inflammatory cascade. Tissue 
ischemia (leading to hypoxia) and oxidative stress increase expression of inflammatory genes 
like cytokines (e.g. TNF-α, IL-1β, IL-6), iNOS, prostaglandins and adhesion molecules [e.g. 
ICAM-1, vascular cell adhesion molecule (VCAM)-1, E-selectin], initiating local inflammation. 
The recruitment of circulating neutrophils at this initial site further amplifies the intensity of 
inflammation and neutrophil infiltration is one of the characteristic microvascular alterations 
noted with I/R injury. In addition, the widespread endothelial cell apoptosis and the loss of 
endothelial cells in the vessels supplying the intestine result in thrombosis directly in the 
intestine (Shah et al., 1997). This injury can further trigger a systemic inflammatory response 
in distant organs resulting in MOF (Turnage et al., 1994; Cuzzocrea et al., 2002; Ceppa et al., 
2003). I/R injury of the gut is associated with the breakdown of intestinal barrier function, 
which facilitates increased intestinal permeability and bacterial translocation into the portal 
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and systemic circulation leading to SIRS (Collard & Gelman, 2001; Fink & Delude, 2005). 
Apoptosis is reported as the major mode of IEC death caused by I/R injury in the small 
intestine (Ikeda et al., 1998; Liu et al., 2008; Wen et al., 2012). Experimental animal models 
of intestinal I/R injury suggest that ROS production during the reperfusion period is largely 
responsible for the injury (Gonzalez et al., 2015). Already in 1986, XO-derived O2 was 
reported to initiate intestinal reperfusion injury (Grisham et al., 1986) (Fig. I.13). The 
presence of a higher concentration of XO in the small intestine makes it more susceptible to 
I/R injury than colon (van der Vliet et al., 1989). Recently, rats subjected to intestinal I/R 
injury were reported to show an increase in gp91phox and p47phox protein expressions in 
small intestinal mucosa suggesting a possible contribution of NOX-derived ROS during I/R 
injury (Gan et al., 2013). To the best of our knowledge, to date, no study is available in the 
literature investigating the involvement of mitochondria-derived ROS in intestinal I/R injury. 
Supplementation with antioxidants was reported to reduce I/R injury-induced mucosal 
damage in many animal studies (Mallick et al., 2004). 
 
I. 3 Treatment of POI and sepsis; the intestinal mucosa as treatment target 
 
I.3.1 Management of POI and sepsis in humans 
 
Management of POI for humans: Prevention or treatment of POI remains mainly supportive 
as no single treatment is available. Due to its multifactorial origin, treating POI generally 
consists of a multimodal approach, also called as fast-track-surgery. This approach includes 
minimally invasive laparoscopy, epidural local anesthetics, and early enteral feeding and 
mobilization (Kehlet, 2008). The fast-track approach has shown to reduce complications, 
accelerate recovery and reduce hospital stay. Other management strategies proposed to 
reduce POI are use of opioid receptor antagonists, opioid free analgesia (NSAIDs), laxatives, 
chewing gum, fluid restriction and avoidance of nasogastric tube feeding (Bauer & 
Boeckxstaens, 2004; Asgeirsson et al., 2010; Vather & Bissett, 2013) (Table I.1). 
 
Management of sepsis for humans: Sepsis is a complex phenomenon characterized by the 
non-specific nature of signs and symptoms to diagnose it. There are no approved drugs that 
specifically target sepsis. So, in addition to life supportive measures, other steps should be 
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Fig. I.13   Mechanism of XO-mediated free radical injury. During the ischemic episode, ATP is catabolized to 
hypoxanthine, which accumulates in the tissues. This results in a low energy state leading to an influx of Ca2+ 
into the cells. The intracellular Ca2+ then triggers the conversion of xanthine dehydrogenase (XDH) to XO via a 
calmodulin-regulated protease. Upon reperfusion, O2 is reintroduced into the tissues and interacts with XO and 
hypoxanthine to generate a burst of O2 and H2O2, which, in their turn, interact to produce the more reactive 
OH. This results in recruitment and activation of granulocytes, which ultimately mediate reperfusion-induced 
microvascular injury (adapted from Granger et al., 1988). 
 
taken depending upon the severity of the clinical condition. However, the difference 
between sepsis, severe sepsis and septic shock is not easily detected in clinical practice. The 
most prominent therapeutic approach for sepsis treatment till date is early goal-directed 
therapy (EGDT) for sepsis (Daniels, 2011). This approach involves screening patients who are 
at high risk for developing sepsis by monitoring certain hemodynamic and physiologic 
parameters intensively (i.e., blood pressure, heart rate and respiratory rate) and 
administering aggressive treatment (i.e., fluids or vasopressor) within the early hours of 
potential treatment (called the “golden hours”) to maintain or restore the patient’s vitals 
back to optimal functioning before the syndrome progresses to a worsened state (Rivers et 
al., 2001). In addition, early administration of appropriate antibiotic therapy together with 
identifying the causative infectious agents (source control) are the other treatment  
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Table I.1 Management of POI by non-pharmacological and pharmacological treatment options 
(adapted from Behm & Stollman, 2003; Vather & Bissett, 2013). 
 
Non-pharmacological treatment options  
Treatment Potential mechanism 
Early enteral nutrition 
(or gum chewing) 
 
Early mobilization 
 
Laparoscopic surgery 
 
 
Stimulates GI motility by eliciting reflex response and 
stimulating release of several hormonal factors 
 
Possible mechanical stimulation 
 
Decreased opiate requirements, decreased pain, less 
abdominal wall trauma 
 
Pharmacological treatment options  
Treatment Potential mechanism 
Laxatives/prokinetic agents 
 
Opiate antagonists 
 
Epidural anesthesia 
 
 
NSAIDs 
 
 
Multimodal therapy 
 
 
Stimulant, prokinetic effects 
 
Block peripheral opiate receptors 
 
Inhibits sympathetic reflex at cord level, opioid-sparing 
analgesia 
 
Opioid-sparing analgesia, inhibits COX-mediated prostaglandin 
synthesis 
 
Combination therapy may work via multiple mechanisms 
 
 
approaches upon a patient’s presentation to the emergency department (Balk, 2004; Green 
& Gorman, 2014). Other treatment strategies for the management of sepsis include surgical 
drainage of infected site, optimizing O2 delivery to patients with lactic acidosis, use of low 
dose corticosteroid, targeted immunological therapy, glycemic control, appropriate nutrition 
and effective supportive therapy (Patel et al., 2003; Skrupky et al., 2011). 
 
I.3.2 Oxidative stress in the intestinal mucosa as treatment target 
The onset of an earlier oxidative burst in the mucosal layer than in the muscular layer 
after intestinal manipulation in a murine model of POI, reported by our group (De Backer et 
al., 2009) suggests that the mucosal layer might not only be a victim but also a (co-)trigger of 
surgically induced intestinal inflammation. Moreover, during SIRS, increase in gut mucosal 
permeability and bacterial translocation due to compromised epithelial barrier function can 
result in further progression of sepsis; this underlines the significance of intestinal mucosal 
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layer. Given the vital role of the intestinal mucosa in the pathogenesis of both POI and 
sepsis, strategies targeting towards protection of the mucosal layer could provide effective 
treatment for these acute GI inflammatory conditions. 
As oxidative stress has been implicated in both POI and intestinal dysfunction during 
sepsis, induction of antioxidant enzymes aimed to increase the antioxidant defense of the 
intestinal mucosa could be one of the ideal therapeutic strategies to combat such disorders. 
Among the set of antioxidant genes induced during stress in cells and tissues, heme 
oxygenase (HO)-1 has been emerging as a novel therapeutic target in the last few decades; it 
exerts an adaptive response to a wide range of injurious stimuli (Bauer et al., 2008; Agarwal 
& Bolisetty, 2013) implicated in many disease conditions (Deshane et al., 2005) including GI 
diseases (Naito et al., 2011). An ever-increasing list of compounds (including natural 
products and synthetic small molecules) known to induce HO-1 expression show therapeutic 
benefits during various disease conditions (Li et al., 2007; Abraham & Kappas, 2008; 
Motterlini & Foresti, 2014). Amongst them, the plant polyphenol resveratrol, in addition to 
its ability to induce HO-1, has gained much attention due to its diverse therapeutic potential 
in various diseases attributed to its antioxidant and anti-inflammatory properties (discussed 
in section I.3.4). 
 
I.3.3 The HO-1/carbon monoxide (CO) system; effects in POI and sepsis 
HO is the rate-limiting enzyme in the catabolism of heme resulting in the generation 
of CO gas, Fe2+ and biliverdin, the latter being subsequently reduced to bilirubin by the 
biliverdin reductase (BVR) enzyme. Originally thought of as a mechanism that only serves to 
dispose of heme, it is now clear that the products of heme metabolism have important 
functions under physiological and pathophysiological conditions. Three isoforms of HO have 
been identified, but there are doubts whether HO-3 has a functional role as it was never 
convincingly reported at the protein level (Hayashi et al., 2004; Wu & Wang, 2005). HO-1 is 
the inducible isoform while HO-2 is constitutive. Low levels of HO-1 is expressed in normal GI 
tract (Coeffier et al., 2002; Barton et al., 2003). HO-2 is present in enteric neurons (Miller et 
al., 2001; Colpaert et al., 2002), but also in non-neuronal cells in particular interstitial cells of 
Cajal (Grozdanovic & Gossrau, 1996; Miller et al., 1998). 
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I.3.3.1 Protective effects of HO-1 induction 
HO-1 is induced by a variety of physical and chemical stressors including heme, 
endotoxin, UV irradiation, heat shock and hemorrhagic shock, all sharing the ability to cause 
oxidative stress (Maines, 1997). Since the first report showing that HO-1 induction crucially 
controls inflammation in a model of carrageenan-induced pleurisy in rats (Willis et al., 1996), 
evidence has accumulated that induction of HO-1 is a fundamental adaptive response to 
oxidative stress and acute inflammation (Bauer et al., 2008), providing antioxidant, anti-
inflammatory and cytoprotective effects. The homeostatic role of HO-1 induction in 
mitigating the inflammatory response makes sense since ROS are indeed involved in the 
initiation and progression of inflammation (Mittal et al., 2014). Possible mechanisms include 
activation of TLRs and the Nacht domain-, Leucine-rich repeat-, and PYD-containing protein 
(Nalp)-3 inflammasome (Cannizzo et al., 2011) and formation of ONOO by rapid 
combination of O2 with NO (Mittal et al., 2014). In the GI tract, expression of HO-1 is 
increased in many experimental models such as intraperitoneal (i.p.) treatment with LPS 
(Otani et al., 2000), intracolonic administration of trinitrobenzene sulfonic acid (Wang et al., 
2001) and surgical intestinal manipulation (De Backer et al., 2009). In patients with IBD, it 
was found that macrophages and epithelial cells of colonic mucosa exhibit an increased 
expression of HO-1 although levels of this protein decreased in the case of high 
inflammatory activity (Paul et al., 2005). Induction of HO-1 by exogenously administered 
hemin reduces GI inflammation and tissue injury (Attuwaybi et al., 2004; Zhong et al., 2010; 
Yoriki et al., 2013). HO-1 induction was also shown to mediate the protective effects of the 
amino acid glutamine in the GI tract (Uehara et al., 2005; Giris et al., 2006; Giris et al., 2007) 
and to be a mechanism of action of 5-aminosalicylic acid, a classic agent used for the 
treatment of IBD (Whittle & Varga, 2010). Similar to what has been proposed for the nervous 
and cardiovascular systems, this opens the possibility of exploiting the HO-1 pathway as a 
therapeutic target for GI inflammation. 
 
I.3.3.2 Role of the by-products of HO-1 
The antioxidant and anti-inflammatory effects of HO-1 induction are related to the 
breakdown of heme, which is known for its pro-oxidant and cytotoxic properties, and to a 
concerted action of the three products of heme metabolism namely Fe2+, biliverdin and CO 
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(Ryter & Choi, 2009). These emerging findings led gradually to the investigation of the 
biological effects and possible pharmacological application of each single by-product of  
HO-1. First of all, free Fe2+ could be expected to act as a pro-oxidant through the generation 
of OH in the Fenton reaction. However, induction of HO-1 is accompanied by a concomitant 
up-regulation of ferritin (Nath et al., 1992; Ren et al., 2007), which sequesters Fe2+ and has 
antioxidant properties (Arosio et al., 2009). Additionally, an anti-apoptotic effect of heavy 
chain ferritin was shown in an I/R model of the liver (Berberat et al., 2003). Biliverdin is 
quickly reduced by BVR to bilirubin, which has been reported to act as potent intracellular 
antioxidant against lipid peroxidation (Stocker et al., 1987). Exogenous administration of 
nanomolar concentrations of bilirubin restored post-ischemic myocardial function and 
minimized infarct size similarly to induction of HO-1 by hemin, suggesting a primary role of 
bilirubin in HO-1-mediated tissue protection against reperfusion injury (Clark et al., 2000). 
Bilirubin also protects against I/R injury in the intestine, an effect that is associated with a 
decrease in intestinal lipid peroxidation products (Ceran et al., 2001; Hammerman et al., 
2002). In a Dutch study, Caucasian patients with Crohn’s disease, where oxidative stress is 
thought to contribute to the pathogenesis, significantly less often beared the uridine 5’-
diphospho-glucuronyltransferase (UGT) 1A1*28 homozygous genotype, the latter genotype 
being associated with Gilbert’s syndrome and increased bilirubin levels (de Vries et al., 
2012). Correspondingly, patients with Crohn’s disease showed significantly lower serum 
bilirubin levels compared to controls in a study in the Czech republic (Lenicek et al., 2014). 
Exogenous applications of bilirubin might thus be considered for the treatment of GI 
conditions where oxidative stress is involved. As biliverdin is rapidly reduced to bilirubin, 
exogenous administration of biliverdin was also attempted with success. In the GI tract, 
biliverdin attenuates transplantation-induced injury of the small bowel (Nakao et al., 2004) 
and ameliorates dextran sodium sulfate-induced colitis (Berberat et al., 2005). CO seems to 
contribute most significantly to the antioxidant, anti-inflammatory and cytoprotective 
effects of the HO-1 pathway (Motterlini & Otterbein, 2010) in line with early reports that 
exogenous CO mimicked the protective effects of HO-1 induction even under inhibition of 
HO-1 activity (Sato et al., 2001). This explains the recent efforts to exploit the use of CO as a 
therapeutic agent to mimic the inherent beneficial actions of the HO-1 pathway. 
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I.3.3.3 Mechanisms of action of CO 
The precise molecular mechanisms by which CO exerts its protective effects have not 
yet been fully elucidated. The major mechanisms of action that have been proposed, mainly 
on the basis of data in cell lines and non-GI tissue, are described below and each of them 
might after all be equally important, with one mechanism prevailing over the other(s) 
depending on the type of cell and/or tissue being considered. CO binds preferentially and 
with high affinity to transition metals, in particular to the reduced form of heme iron (Fe2+) 
present in hemoproteins like hemoglobin, soluble guanylate cyclase (sGC), COX, cytochrome 
p450, cytochrome c oxidase, NOS, and NOX (Estabrook et al., 1970; Dioum et al., 2002; 
Akamatsu et al., 2004; Roberts et al., 2004; Ryter & Otterbein, 2004; Boczkowski et al., 
2006). 
Activation of sGC/p38 mitogen-activated protein kinase (MAPK) by CO: CO is believed to 
act via activation of sGC, leading to an increase in intracellular cyclic guanosine 
monophosphate (cGMP). The inhibitory effect of CO on leukocyte adhesion in mesenteric 
venules and on neutrophil migration into the peritoneal cavity induced by carrageenan is 
counteracted by the sGC inhibitor 1H[1,2,4,]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) 
(Freitas et al., 2006). CO seems to modulate MAPK-related pathways (Ryter et al., 2006; Kim 
et al., 2007). Accordingly, the inhibitory effect of CO on LPS-stimulated macrophages was 
related to further enhancement of p38 MAPK expression (Otterbein et al., 2000) and the 
involvement of p38 MAPK activation in the beneficial effects of CO has since been reported 
in many models in vivo (Otterbein et al., 2003; Zhang et al., 2003; Kohmotoa et al., 2007). 
However, CO is unlikely to activate p38 MAPK directly as it lacks a transition metal centre in 
the protein structure that would function as a binding site for the gaseous molecule. Thus, 
the p38 MAPK activation by CO might be the result of another upstream target. 
Interaction of the HO-1/CO pathway with iNOS: In LPS-stimulated macrophages, CO 
decreased nitrite (marker of NO production) levels without changing iNOS protein 
expression (Sawle et al., 2005) suggesting that CO might inhibit iNOS activity. However, in 
the same model, Tsoyi et al., (2009) reported that CO is able to reduce iNOS expression, and 
this was also observed in LPS-treated human umbilical vein endothelial cells (Sun et al., 
2008). 
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Anti-/pro-oxidant effect of CO: Inhibition of NOX by CO, probably by binding to the heme-
containing gp91phox/NOX2 unit, was shown to be involved in the anti-inflammatory actions 
of CO in LPS-stimulated macrophages (Nakahira et al., 2006) and its anti-proliferative actions 
in human airway smooth muscle cells (Taille et al., 2005). The inhibitory effect of CO on 
vascular smooth muscle cell migration has been related to inhibition of NOX1 (Rodriguez et 
al., 2010). In contrast, binding of CO to cytochrome c oxidase (complex IV of the 
mitochondrial respiratory chain) was reported to result in a significant burst of 
mitochondrial ROS production and a concomitant conditioning of the cell with up-regulation 
of antioxidant and cytoprotective genes, which protects it upon subsequent stress 
stimulation (Bilban et al., 2008). Moreover, in a CLP model, CO induced a mild mitochondrial 
oxidative stress response in the heart which stimulated mitochondrial biogenesis and 
improved bioenergetics in association with a reduced inflammatory response (Lancel et al., 
2009). This was confirmed in a recent study performed in isolated rat heart mitochondria (Lo 
Iacono et al., 2011) showing that low micromolar concentrations of CO, probably by binding 
to cytochrome c oxidase and/or other unidentified targets in the respiratory chain, increase 
oxygen consumption and mitochondrial H2O2 production when physiologically stimulating 
the electron transfer chain with pyruvate/malate, but significantly decrease the burst of ROS 
induced by stimulating the reverse electron flow in mitochondria, a phenomenon that 
appears to typify oxidative and inflammatory disease states (Chen et al., 2007). The latter 
effect of CO limiting excessive mitochondrial ROS production was attributed to mild 
“uncoupling” of respiration from ATP synthesis by CO, with a drop in Ψm due to movement 
of protons from the intermembrane space to the mitochondrial matrix (Lo Iacono et al., 
2011). 
Induction of HO-1 by CO: The beneficial effects of CO might also be related, at least in some 
circumstances, to induction of HO-1 providing a positive feedback loop (CO→ induction of 
HO-1→ more CO→ further induction of HO-1) and allowing the ROS scavenging properties of 
biliverdin/bilirubin to come into play (Rodella et al., 2006). In human endothelial cells, CO 
induces HO-1 expression through a mechanism involving Nrf2 activation. This has been 
shown to be associated with upstream activation of PERK (protein kinase R-like endoplasmic 
reticulum kinase), one of the three endoplasmic reticulum stress sensors; this correlated 
with protection against endoplasmic reticulum stress-induced endothelial cell apoptosis (Kim 
et al., 2007). 
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I.3.3.4 Administration of CO as therapeutic agent 
CO gas: The recognition that HO-1-derived CO functions as a signaling and cytoprotective 
intracellular mediator prompted scientists to devise strategies to deliver CO safely for 
therapeutic purposes. CO administered as gas at doses that do not compromise the oxygen 
carrying capacity of hemoglobin (Hb) was firstly used in vivo to show that it protects against 
hyperoxic injury in rat lung (Otterbein et al., 1999). Since then, inhalation of CO gas at doses 
of 250 ppm (i.e., particles per million) for a short period of time has shown efficacy in many 
animal models of disease and devices for applying CO gas by inhalation in man have been 
developed (Motterlini & Otterbein, 2010). Recently, the distribution of CO upon CO 
inhalation was reported to be tissue-specific, with the increase in CO levels versus basal, 
immediately after inhalation of 250 ppm CO for 1 h in rats, ranging from 32-fold in spleen to 
2-fold in intestine (Vanova et al., 2014). Despite the fact that these recent findings 
emphasizing the potential use of CO gas as a therapeutic agent in pathophysiological states, 
the undesired effect of CO gas inhalation on the oxygen-carrying capacity of Hb is a crucial 
aspect that needs to be addressed before CO gas can be approved as a therapeutic agent. 
CO in preservation solution: In transplantation surgery, CO has also been proposed to be 
used ex vivo as an adjuvant to preservation solution in which organs are normally stored 
prior to grafting. Indeed, cold storage of rat intestinal grafts in University of Wisconsin 
solution vigorously bubbled with 5% CO for 5 min before transplantation in recipient animals 
has been reported to markedly reduce the up-regulation of inflammatory mediators and 
improve graft blood flow and mucosal barrier function (Nakao et al., 2006b). Similar data 
have been obtained for rat kidney and lung grafts (Kohmoto et al., 2008; Nakao et al., 2008) 
and for renal transplantation in pigs (Yoshida et al., 2010). In contact with air, the CO-
bubbled storage solution quickly loses CO by release into air, so that the CO-bubbled 
solution must be kept in a tightly sealed container without an air layer to keep the CO 
concentration constant (Kohmoto et al., 2008). 
CO-releasing molecules (CO-RMs): For this and other reasons, CO-RMs were developed to 
create the opportunity to deliver CO in a more practical, controllable and accurate way to 
the target site in comparison to CO gas inhalation. The most extensively studied CO-RMs 
today consist of two classes: 1) metal carbonyl complexes containing ruthenium, manganese 
Chapter I 
Literature survey 
 
50 
 
or molybdenum which carry CO bound to metals and 2) boranocarbonates, which do not 
contain transition metals and release CO spontaneously based on pH changes (Fig. I.14). 
While the original CO-RMs (CORM-1 and CORM-2) had to be dissolved in organic solvents 
like dimethyl sulfoxide (DMSO) (Motterlini et al., 2002), water-soluble CO-RMs such as 
CORM-A1 and CORM-3 have been subsequently developed with different CO release kinetics 
(Clark et al., 2003; Motterlini et al., 2005). 
In many animal models of inflammation, I/R injury and oxidative stress, these and 
other similar CO-RMs were shown to have beneficial effects similar to CO gas (Motterlini, 
2007; Motterlini & Otterbein, 2010). In the context of organ preservation, and similarly to 
what has been described with CO gas above, addition of CORM-A1 and CORM-3 during 
kidney cold storage markedly increased glomerular filtration rate, vascular activity and 
energy metabolism at reperfusion (Sandouka et al., 2006). Despite these agents need to be 
optimized and one has to keep in mind the possible toxicity originating from the molecule 
after release of CO especially when used chronically, CO-RMs offer a great opportunity in 
drug discovery as they diverge from classical organic drugs and represent one of the few 
examples where transition metals are used as scaffolds to deliver the active principle. For 
instance, a metal within the CO-RMs scaffold can be viewed as the “Achilles heel” in the 
development of these molecules to drugs, due to the common perception that transition 
metals per se can catalyze cytotoxic reactions. However, a great portion of structural and 
enzymatic proteins in cells contain transition metals, and several metal-handling proteins 
that protect cells against potentially toxic metal-based reactions are known, suggesting that 
biological tissues may be able to tolerate low levels of metal carbonyls (Foresti & Motterlini, 
2013). Interestingly, we are gradually learning that the transition metal in CO-RMs appears 
to be influential in transferring efficiently CO into the cells and limiting the potential toxic 
effects of free CO gas (Foresti & Motterlini, 2010; Michel et al., 2012). 
 
I.3.3.5 Toxicity of exogenous CO 
The interaction of CO with transition metals is central to the dichotomous nature 
(toxicity vs. beneficial effects) of this gaseous molecule. CO binds to Hb with a 200 to 250 
times higher affinity than O2 forming carbon monoxide-hemoglobin (COHb), that decreases 
the capacity of blood to deliver O2 to the tissues. The basal COHb level in man is 0.1 to 1%  
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Fig. I.14  Chemical structures and features of the first generation of CO-RMs (adapted from Foresti et al., 2008). 
 
in the absence of environmental contamination or smoking (Ryter & Choi, 2013). Toxicity 
symptoms can occur by COHb levels from 10% on (Von Burg, 1999). Using COHb levels as a 
marker, it was shown that the systemic amounts of CO upon exogenous CO administration 
must be of a much higher order than when stimulating endogenous CO production by HO-1 
induction (Foresti et al., 2008). In experimental studies with CO or CO-RMs, one thus usually 
attempts to keep COHb levels below 10%, levels that are also occasionally encountered in 
heavy smokers. Still, one can be reluctant to apply chronically CO or CO-RMs e.g. for 
treatment of IBD, in doses inducing COHb levels of 5-10%. Deleterious effects to the heart 
were indeed shown for chronic ambient CO levels as low as 30 ppm with peaks of 100 ppm 
(Andre et al., 2010; Reboul et al., 2012). Short term CO therapy should be devoid of such 
effects and can be expected to be easier acceptable for application in man. 
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I.3.3.6 Effect of CO in POI 
The preclinical studies investigating the influence of CO on the inflammatory phase of 
POI by manipulating the small intestine after laparotomy and measuring transit 24 h after 
surgery, are summarized in Table I.2. 
CO gas: Moore et al., (2003) reported that inhaled CO (250 ppm for 1 h before and for 24 h 
after surgery) in mice significantly improved the prolongation of transit induced by surgery, 
corresponding with improvement of the surgery-induced suppression of spontaneous and 
betanechol-induced activity in small intestinal circular muscle strips obtained 24 h after 
surgery. CO is known to relax GI smooth muscle in vitro, and might retard GI transit in vivo by 
this effect, but CO inhalation in control non-operated animals did not significantly influence 
transit. Surgery increased iNOS mRNA expression in the small intestinal muscular layer at 3 
and 6 h, and nitrite release in the culture medium of muscular material obtained 24 h after 
surgery; these effects were suppressed by CO inhalation, suggesting that CO might act by 
inhibiting iNOS gene expression as well as iNOS activity. Surgery also increased the mRNA 
expression of pro-inflammatory IL-1β, IL-6 and COX-2, and of anti-inflammatory IL-10 and 
HO-1; CO reduced IL-1β expression and further enhanced IL-10 and HO-1. This supports that 
the beneficial effects of CO are at least partially due to increased HO-1 expression. 
Interestingly, the increase in muscular leukocyte infiltration by surgery was not suppressed 
by CO. 
The same group (Moore et al., 2005) showed in rats that inhaling 250 ppm CO for 3 h 
before surgery was sufficient to fully reverse surgery-induced retardation in transit, even 75 
ppm being sufficient; this certainly means a more feasible schedule for testing in humans 
than prolonged inhalation. They also showed that 250 ppm for 3 h before surgery is effective 
in pigs that received repetitive opioid analgesia after surgery to mimic the human condition 
where the GI inhibitory effects of opioid analgesics also contribute to ileus. Blood COHb 
levels reached 6% just before surgery and progressively declined thereafter. Although CO 
inhalation suppressed the increase in total blood white cell count at 4 h after surgery, it did 
not suppress muscular leukocyte infiltration at 24 h, again suggesting that CO by inhalation is 
not able to inhibit additional leukocyte recruitment during the pathogenesis of POI. 
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Table I.2 Effects of CO on GI motility and on inflammatory parameters in the muscular layer in 
preclinical models of postoperative ileus. 
 
Reference 
Moore et al., 
2003 
Moore et al., 
2005 
Moore et al., 
2005 
Nakao et al., 
2006a 
De Backer et al., 
2009 
      Species Mouse Rat Pig Mouse Mouse 
      CO source Inhalation 
250 ppm 
1h before to 24h 
after surgery 
Inhalation 
250 ppm 
3h before 
surgery 
Inhalation 
250 ppm  
3h before 
surgery 
Intraperitoneal 
Ringer's 
lactate, 100% 
CO bubbled, at 
end of surgery 
Intraperitoneal 
CORM-3 
40 mg.kg-1 
3h and 1h before 
surgery 
Blood carboxyhemoglobin - - 6% 8% 2.3% 
      
 
POI        +CO POI        +CO POI        +CO POI        +CO POI        +CO 
GI transit (24h)   ↓           ↑    ↓           ↑                   ↑    ↓           ↑    ↓           ↑  
In vitro muscle activity   ↓           ↑            -           -           -   ↓           ↑  
In vitro betanechol   ↓           ↑            -   ↓           ↑            -           - 
      sGC involvement in CO effect           -           -           -                 Yes           - 
      p38 MAPK phosphorylation           -           -           -   ↑            =   ↑           ↑  
ERK MAPK phosphorylation           -           -           -   ↑           ↓    ↑           ↓  
JNK MAPK phosphorylation           -           -           -   ↑           ↓        ↑            = 
      iNOS mRNA   ↑           ↓            -           -   ↑           ↓            - 
          activity           -           -           -           -   ↑           ↓  
      ROS           -           -           -           -   ↑           ↓  
      HO-1 mRNA   ↑           ↑            -           -   ↑            =           - 
          protein           -           -           -           -   ↑           ↑  
HO total activity           -           -           -           -   ↑           ↑  
      MPO (infiltrating leucocytes)   ↑            =           -   ↑            =   ↑           ↓    ↑           ↓  
      IL-1 β mRNA   ↑           ↓           -           -   ↑           ↓            - 
IL-6 mRNA (protein in 4)   ↑            =           -           -   ↑            =   ↑           ↓  
IL-10 mRNA (protein in 4)   ↑           ↑            -           -   ↑           ↑    ↑           ↑  
      COX-2 mRNA   ↑            =           -           -   ↑           ↓            - 
      ICAM-1 mRNA (protein in 4)           -           -           -   ↑           ↓    ↑           ↓  
MCP-1 mRNA (protein in 4)           -           -           -   ↑            =   ↑           ↓  
      NF-κB DNA binding activity           -           -           -   ↑           ↓            - 
 
-: not determined. 
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CO in i.p. solution: Following the report that intestinal grafts performance is enhanced by 
preserving them in organ preservation solutions saturated with CO (Nakao et al., 2006b), 
Nakao et al., (2006a) showed that an i.p. injection of Ringer’s lactate solution bubbled with 
100% CO for 15 min just before closure of the abdomen prevented postsurgical ileus in mice. 
COHb levels attained almost 8% at 5 min after administration of CO but decreased to less 
than 4% within 30 min. This very elaborated study showed that treatment with solutions 
containing CO affects surgery-induced mRNA expression of pro- and anti-inflammatory 
parameters as reported for inhaled CO, except that the induction of HO-1 mRNA was not 
further enhanced by CO (Moore et al., 2003). Importantly, CO by i.p. injection suppressed 
muscular leukocyte infiltration. The study further showed that surgery induced activation of 
the MAPK p38, extracellular signal-regulated kinase (ERK) and c-Jun amino-terminal kinases 
(JNK), and of the transcription factor NF-κB; except for p38, these effects were suppressed 
by CO. The majority of the effects of CO were diminished by pretreatment with the sGC 
inhibitor ODQ, suggesting activation of sGC by CO early in its protective pathway. 
CO-RMs: An i.p. injection of the “fast” CO-releaser CORM-3 (40 mg/kg at 3 and 1 h before 
surgery), inducing maximal blood COHb levels of 2.3% at 10 min after injection, provided 
partial protection against retarded transit by surgery in mice, while the inactive compound  
i-CORM-3 was not effective (De Backer et al., 2009). A similar effect was obtained with 
equimolecular amounts of the “slow” CO releaser CORM-A1 but COHb levels increased to 
8.4% at 20 min after injection. Similar to data obtained with CO in i.p. solution, i.p. 
administration of CORM-3 suppressed muscular leukocyte infiltration at 6 and 24 h after 
surgery, and decreased ERK activation, but it increased MAPK p38 activation. Surgery 
induced a progressive increase in protein expression of HO-1 and in total HO activity; this 
was further enhanced by CORM-3 at 1 to 6 h after surgery in a p38 MAPK dependent way, as 
prevented by a p38 MAPK inhibitor. Finally, the study showed that CORM-3 suppresses the 
progressive increase in muscular oxidative stress levels induced by surgery, illustrating that 
also anti-oxidative effects of CO might contribute to its beneficial effect in POI. In contrast to 
previous studies, De Backer et al., (2009) also investigated the role of the mucosal layer. 
Surgery did not induce pronounced expression of pro-inflammatory cytokines in the mucosa, 
but it led to an early mucosal oxidative stress burst at 1 h after surgery, which might co-
trigger the intestinal epithelial barrier dysfunction during POI (Snoek et al., 2012). CORM-3 
reduced this early mucosal oxidative burst in a fully HO-1-dependent way, as shown with the 
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HO inhibitor chromium mesoporphyrin, while the anti-inflammatory/anti-oxidative effects of 
CORM-3 in the muscularis are only partially HO-1 dependent. 
 
I.3.3.7 Effect of CO on the intestine in sepsis 
In different animal models of sepsis, CO either inhaled as a gas or supplied as CO-RMs 
was shown to increase survival and to decrease inflammation and tissue damage in critical 
organs involved in septic MOF, i.e. lung, liver, heart and kidney (Sarady et al., 2004; Hoetzel 
et al., 2007; Cepinskas et al., 2008; Lancel et al., 2009; Mizuguchi et al., 2009; Lee et al., 
2014). In most studies, CO is applied before or just after administering the septic stimulus, 
which is clinically irrelevant in patients with established sepsis, but a recent study showed 
that inhalation of CO in a therapeutic way (i.e. 2.5 h after starting the LPS infusion) still 
provides some degree of protection (Koulouras et al., 2011). 
Studies concentrating on the effect of CO in the intestine during experimental sepsis 
are summarized in Table I.3. The intestinal readouts involve whole tissue homogenates of 
small intestinal fragments without separation of mucosal or muscular layers. (Liu et al., 
2007) reported that CO inhalation at 250 ppm from 1 to 4 h after intravenous (i.v.) injection 
of LPS in rats ameliorated intestinal injury measured at 4 h after LPS. This corresponded with 
significant suppression of the LPS-induced intestinal cell apoptosis. Although inhalation of 
CO gas induced an increase in arterial COHb levels to 6.9%, no significant differences in the 
partial arterial oxygen pressure and arterial oxygen saturation were observed. Injection of 
LPS increased intestinal HO-1 mRNA expression, which was further augmented following CO 
inhalation. CO inhalation reduced the LPS-induced increase in intestinal ICAM-1 and platelet 
activating factor (PAF) expression as well as leukocyte infiltration and lipid peroxidation so 
that CO might exert its protective effect via anti-inflammatory, anti-oxidative and anti-
apoptotic actions. Similar protective effects were obtained when continuously perfusing 2 
l/min of 250 ppm CO (from CO gas compressed at 250 ppm with balanced air in a cylinder) 
into the peritoneal cavity (through an inlet in the hypogastric right region with an outlet in 
the epigastric left section) from 1 to 7 h after i.v. administration of LPS (Liu et al., 2010a). 
Parameters were measured after 1, 3 and 6 h of CO treatment and illustrated that the 
beneficial effect of CO was maintained for the whole perfusion period. As measured at 3 h 
after LPS challenge, p38 MAPK phosphorylation was increased by LPS and further enhanced 
by CO treatment. The group of Liu et al., (2010b) then also investigated the effect of a single  
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Table I.3 Effects of CO on intestinal tissue integrity and on inflammatory parameters in preclinical 
models of sepsis. 
 
Reference Liu et al., 2007  Liu et al., 2010a Liu et al., 2010b Wang et al., 2012 
  
   
Species Rat Rat Rat Mouse 
  
   
Model 
 
LPS injection 
i.v. 
LPS injection  
i.v. 
LPS injection 
i.v. 
Cecal ligation and 
puncture (CLP) 
  
   
CO source Inhalation 
250 ppm 
from 1 to 4 h 
after LPS 
challenge 
 
Intraperiton. 
perfusion 
2 l/min 
250 ppm CO 
from 1 to 7 h 
after LPS 
challenge 
Intraperiton. 
bolus 
2 ml/kg 
250 ppm CO  
1 h after LPS 
challenge 
i.v. 
CORM-2 
8 mg/kg 
immediately after 
CLP 
 
Blood carboxyhemoglobin 6.9% 7.0% 2.6% - 
  
   
 
LPS        +CO LPS        +CO LPS        +CO CLP        +CO 
Intestinal tissue damage   ↑           ↓   ↑           ↓   ↑           ↓   ↑           = 
Intestinal cell apoptosis   ↑           ↓   ↑           ↓    ↑           ↓            - 
  
   
p38 MAPK phosphorylation           -   ↑           ↑   ↑           ↑           - 
  
   
iNOS protein           -           -           -   ↑           ↓ 
NO production           -           -           -   ↑           ↓  
  
   
ROS   ↑           ↓   ↑           ↓   ↑           ↓   ↑           ↓  
SOD activity           -           -   ↓           ↑           - 
  
   
HO-1 mRNA   ↑           ↑           -           -           - 
  
   
MPO (infiltrating leucocytes)   ↑           ↓   ↑           ↓    ↑           ↓    ↑           ↓ 
  
   
TNF-α protein           -           -           -   ↑           ↓ 
IL-1β protein           -           -           -   ↑           ↓ 
IL-10 protein           -           -   ↓           ↑            - 
  
   
ICAM-1 protein   ↑           ↓    ↑           ↓    ↑           ↓    ↑           ↓ 
  
   
PAF-1 protein   ↑           ↓    ↑           ↓    ↑           ↓            - 
 
-: not determined. 
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i.p. injection of 2 ml/kg of 250 ppm CO, 1 h after LPS treatment. At 1 and 3 h after injection 
of CO, the LPS-changed parameters were beneficially influenced by CO but no longer at 6 h. 
In addition to their previous studies, intestinal levels of SOD activity and IL-10 protein were 
measured; both markers were suppressed by LPS but partially reversed by CO, with IL-10 
being still elevated at 6 h after CO treatment. Although not studying intestinal tissue per se, 
Dal-Secco et al., (2010) confirmed in mice the importance of ICAM-1 for LPS-induced 
neutrophil migration. The increased expression of ICAM-1 on mesenteric venular 
endothelium observed 2 h after intraperitoneal injection with LPS was significantly reduced 
by treating the animals with the CO donor dimanganese decacarbonyl (3 mg/kg 
subcutaneously) 30 min before LPS challenge. The effect of the CO donor was prevented by 
ODQ, illustrating that it depends on sGC activation. Recently, Wang et al., (2012) studied the 
mouse small intestine 24 h after CLP. The intestine showed increased lipid peroxidation, 
leukocyte infiltration (MPO activity), and TNF-α, IL-1β, ICAM-1 and iNOS protein levels, the 
latter corresponding with increased NO production. All these effects were attenuated by 
CORM-2 (8 mg/kg) injected i.v. immediately after the cecal ligation procedure. Histological 
analysis revealed hydropic degeneration and granulocyte infiltration by the septic 
procedure; while CORM-2 decreased granulocyte infiltration, it did not improve the hydropic 
degeneration. 
These studies clearly support the idea that the beneficial effect of CO in sepsis might 
be due, at least in part, to prevention or recovery of intestinal inflammation and tissue 
damage, therefore avoiding the triggering role of the intestine in sepsis. Although none of 
the studies in Tables I.3 measured gut barrier function, it can be expected that the anti-
inflammatory and antioxidant effects of CO in the intestine will also decrease the intestinal 
barrier dysfunction in sepsis. Additionally, the enhancement of host bacterial clearance 
(Chung et al., 2008; Onyiah et al., 2013) and direct bacteriostatic/bactericidal effects by CO 
and CO-RMs (Desmard et al., 2012) might contribute to the beneficial effect in sepsis. 
 
I.3.4 Resveratrol; effects in POI and sepsis 
 
I.3.4.1 Resveratrol 
Human health is greatly affected by environmental factors including bioactive 
molecules found in food. Plants produce a wide spectrum of diverse metabolites that are 
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being investigated for their potential utility in the prevention and treatment of human 
disease. Phytoalexins are one such group of molecules that are produced by plants in 
response to exogenous stressors or pathogen attack and have potent antimicrobial activity 
(Ahuja et al., 2012). Phytoalexins are chemically diverse and show biological activity towards 
a variety of pathogens; they help in disease resistance as plant antibiotics. “Polyphenols” are 
the plant derived chemical products that are characterized by the presence of two or more 
phenolic groups in their structure. They are capable of reducing ROS and thus could serve as 
antioxidants. Many phytoalexin molecules are polyphenolic in nature. The phytoalexins 
produced by Vitis vinifera (grape) and found abundantly in red wines became a popular 
subject of biomedical research following the discovery of the “French Paradox”, an 
observation of low incidence of cardiovascular disease in populations in France that regularly 
consume red wine, in spite of other risk factors including a high-fat diet (Renaud & de 
Lorgeril, 1992). Red wines are a rich source of phytoalexins and polyphenols (Quideau et al., 
2011). Of the many polyphenolic phytoalexins found in red wines, resveratrol (3,4’,5-
trihydroxy-stilbene) is perhaps the most extensively studied to date. Resveratrol exists in 
both cis and trans forms (Fig. I.15). The trans-isomeric form displays greater stability than 
the cis form when protected from high pH and light; hence the beneficial effects so far 
known from the majority of studies are based on investigations with trans-resveratrol (Leiro 
et al., 2004). The concentrations and thus the ratio of cis and trans isomers of resveratrol 
vary in different wines depending upon the variety of grapes used in wine preparation. 
Resveratrol is insoluble in water but soluble in organic solvents like DMSO and ethanol; thus 
a diet high in fat might actually enhance the uptake of lipid-soluble resveratrol to account for 
its beneficial effect reported with the “French Paradox”. Resveratrol is produced by at least 
72 different plant species, some of which are a part of the human diet such as grape skins, 
soy, peanuts and mulberries; these are thus important dietary sources of this polyphenol 
(Soleas et al., 1997). 
In vivo studies using experimental animals (mice, rats and dog models) suggest that 
resveratrol is absorbed satisfactorily in the GI tract, with significant concentrations being 
found in the blood and a number of internal organs (Bertelli et al., 2001). 
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Fig. I.15   Chemical structures of resveratrol isomers showing conversion to cis-resveratrol after the irradiation 
of trans-resveratrol with UV light 
 
I.3.4.2 Mechanisms of action of resveratrol 
As an isolated compound resveratrol has gained attention in both the scientific 
community and general public for its plethora of beneficial effects against 
neurodegenerative disease, cardiovascular disease, obesity, diabetes and cancer, and its 
lifespan extension (Smoliga et al., 2012). These beneficial effects of resveratrol are due to its 
anti-inflammatory, anti-oxidative, anti-proliferative and anti-cancer properties. Resveratrol 
appears to influence the activity of a vast number of enzymes, and the list of downstream 
targets and affected signaling pathways is continuously growing. 
Anti-/pro-oxidant effect of resveratrol: Many of resveratrol’s beneficial effects are 
consistent with a reduction in intracellular oxidative stress. Resveratrol has an inherent 
antioxidant activity related to its chemical structure. At the level of ROS, resveratrol has H2O2 
and OH scavenging activity (Leonard et al., 2003; Ungvari et al., 2007). Moreover, being a 
lipid antioxidant, resveratrol has the ability to prevent lipid peroxidation by scavenging 
peroxyl radicals (ROO where R denotes an organic group) within the membrane (Tadolini et 
al., 2000). Correspondingly, resveratrol has been reported to reduce the copper catalyzed 
oxidation of human low-density lipoprotein (LDL), a crucial step in the pathogenesis of 
atherosclerosis and thus could exert cardioprotection (Frankel et al., 1993). Resveratrol was 
also reported to decrease ROS by reducing the NOX expression in murine aortic walls after 
vascular injury (Sarr et al., 2006; Vecchione et al., 2009) and NOX activity in angiotensin II or 
oxidized LDL-treated cultured human endothelial cells (Chow et al., 2007). One advantage of 
resveratrol as compared to other polyphenols is that this compound does not chelate iron, 
hence it does not affect iron absorption (Brune et al., 1989). However, resveratrol has a 
potential to chelate copper (Belguendouz et al., 1997). 
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Polyphenols, in general, can act either as anti- or pro-oxidants, i.e. inhibitors or 
enhancers of oxidative and radical chain processes (Halliwell, 2008). Besides the redox 
potential of the polyphenol, whether an anti- or a pro-oxidant effect predominates, depends 
on the abundance of metal ions sustaining a redox cycle (Fe2+/Fe3+, Cu+/Cu2+) and/or of 
oxidizing enzymes, the ion-chelating properties of the molecule, pH, the concentration of the 
polyphenol, and the subcellular compartment (Babich et al., 2011). Being a polyphenol, 
resveratrol also exhibits some pro-oxidant activities under certain conditions. E.g. in the 
presence of Cu2+, resveratrol was shown to catalyze the reduction of Cu2+ to Cu+ with the 
resulting oxidized resveratrol products exhibiting pro-oxidative behavior (Ahmad et al., 
2000). 
Resveratrol also decreases oxidative stress by activating the molecular pathways to 
increase the level and activity of cellular antioxidant enzymes (Kovacic & Somanathan, 
2010). In cultured human lung fibroblasts treated with micromolar concentrations of 
resveratrol for 48 h or two weeks, a significant increase in MnSOD protein level and activity 
is observed, an effect that reaches nearly 5-fold at the two week time point (Robb et al., 
2008a). This increase in MnSOD is accompanied by a slight increase in the activity of Gpx, but 
is not accompanied by a general increase in antioxidant enzyme activity, as Cu/Zn SOD and 
catalase activity are unaffected by resveratrol. The observation of increase in MnSOD 
protein level and activity by resveratrol was subsequently reported in murine skeletal muscle 
(Ryan et al., 2010), murine neuronal (Fukui et al., 2010; Kairisalo et al., 2011) and human 
coronary endothelial (Ungvari et al., 2009) cells. These reports suggest that increase in 
MnSOD is a common mechanism of antioxidant activity by resveratrol. Resveratrol also 
increases the expression of detoxification enzymes like NAD(P)H: quinone oxidoreductase 
(Rubiolo et al., 2008) and of Nrf2, which ultimately leads to upregulation of HO-1 (Chen et 
al., 2005). Additionally, resveratrol can also increase mitochondrial biogenesis (Csiszar et al., 
2009). 
Activation of sirtuins: The biological activities of resveratrol have been hypothesized to arise 
from its interaction with numerous substrates; sirtuins attracted most attention. Sirtuins are 
a family of highly conserved protein deacetylase enzymes named after the founding 
member, the Saccharomyces cerevisiae silent information regulator 2 (Sir2) protein. In yeast, 
Sir2 was identified as a putative longevity protein following an observation that its 
overexpression extends lifespan in Caenorhabditis elegans (Tissenbaum & Guarente, 2001). 
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Mammalian silent mating type information regulator 2 homolog 1 (SIRT1) is closely related 
to the C. elegans protein Sir2. Resveratrol has been identified to be a potent activator of 
SIRT1 and hence is implicated in increasing lifespan (Howitz et al., 2003) SIRT1 being a key 
regulator of cellular defenses and cell survival in response to stress. Resveratrol attenuates 
mitochondrial ROS production via a pathway that involves the activation of SIRT1 and the 
upregulation of antioxidant defense mechanisms (Ungvari et al., 2009). Activating SIRT1 has 
been proposed to be a possible strategy of resveratrol to inhibit NF-κB and/or activator 
protein (AP)-1 signaling pathways during inflammation and oxidative stress, respectively 
(Chung et al., 2010). 
Estrogen like effects of resveratrol: Resveratrol is capable of binding to estrogen receptors 
to stimulate transcriptional responses (Gehm et al., 1997). Moreover, resveratrol can act as 
a phytoestrogen, plant derived compounds that mimic the activity of 17-β-estradiol (E2), the 
primary female sex hormone. Owing to these facts, there is remarkable overlap between the 
health effects of resveratrol and those of estrogen. Similar to resveratrol, estrogen is 
neuroprotective, and prevents neurodegeneration in models of Parkinson’s disease, 
Alzheimer’s disease and ischemia reperfusion (Wise et al., 2001; Brinton, 2008; Robb & 
Stuart, 2010). Similarly, resveratrol and estrogen both have beneficial effects on metabolism 
and cardioprotection (Nikolic et al., 2007; Wu & Hsieh, 2011; Faulds et al., 2012; Voloshyna 
et al., 2012). Although resveratrol does not dramatically affect reproductive physiology, 
many of its in vivo effects, such as its positive effects on bone health in ovariectomized 
rodents, are very similar to observations made with estrogen treatment (Lin et al., 2005). 
Resveratrol stimulates the transcription of an estrogen controlled luciferase reporter gene in 
a dose-dependent manner in a human breast cancer cell line (MCF-7). Estrogen antagonists 
inhibit the activation of the reporter gene by resveratrol, and in a competition assay 
resveratrol successfully prevented the binding of radiolabeled estradiol to estrogen 
receptors, demonstrating that resveratrol is an estrogen receptor agonist in vitro (Gehm et 
al., 1997). Resveratrol is an agonist for both estrogen receptor-α and estrogen receptor-β 
(Bowers et al., 2000). Interestingly, both mitochondria and MnSOD are major downstream 
targets of E2 signaling (Borras et al., 2005) and it is plausible that resveratrol could exert its 
effect at the mitochondrial level through E2 signaling. 
Inhibition of NF-kB: The exact mechanisms through which resveratrol exerts anti-
inflammatory effects remain unclear, but mounting evidence supports that resveratrol 
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seems to affect a wide range of inflammatory parameters. NF-κB is likely to be the major 
molecular target for the anti-inflammatory effects of resveratrol. The presence of resveratrol 
prevented the activation of NF-κB triggered by exposure of varied cell types (myeloid, 
lymphoid and epithelial) to diverse inflammatory triggers like TNF-α, phorbol 12-myristate 
13-acetate (PMA), H2O2, LPS, okadaic acid and ceramide (Manna et al., 2000b). Thus, 
treatment with resveratrol suppressed NF-κB-regulated gene products involved in 
inflammation like TNF-α, IL-6, IL-1β, IL-8, COX-2, iNOS, etc (Csaki et al., 2009). Still, activation 
of NF-κB by resveratrol has also been reported in IECs (see section 1.4.2). 
 
I.3.4.3 Administration of resveratrol as therapeutic agent 
In animal studies investigating the beneficial effects of resveratrol, it has been 
administered by i.v., i.p., and oral routes (Shigematsu et al., 2003; Alfaras et al., 2010; 
Larrosa et al., 2011; Petrat & de Groot, 2011). For a substance present in the human diet 
obviously one thinks of oral administration in humans. The bioavailability and 
pharmacokinetics of resveratrol have been studied in experimental animals and humans. 
Resveratrol supplementation has been demonstrated to be safe for humans based on a 
phase I study where healthy volunteers were provided with up to 5 g of resveratrol orally, 
with no major adverse events (Boocock et al., 2007). An enterohepatic cycle has been 
proposed for resveratrol in both rats and humans. Upon oral administration, resveratrol is 
rapidly metabolized by extensive first-pass glucuronidation and sulfation both in the 
intestine by IECs and in the liver; the metabolized forms then circulate to other organs 
(Goldberg et al., 1995; Bertelli et al., 2001; Soleas et al., 2001; Vitrac et al., 2003; Yu et al., 
2009). The glucuronide and sulfate conjugates are also secreted back to the intestine where 
they may be deconjugated and the resulting resveratrol reabsorbed, or excreted in the feces 
(Marier et al., 2002; Walle et al., 2004). Thus, the enterohepatic cycle, along with rapid 
metabolism in the liver, likely explains the low concentration of unchanged resveratrol in the 
blood stream. Both in humans and rats, unchanged resveratrol reaches a maximum plasma 
concentration of 1.9% within an hour following oral administration of trans-resveratrol 
(Goldberg et al., 2003; Walle et al., 2004; Boocock et al., 2007). In humans, resveratrol 
administered intravenously, avoiding first-pass metabolism, was found to be converted into 
a sulfate conjugate within 30 min (Walle et al., 2004). In the same study, most of the 
resveratrol following a single 25 mg oral dose was recovered in urine as its glucuronide and 
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sulfate conjugated metabolites, with only trace amounts of unchanged resveratrol  
(<5 ng/ml) detected in plasma. Similarly, in rodents also, oral intake of resveratrol in the 
hundreds of milligrams range yields only low nanomolar plasma levels of unmetabolized 
resveratrol (Marier et al., 2002; Teng et al., 2012). These results further underline that most 
of resveratrol taken up orally is eliminated from the body leaving only a small fraction of the 
parent compound. However, the composition of the food matrix can have an impact on the 
bioavailability of ingested resveratrol. Correspondingly, significant improvement in energy 
metabolism and aerobic exercise endurance is observed in mice when resveratrol is added 
to diets with fat contents equal to or greater than 40%, but not when resveratrol is added to 
a standard composition diet (Baur et al., 2006; Lagouge et al., 2006). Similarly, resveratrol 
given in a high-fat diet increases brain antioxidant enzyme activities by approximately 2-fold, 
while the same dose given in a standard mouse diet does not have a significant effect (Robb 
et al., 2008b). 
Given the low bioavailability and extensive metabolism of oral resveratrol, solutions 
are sought to increase the bioavailability of resveratrol in order to achieve in plasma the 
concentrations previously shown to have biological activity in in vitro assays (5-100 µmol/L) 
(Poulsen et al., 2013). New administration strategies are currently under development to 
help bypass metabolic breakdown of resveratrol and increase its bioavailability. Resveratrol-
containing lozenges have been reported to increase buccal absorption of resveratrol (Asensi 
et al., 2002). Nanoparticles and liposomes are investigated as potential carriers of 
resveratrol to improve its bioavailability (Teskac & Kristl, 2010; Santos et al., 2011; Gokce et 
al., 2012). Recently, structural derivatives of resveratrol were shown to have manifold higher 
antioxidant potential than the native molecule; these derivatives could be of benefit to 
achieve effective therapeutic concentration of resveratrol in vivo (He & Yan, 2013). 
 
I.3.4.4 Effect of resveratrol in POI 
In only one study, treatment of rats with resveratrol (10 mg/kg; i.v.) 1 h before 
operation partly reversed the retarded transit induced by gut manipulation; no inflammatory 
parameters were studied (Korolkiewicz et al., 2003). 
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I.3.4.5 Effect of resveratrol on the intestine in sepsis 
In experimental models, resveratrol improved sepsis-induced acute organ injury, like 
lung (Kolgazi et al., 2006) and kidney (Kolgazi et al., 2006; Holthoff et al., 2010), when 
administered either before or shortly after the septic insult. Similarly, in the GI tract, 
resveratrol (100 mg/kg, i.p.) treatment immediately after CLP to induce sepsis in rats 
improved ileal smooth muscle reactivity, as measured by smooth muscle contractile 
response to KCl and carbachol; this was accompanied by suppression of serum TNF-α and  
IL-6 levels (Gacar et al., 2012). Oral administration of rats with resveratrol (50 mg/kg) 
reduced the levels of LPS-induced increase in lipid peroxidation (thiobarbituric acid reactive 
substances; TBARS) in the small intestine and colon (Larrosa et al., 2011). In this study, 
resveratrol was administered orally by gastric probe for 3 days; then followed by i.p. 
injection of LPS with a fourth dose of resveratrol given 45 min after LPS injection. 
Interestingly, the administration of LPS caused a decrease in resveratrol absorption as 
assessed from plasma samples; while both glucuronide and sulfate derivatives were found in 
the resveratrol treated group, LPS-resveratrol treated group showed only glucuronide 
derivative, with a level 15 fold lower than the resveratrol treated group. 
 
I.4 IECs as model to study mucosal injury 
 
Many studies investigating intestinal pathologies using mouse models suggest that 
apoptosis of IECs triggers intestinal inflammation (Nenci et al., 2007; Kajino-Sakamoto et al., 
2008; Roulis et al., 2011). Enterocytes are the most abundant cell type in the intestinal 
epithelial cell layer; however, the cellular and molecular mechanisms regulating the cell 
death of enterocytes and their role in maintenance of mucosal homeostasis are still poorly 
understood. As in vivo studies using experimental animals involve multiple cell components, 
investigations with isolated cells could be a possible alternative to understand how IECs 
could individually respond to various inflammatory and oxidative triggers. However, given 
the low viability of primary IECs after isolation and when grown in culture (Schwerk et al., 
2013), in vitro studies involving immortalized epithelial cell lines are frequently used to 
understand how inflammatory mediators or cells can alter epithelial cell ion transport, 
permeability and barrier defects, triggering inflammation (Sambruy et al., 2001). Human 
colon epithelial cell lines like Caco-2, DLD-1, T84, HT-29, HCA-7, LS174T, HCT-8, and I-407 are 
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often used in scientific investigations. Indeed, the Caco-2 cell line with characteristics of 
enterocyte-like phenotype, forming confluent cell monolayers bearing properties of 
transporting epithelia has been internationally recognized as a gold standard model in many 
pharmaceutical studies to determine intestinal permeability and oral drug uptake (Sambuy 
et al., 2005; Araujo & Sarmento, 2013). However, all the aforementioned cell lines are 
colonic and carcinogenic in origin. IEC lines from rodent origin like IEC-4.1, IEC-6 and IEC-18 
(from rat), and m-ICc12, MODE-K and YAMC (from mouse) have been used as mammalian 
surrogates of non-cancerous nature. They are derived from small intestine (with the 
exception of the murine YAMC cell line). Notably, all the rat derived IEC lines retain many of 
the characteristics of crypt cells (Podolsky, 2000). However, the murine MODE-K cells exhibit 
morphological and phenotypic characteristics of normal enterocytes, including intercellular 
junctions, and expression of cytokeratin and villin (Vidal et al., 1993). The murine m-ICc12 
cell line is derived from the bases of small intestinal villi and hence maintains a crypt 
phenotype (Bens et al., 1996). Thus, the MODE-K cell line represents a suitable model for the 
analysis of IEC function in mucosal immunity (Vidal et al., 1993). Recently, the development 
of three-dimensional (3D) intestinal epithelial organoids (also called “epithelial mini-guts”) 
has been proposed as a possible means of maintaining primary IECs in continuous culture 
(Sato & Clevers, 2013). However, organoid cultures are time-consuming and expensive, 
obviously making them impractical for large-scale analyses (Schwerk et al., 2013). 
TNF-α is a pleiotropic cytokine that has a key role in inflammation induced by 
infection or tissue injury. TNF-α signaling is primarily executed through TNF-α receptor 1 
(TNFR1) which induces direct pro-inflammatory signaling with increased expression of many 
genes that regulate inflammation (without cytotoxicity in many cell types). However, in 
cultured cells (of both normal and cancerous nature), TNF-α can induce cell death upon 
sensitizing the cells by treatment with a protein kinase (staurosporine), transcription 
(actinomycin-D) or translation (cycloheximide; CHX) inhibitor (Beyaert et al., 1993). In such 
sensitized cells, binding of TNF-α to TNFR1 can induce apoptosis or necrosis depending upon 
the availability of death regulatory and execution factors (Jones et al., 2000; Pasparakis & 
Vandenabeele, 2015). The signaling complex formed by TNFR1 activates initiator caspases 
(like caspase-8) which then results in activation of executioner caspases (like caspase-3 and 
caspase-7) to mediate apoptotic cell death (Van Herreweghe et al., 2010). 
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I.4.1 CO in IEC lines 
Publications on the protective effect of CO in IEC lines are summarized in Table I.4. 
The IEC lines studied are from murine, rat and human origin; the rodent cell lines (MODE-Κ, 
YAMC and IEC-6) are derived from non-cancerous GI tissues while the human cell lines 
(Caco-2, HT-29 and DLD-1) are from tumorous tissue sources. TNF-α is also an important 
inflammatory mediator in GI inflammation (Holtmann et al., 2002) explaining why studies so 
far investigating the effect of CO or CO-RMs involved exposing monolayers of IECs to either 
TNF-α alone or in combination with other pro-inflammatory cytokines such as IL-1β and 
interferon (IFN)-γ (cytokine mix). All these studies involve acute measurements where the 
cells were exposed to TNF-α or cytokine mix from 30 min to maximally 24 h followed by 
cellular and transcriptional readouts. 
CO treatment protects against IEC death induced by inflammatory cytokines as 
shown with CO gas in rat IEC-6 cells (Zuckerbraun et al., 2005). With regard to the 
mechanism of its protective effect, none of the studies have investigated the involvement of 
sGC and only the study by Megias et al., (2007) examined a possible contribution of p38 
MAPK. In fact, CORM-2 treatment reduced the cytokine-induced increase in phosphorylation 
of MAPK p38, similar to its effect on ERK 1/2 and JNK 1/2 phosphorylation. This is in contrast 
with many in vivo studies on acute GI inflammation reporting that CO further enhances 
inflammation-induced p38 MAPK phosphorylation (see Tables I.2 and I.3). CO treatment 
reduced the cytokine-induced expression of iNOS at the mRNA or protein level, correlating 
with suppression of nitrite production (Dijkstra et al., 2004; Zuckerbraun et al., 2005; Megias 
et al., 2007). No evidence for a selective effect of CO on iNOS activity as previously reported 
(Sawle et al., 2005) has been obtained. In a study with rat IEC-6 cells, CO also inhibited LPS- 
and/or hypoxia (1% O2)-induced increase in iNOS protein expression which was corroborated 
by the decrease in the transcriptional activation of the iNOS promoter (Zuckerbraun et al., 
2005). The effect of CO on iNOS in IECs might be related to its upstream influence on 
transcription factors involved in inflammation-induced iNOS expression. CORM-2 reduced 
the transcriptional activation of NF-κB triggered by a cytokine mixture with reduction of the 
increased expression of IL-8 in Caco-2 cells (Megias et al., 2007). CORM-2 also inhibited gene 
expression and protein production of keratinocyte chemoattractant (KC), a functionally 
related homologue of IL-8 in humans, along with inhibition of NF-κB transcriptional  
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Table I.4 Effects of CO on IEC lines. 
Cell type 
 
 
Inflammatory 
trigger 
 
CO source 
 
 
Effect of inflammatory 
markers/overall 
outcome 
Reference 
 
 
Human colonic epithelial cell 
line, DLD-1 
CM* 
 
250–400 ppm CO 
 
↓ iNOS mRNA 
expression 
Dijkstra et 
al., 2004 
Rat small intestinal 
epithelial cell line, IEC-6 
 
CM 
 
 
250 ppm CO 
 
 
↓ iNOS protein 
expression 
↓ nitrite production 
Zuckerbraun 
et al., 2005 
 
 
TNF-α plus 
actinomycin-
D 
250 ppm CO 
 
↓ cell death (apoptosis) 
 
 
 
LPS/hypoxia 
 
 
 
 
 
250 ppm CO 
 
 
 
 
 
↓ cell death 
↓ iNOS protein 
expression 
↓ transcriptional 
activation of iNOS 
promoter 
 Human colonic epithelial cell 
line, HT-29 
 
TNF-α 
 
 
CORM-2 (5-20 µM) 
 
 
↓ IL-8 mRNA expression 
↓ ICAM-1 and COX-2 
protein expression 
Lee et al., 
2007 
 
Human colonic epithelial cell 
line, Caco-2 
 
 
 
 
 
 
 
 
 
CM 
 
 
 
 
 
 
 
 
 
 
CORM-2 (50-150 µM) 
 
 
 
 
 
 
 
 
 
 
↓ nitrite production 
↓ iNOS mRNA 
expression 
↓ IL-8 protein 
expression 
↓ transcriptional 
activation of NF-kB 
↓ IκBα phosphorylation 
↓ MAPK (p38, ERK 1/2 
and JNK 1/2) 
phosphorylation 
Megias et 
al., 2007 
 
 
 
 
 
 
 
 
 
Young adult mouse colonic 
epithelial cell line, YAMC 
No trigger** 
 
CORM-2 (1-10 µM) 
 
↑ wound repair of cell 
monolayer 
Uchiyama et 
al., 2010 
Young adult mouse colonic 
epithelial cell line, YAMC 
 
TNF-α 
 
 
CORM-2 (10 µM) 
 
 
↓ KC mRNA expression 
↓ KC production 
↓ NF-kB activity 
Takagi et al., 
2011 
 
 
* CM: cytokine mixture (combination of TNF-α, IL-1β and IFN-γ) 
** No inflammatory trigger is used; central manual scraping of monolayer creating a wound 
 
activation in TNF-α stimulated young adult mouse colonic epithelial cells (Takagi et al., 
2011). CORM-2 also showed beneficial effect on IEC restitution (Uchiyama et al., 2010). 
The anti-inflammatory effects of CO/CO-RMs required HO-1 induction in other 
isolated cell systems such as hepatocytes (Zuckerbraun et al., 2003), macrophages (Sawle et 
al., 2005), microglia (Min et al., 2006) and endothelial cells (Kim et al., 2007); however, 
treatment with CO-RMs does not influence HO-1 protein expression in human Caco-2 cells 
(Megias et al., 2007) and thus no evidence for a positive feedback loop CO/HO-1/CO was 
obtained. 
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In another human colonic epithelial cell line, HT-29, bilirubin per se had a similar 
inhibitory effect as CORM-2 on TNF-α-induced IL-8, ICAM-1 and COX-2 expression, and the 
effect was additive when CORM and bilirubin were incubated together suggesting that 
pharmacological induction of HO-1 might lead to more pronounced beneficial effects than 
exogenous CO (Lee et al., 2007). However, the HO-1 inducer cobalt protoporphyrin 
decreased TNF-α plus actinomycin D-induced apoptotic cell death of IEC-6 cells only to the 
same extent as exogenous CO gas (Zuckerbraun et al., 2005). 
All studies in IEC lines thus support that CO can reduce acute mucosal inflammation 
and damage, and even stimulate IEC restitution. 
 
I.4.2 Resveratrol in IEC lines 
The publications on the protective effect of resveratrol in IEC lines are summarized in 
Table I.5. The first study investigating the effect of resveratrol in human HT-29 cells showed 
that resveratrol tested at the concentrations of 25-50 µM promoted NF-κB activity induced 
by LPS challenge (Jeong et al., 2004). Subsequently, resveratrol at 50 µM concentration was 
reported to increase NF-κB activity in Caco-2 cells treated with different inflammatory 
agents like LPS, IL-1β or TNF-α; moreover, resveratrol also increased IL-8 production after  
IL-1β stimulation in the same cell system (Romier et al., 2008). These results together 
suggest that resveratrol promoted NF-κB activation after inflammatory stimuli in human 
colonic epithelial cells; however, this is in sharp contrast to the inhibition of NF-κB activity 
observed with resveratrol in non-intestinal cell types like human monocytes (THP-1), 
macrophages (U-937), lymphoid (Jurkat), hepatic (HeLa) and glioma (H4) cells (Holmes-
McNary & Baldwin, 2000; Manna et al., 2000a; Csiszar et al., 2006). Based on their findings 
with three inflammatory stimuli, Romier et al., speculated that the permanent exposure of 
the intestinal cells to high levels of resveratrol for decades might have modified their genetic 
print, compared with cells present in blood and other organs that are exposed only to small 
levels of resveratrol (Romier et al., 2008). However, the exact mechanisms for the ability of 
resveratrol to activate NF-κB in intestinal cells are still not clear. 
Resveratrol decreased the LPS-induced increase in iNOS gene and protein expression, 
nitrite production, and IκBα phosphorylation in Caco-2 and SW480 cell lines (Panaro et al., 
2012). In the same study, resveratrol also decreased the protein expression of TLR4; this is  
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Table I.5 Effects of resveratrol on IEC lines. 
Cell type 
 
 
Inflammatory 
trigger 
 
Concentration of 
resveratrol 
 
Effect of inflammatory 
markers/overall 
outcome 
Reference 
 
 
Human colonic epithelial cell 
line, HT-29 
LPS 
 
25–50 µM 
 
↑ NF-κB activity 
 
Jeong et al., 
2004 
Human colonic epithelial cell 
line, Caco-2 
 
 
LPS, IL-1β or 
TNF-α 
 
IL-1β 
50 µM 
 
 
 
↑ NF-κB activity 
 
 
↑ IL-8 production 
Romier et 
al., 2008 
 
 
Human colonic epithelial cell 
lines, Caco-2 and SW480 
 
 
 
 
LPS 
 
 
 
 
 
30–50 µM 
 
 
 
 
 
↓ iNOS mRNA and 
protein expression 
↓ nitrite production 
↓ IκBα phosphorylation 
↓ TLR-4 protein 
expression 
Panaro et 
al., 2012 
 
 
 
 
Human colonic epithelial cell 
line grown in three 
dimensional culture system, 
Caco-2 spheroids 
 
FAEEs 
 
 
 
 
10 µM 
 
 
 
 
↓ ROS production 
↓ epithelial 
permeability 
↑ ZO-1 and occludin 
protein levels 
Elamin et 
al., 2013 
 
 
 
Human colonic epithelial cell 
line, HT-29 
 
 
 
 
 
CM* 
 
 
 
 
 
 
25 µM 
 
 
 
 
 
 
↓ iNOS mRNA and 
protein expression 
↓ nitrite production 
↓ PGE2 production 
↓ COX-2 mRNA and 
protein expression 
↓ ROS production 
Serra et al., 
2014 
 
 
 
 
 
* CM: cytokine mixture (combination of TNF-α, IL-1α and IFN-γ) 
 
the best studied member of TLR family, which is involved in the recognition of endotoxins or 
bacterial LPS (Triantafilou & Triantafilou, 2005). 
Ingested ethanol can be non-oxidatively metabolized in humans resulting in the 
formation of fatty acid ethyl esters (FAEEs) like ethyl oleate and ethyl palmitate. FAEEs might 
induce intestinal barrier dysfunction. Indeed, they increased epithelial permeability and ROS 
production, accompanied by decrease in zona occludens-1 (ZO-1) and occludin tight junction 
protein levels, in a three-dimensional epithelial cell culture model of Caco-2 cells (Caco-2 
spheroids). Resveratrol partially attenuated all these effects; this was attributed to its 
antioxidant effect (Elamin et al., 2013). In HT-29 cells, resveratrol reduced nitrite and PGE2 
production, gene and protein expression of iNOS and COX-2, and ROS production induced by 
a cytokine mix challenge (Serra et al., 2014). 
All these studies suggest that resveratrol can reduce mucosal inflammation and such 
protect the gut from mucosal damage and epithelial barrier dysfunction. 
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Chapter II   Aims 
 
The IEC layer plays a crucial role in acute GI inflammation. Among the myriad of 
signaling agents, TNF-α is one of the pro-inflammatory cytokines well known to initiate 
inflammation in the GI mucosa (Guy-Grand et al., 1998; Ruemmele et al., 1999). TNF-α is 
known to induce both apoptosis and cell shedding (Piguet et al., 1999) involving TNFR1 
(Roulis et al., 2011), increase gap formation with associated cell loss (Kiesslich et al., 2007), 
and decrease the intestinal permeability barrier (Watson et al., 2009) in mouse models. 
However, TNF-α alone does not induce apoptosis of isolated IEC lines but requires the 
inhibition of protein translation with CHX (Bhattacharya et al., 2003; Pajak et al., 2005). 
HO-1 confers protection against oxidative stress and inflammation in vitro and in vivo 
(Ryter & Choi, 2002). Although the mechanisms of HO-1-dependent cytoprotection remain 
incompletely understood, accumulating evidence has implicated contributory roles for the 
products generated from HO activity in particular CO. HO-1 is upregulated by numerous 
stimuli including oxidative stress and pro-inflammatory cytokines like TNF-α. Recently, the 
water soluble CO-RMs, CORM-3 and CORM-A1 have facilitated examination of the 
therapeutic potential of CO in disease models including GI ones and open prospects for 
practical clinical delivery of CO. 
Oxidative stress has been a common denominator in several acute GI disorders. In a 
previous study in our laboratory, the possible protective effect of CORM-3 on POI was 
studied in a mouse model (De Backer et al., 2009). Surgical manipulation of the small 
intestine induces intestinal dysmotility and retarded GI transit, driven by a muscular 
inflammatory process; TNF-α is one of the early inflammatory mediators involved (Lubbers 
et al., 2009; Schmidt et al., 2012). Already 1 h after intestinal manipulation, both the 
mucosal layer and the muscular layer of the small intestine showed a clear cut increase in 
oxidative stress, the increase in the mucosal layer being most pronounced. In the muscular 
layer, the increase was maintained for 24 h, but in the mucosal layer the increase at 1 h 
formed a peak. CORM-3 clearly reduced the surgery-induced intestinal dysmotility and also 
significantly reduced this oxidative stress. This suggests that oxidative stress through the 
production of ROS in the intestinal wall might contribute to the pathogenesis of POI. These 
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results led to the hypothesis that early oxidative stress in the small intestinal epithelial cell 
layer might lead to cell damage and increased intestinal permeability, contributing to or 
triggering muscular inflammation. In this thesis, in order to further investigate the in vivo 
observation in an in vitro setting, a murine small IEC line MODE-K was selected with TNF-α as 
an inflammatory stimulus. 
Although the expression of HO-1 in most tissues is low, it can be strongly up-
regulated endogenously by a wide variety of stimuli including heme but also non-heme 
stimuli like cytokines, ROS and hypoxia (Pae et al., 2008). A large number of pharmacologic 
compounds have been demonstrated to induce HO-1 and this induction of HO-1 provides 
potent cytoprotective effects (Li et al., 2007). Thus, targeted induction of HO-1 can be used 
as a therapeutic strategy to combat oxidative stress conditions, which may facilitate the 
development of novel drugs. Among the search for naturally occurring HO-1 inducers, 
resveratrol, a plant polyphenol with anti-oxidative and anti-inflammatory effects, has 
recently gained much interest as a potent HO-1 inducer (Son et al., 2013). 
Therefore, the aim of this thesis was to establish an in vitro IEC model to assess  
TNF-α-induced oxidative stress, inflammation and cell death, and to investigate the 
protective effects of CO-RMs and resveratrol versus the TNF-α-induced dysfunction 
concentrating on their anti-oxidative effect. 
In a first project, the murine MODE-K IEC line was established as a model to assess  
TNF-α/CHX-induced oxidative stress and apoptosis, showing parallel occurrence of ROS and 
apoptosis. As in the case of many GI cell lines, our preliminary studies showed that TNF-α 
requires the combination with CHX to initiate apoptosis in MODE-K cells and hence TNF-
α/CHX was selected. The influence of the CO-RMs CORM-A1 and CORM-3, and resveratrol on  
TNF-α/CHX-induced ROS and apoptosis was investigated. In comparison, a series of 
compounds was tested : the HO-1-derived products biliverdin and bilirubin, the NOX 
inhibitors apocynin and diphenylene iodonium (DPI), a mitochondrial targeted water-soluble 
antioxidant Mito-TEMPO, an inhibitor of prolyl hydroxylase dimethyoxallyl glycine (DMOG), 
and nitrite (as sodium nitrite). For CORM-A1, resveratrol, bilirubin and nitrite, the 
contribution of HO-1 induction to their protective effects was examined. These results are 
summarized in chapter III. 
ROS production from NOXs and mitochondria was implicated in TNF-α-induced 
apoptosis of rat small IECs (Jin et al., 2008; Baregamian et al., 2009). However, the sources of 
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TNF-α-induced ROS in mouse small IECs are unknown. Hence, in the second project, we 
investigated the various sources of ROS production during TNF-α/CHX-induced oxidative 
stress in MODE-K cells using pharmacological inhibitors of various ROS-generating systems 
(NOX, ETC complexes and xanthine/xanthine oxidase), ROS scavengers and antioxidants. 
Given the role of mitochondria in ROS production and cell death, the influence of TNF-α/CHX 
on Ψm, mitochondrial function and cellular respiration was also studied. The results are 
summarized in chapter IV. 
Reducing oxidative stress in the GI epithelial cell layer may be a reasonable 
therapeutic approach to treat acute GI diseases. The slow releasing water soluble CO-RM, 
CORM-A1, and resveratrol were the two agents which effectively reduced TNF-α/CHX-
induced oxidative stress and cell death of MODE-K cells suggesting a correlation between the 
antioxidant and cytoprotective effects of these agents (chapter III). The aim of our last 
project was therefore to investigate the influence of CORM-A1 and resveratrol on the 
different sources of TNF-α/CHX-induced ROS production in MODE-K cells in comparison with 
their effect versus H2O2-, rotenone- or antimycin-A-induced ROS-generating systems. The 
influence on TNF-α/CHX-induced changes in Ψm, mitochondrial function and cellular 
respiration was also studied. The results are summarized in chapter V. 
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Chapter III 
TNF-α/cycloheximide-induced oxidative stress and apoptosis in murine 
intestinal epithelial MODE-K cells 
 
III.1 Abstract 
Background. In the mouse postoperative ileus model, we have shown an increase in 
oxidative stress after intestinal manipulation occurring earlier in the mucosa than in the 
muscular layer, which might contribute to epithelial barrier dysfunction. To address these 
findings in vitro, we assessed TNF-α/cycloheximide (CHX)-induced oxidative stress and 
apoptosis in a mouse intestinal epithelial cell line, MODE-K. 
Methods. The influence of heme oxygenase (HO)-1-related products and agents 
known to reduce reactive oxygen species (ROS) production on TNF-α/CHX-induced oxidative 
stress and apoptosis were investigated. MODE-K cells were exposed to different 
concentrations of TNF-α/CHX in the absence/presence of the test agents. Cell viability, 
caspase-3/7 activity, apoptosis, reduced glutathione (GSH) level and intracellular ROS 
production were measured. 
Key results. TNF-α/CHX decreased cell viability, increased caspase-3/7 activity, 
induced apoptosis, reduced the GSH level and increased ROS production in a concentration-
dependent manner in MODE-K cells. All these effects of TNF-α/CHX were partially prevented 
by pretreatment with a carbon monoxide-releasing agent (CORM-A1) and nitrite. The 
antioxidant resveratrol abolished TNF-α/CHX-induced increase in ROS production and 
caspase-3/7 activity, but apoptosis was only partially prevented. MODE-K cells are sensitive 
to TNF-α-induced apoptosis in the presence of CHX, which is associated with increased 
intracellular ROS production and caspase-3/7 activation. The effects were partially mitigated 
by CORM-A1, nitrite and resveratrol. 
Conclusions. Thus, these agents could be of potential use in protecting the epithelial 
barrier against oxidative stress during intestinal ischemia/reperfusion injury. 
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III.2 Introduction 
Sepsis is an infection with a systemic inflammatory response syndrome, that can 
progress to multiple organ failure and septic shock. This complex disorder is triggered by an 
inflammatory cascade initiated by bacteria-derived molecules such as endotoxin, with 
subsequent formation of endogenous inflammatory cytokines such as tumor necrosis factor 
(TNF)-α, leading to ischemia/reperfusion, mitochondrial dysfunction and apoptosis (Cinel & 
Opal, 2009). The gut is a triggering factor in the progression of sepsis (Hassoun et al., 2001a). 
Severe stress caused by conditions such as major trauma, burns, hemorrhagia and major 
surgery leads to intestinal ischemia/reperfusion and local production of pro-inflammatory 
cytokines, that contribute to the systemic inflammation. In addition, ischemia/reperfusion 
causes disturbance of the intestinal epithelial barrier and bacterial translocation (Balzan et 
al., 2007), which is facilitated by impairment of bowel motility (ileus) (Hassoun et al., 2001b). 
The mechanism of sepsis-induced ileus, assessed by injecting endotoxins in animal models, 
shows similarity to postoperative ileus occurring after abdominal surgery, as endotoxin 
exposure or intestinal manipulation results in activation of the resident macrophages in the 
intestinal muscle, leading to production of pro-inflammatory cytokines such as TNF-α, 
chemokines and adhesion molecules. The latter are essential for further recruitment of 
circulatory leukocytes into the intestinal muscularis (De Winter & De Man, 2010). The 
mucosal layer seems a victim rather than an instigator in the pathogenesis of ileus. 
Notably, in a mouse model of postoperative ileus we recently reported an early and 
transient increase in oxidative stress in the mucosal layer, with a peak value at 1 h after 
intestinal manipulation, preceding the peak in the muscularis (De Backer et al., 2009). The 
combination of oxidative stress-induced epithelial cell damage, increased intestinal 
permeability and translocation of intraluminal endotoxins might trigger the muscular 
inflammation (Anup et al., 1999); TNF-α may play a role in this epithelial distress. When 
combined with the protein synthesis inhibitor cycloheximide (CHX), TNF-α was shown to 
initiate apoptosis in isolated gastrointestinal epithelial cells (Bhattacharya et al., 2003; Pajak 
et al., 2005). Moreover, TNF-α/CHX-induced oxidative stress has been implicated in 
intestinal epithelial cell apoptosis (Jin et al., 2008). To our knowledge, no in vitro study has 
yet fully explored TNF-α/CHX-induced apoptosis in a murine epithelial cell line. The murine 
intestinal epithelial cell line MODE-K is an undifferentiated cell line, which has the advantage 
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of not being derived from tumor tissue, but from the duodenum-jejunum from normal 
young mice. Hence, it is considered to be an important model exhibiting phenotypic and 
functional properties of normal mouse enterocytes (Gopal et al., 2008; Hoffmann et al., 
2011). The first aim of our present study was to investigate the relationship between 
oxidative stress and apoptosis by TNF-α/CHX in MODE-K cells. 
Heme oxygenase (HO) is an ubiquitous rate limiting enzyme that catabolizes heme 
into ferrous iron, carbon monoxide (CO) and biliverdin, which is subsequently reduced to 
bilirubin. The stress inducible isoform HO-1, which is upregulated by numerous stimuli 
including oxidative stress and pro-inflammatory cytokines (Abraham & Kappas, 2005), serves 
as a cytoprotective gene by virtue of its potent antioxidant, anti-apoptotic and anti-
inflammatory properties (Ryter et al., 2007). Biliverdin and its end product bilirubin are 
potent antioxidants and were shown to have cytoprotective effects (Ryter et al., 2006; Ryter 
& Choi, 2009). Accumulating evidence indicates that also CO can mediate many of the 
biological functions of HO-1 (Ryter et al., 2006). Accordingly, CO-releasing molecules  
(CO-RMs) have been developed to deliver CO in a controllable manner under physiological 
conditions providing an advantage of reduced risk of systemic toxicity (Alberto & Motterlini, 
2007; Motterlini, 2007; Motterlini & Otterbein, 2010). The water soluble CO-RMs (CORM-3 
and CORM-A1) (Clark et al., 2003; Motterlini et al., 2005) have gained increasing interest 
recently due to their promising pharmacological properties as carriers of therapeutic doses 
of CO in models of disease including gastrointestinal disorders (Megias et al., 2007; Sun et 
al., 2007). Indeed, in a murine model of postoperative ileus, we have shown that the “fast” 
CO releaser CORM-3 markedly reduced the manipulation-induced inflammation of the 
muscularis and improved surgically induced intestinal dysmotility. This was accompanied by 
reduction of the early oxidative burst in the mucosa (De Backer et al., 2009). The second aim 
of our present study was therefore to investigate the influence of HO-1-related products 
(bilirubin, biliverdin and CO-RMs) on the oxidative/apoptotic response of the MODE-K cell 
line to TNF-α/CHX. For comparison, several agents that are known to reduce the excessive 
production of reactive oxygen species (ROS) were also tested: apocynin and diphenylene 
iodonium (DPI), which can inhibit nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase activity; nitrite, that can inhibit mitochondrial ROS production (Shiva et al., 2007); 
Mito-TEMPO, a mitochondria-targeted antioxidant; and dimethyloxallyl glycine (DMOG), a 
prolyl hydroxylase inhibitor, that attenuates hypoxia-induced intestinal mucosal 
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inflammation (Morote-Garcia et al., 2009) and decreases hypoxia-induced ROS production in 
a human synovial cell line (Biniecka et al., 2011). Finally, resveratrol, a cytoprotective 
bioactive polyphenol present in red wine, was tested given its potential to attenuate 
intestinal ischemia/reperfusion injury (Ozkan et al., 2009) and its HO-1 related 
neuroprotective action against stroke (Sakata et al., 2010). 
 
III.3 Materials and methods 
III.3.1 Chemicals and reagents 
Bilirubin, biliverdin (biliverdin IX hydrochloride) and cobalt protoporphyrin IX (CoPP) 
were purchased from Frontier Scientific Europe Ltd. (Carnforth, UK). 2-(2,2,6,6-
tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl triphenylphosphonium chloride 
monohydrate (Mito-TEMPO) was purchased from Enzo Life Sciences. Apocynin, 
cycloheximide, DMOG, dimethyl sulfoxide (DMSO), DPI, nitrite (as sodium nitrite), propidium 
iodide (PI), resveratrol and ribonuclease-A were obtained from Sigma (St. Louis, MO, USA). 
Recombinant murine TNF-α was purchased from R&D system (Minneapolis, MN, USA). Fetal 
bovine serum, Dulbecco’s modified Eagle’s medium (DMEM), penicillin/streptomycin, and 
glutamax were obtained from Gibco BRL (Grand Island, NY, USA). All other chemicals were 
reagent grade and obtained from Sigma unless otherwise stated. 
III.3.2 Cell culture 
The mouse small intestinal epithelial cell (IEC) line, MODE-K (a generous gift from Dr. 
Ingo B. Autenrieth, University of Tübingen, Germany) was used in our study. These are small 
IECs from C3H/HeJ mice immortalized by simian virus (SV)-40 large T gene transfer, 
exhibiting morphological and phenotypic characteristics of normal enterocytes (Vidal et al., 
1993). MODE-K cells (passage 10–35) were cultured in high-glucose DMEM supplemented 
with 10% fetal bovine serum, 2 mM L-glutamine, and 5% penicillin/streptomycin. Cultures 
were maintained in a humidified 5% CO2 atmosphere at 37°C and experiments were 
conducted on cells at approximately 80-90% confluence. MODE-K cells were seeded at either 
3.5 x 105 cells per 2 ml of culture medium containing 10% serum in a six-well plate (for 
apoptosis assay) or at 1 x 104 cells per 200 µl of culture medium in a 96-well microtiter plate 
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(for all other assays), grown for 36 h and then serum starved overnight. On day 3, cells were 
treated with various concentrations of TNF-α/CHX for 0-6 h. Test drugs were pre-incubated 
for 1 h followed by co-incubation of drugs with various concentrations of TNF-α/CHX for 3-6 
h, with the exception of CoPP that was incubated for 3 h from 24 h till 21 h before exposure 
to TNF-α/CHX. The influence of test drugs alone on cell viability was studied on day 3 by 
incubating MODE-K cells for 12 h. 
III.3.3 Determination of cell viability 
Cell viability was assessed by luminescent cell viability assay with CellTiter-Glo 
(Promega, Madison, WI, USA) according to the manufacturer's protocol. This assay 
determines the number of viable cells in culture based on quantitation of ATP present, an 
indicator of metabolically active cells. Briefly, MODE-Κ cells were plated into 96-well plates 
and treated as described under cell culture. At the end of the incubation period with agents 
on day 3, an equivolume of the luminescent substrate and lysis buffer mix from the assay kit 
was added. The mixture was transferred to an opaque 96-well plate and luminescence was 
recorded using a GloMax Microplate Luminometer (Promega). The index of cellular viability 
was calculated as percentage of luminescence with respect to untreated control cells. 
III.3.4 Measurement of caspase-3/7 activity 
Caspase-3/7 activity was determined using the chemiluminescent Caspase-Glo 3/7 
Assay (Promega, Madison, WI, USA) according to the manufacturer’s instructions. The assay 
provides a luminogenic caspase-3/7 substrate, which contains the tetrapeptide sequence 
DEVD, in a reagent optimized for caspase activity, luciferase activity, and cell lysis. Briefly, 
MODE-Κ cells were plated into 96-well plates and treated as described under cell culture. 
After incubation, an equivolume of luminescent caspase-3/7 Glo substrate buffer was then 
added followed by gentle agitation for 30 min. The mixture was transferred to an opaque 96-
well plate and luminescence was recorded using a GloMax Microplate Luminometer 
(Promega). Relative luminescence units were noted and the results are expressed as 
percentage of luminescence with respect to untreated control. 
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III.3.5 Flow cytometry analysis of apoptosis 
Cellular DNA content and apoptosis were analyzed by flow cytometry as described 
previously (Nicoletti et al., 1991). This assays is based on the principle that the apoptotic 
cells with degraded DNA appear as cells with hypodiploid DNA content and are represented 
in so-called "sub-G1" peaks on DNA histograms. Briefly, cells were plated into six-well plates 
and after treatment for the indicated time, the cells were rinsed with PBS, harvested and 
then fixed by the progressive addition of ice-cold 70% ethanol. The fixed cells were washed 
twice with PBS before staining with PI at 100 µg/ml and RNase at 50 µg/ml in PBS for 20 min. 
Cell viability was determined by flow cytometry (FACSCalibur, BD Bioscience, NJ) and 
CellQuest software (Becton Dickinson, San Jose, CA, USA). Cell debris was excluded from 
analysis by appropriate raising of the forward scatter threshold. The percentage of cells that 
had undergone apoptosis was assessed to be the ratio of the fluorescent area smaller than 
the G0-G1 peak to the total area of fluorescence. The average of the results from at least 
three samples for each experimental condition is presented. 
III.3.6 Measurement of intracellular reduced glutathione (GSH) levels 
The intracellular content of reduced glutathione (GSH) was quantified using the 
bioluminescent GSH-Glo Glutathione Assay (Promega, Madison, WI, USA), essentially as 
recommended by the supplier. In brief, MODE-Κ cells were plated into 96-well plates and 
treated with TNF-α/CHX ± test drugs as described above. After incubation, adherent cells 
were directly lysed in 100 μl GSH-Glo lysis and reaction buffer. After addition of 100 μl GSH-
Glo Luciferin detection reagent, the mixture was transferred to an opaque 96-well plate and 
luminescence was detected using a GloMax Microplate Luminometer (Promega). The GSH 
levels of treated cells are expressed as percentage of the value in untreated control cells. 
III.3.7 Measurement of intracellular reactive oxygen species (ROS) generation 
The intracellular ROS level was detected using 5-(and-6)-carboxy-2′,7′-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) (Molecular Probes, Eugene, OR, 
USA) as reported (Wang & Joseph, 1999). Carboxy-H2DCFDA is a cell-permeable indicator for 
ROS that is nonfluorescent until the acetate groups are removed by intracellular esterases 
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and oxidation occurs within the cell. When oxidized by various active oxygen species, it is 
irreversibly converted to the fluorescent form, DCF. The fluorescence generated by DCF is 
proportional to the rate of carboxy-H2DCFDA oxidation, which is in turn indicative of the 
cellular oxidizing activity and intracellular ROS levels. For ROS measurements, briefly,  
MODE-Κ cells were plated into black 96-well plates and treated as described. Cells were 
washed twice in Hanks’ balanced salt solution (HBSS) and then incubated in HBSS containing 
carboxy-H2DCFDA (10 μM) for 40 min in the dark at 37°C. Fluorescence was measured using 
an excitation of 485 nm and emission of 530 nm, in a fluorescence plate reader (Wallac 
EnVision 2101 multilabel reader, Perkin Elmer, Zaventem, Belgium). Basal ROS generation in 
the cells treated without the stimulus was used as a control. 
III.3.8 Western blotting 
Total cell extracts were prepared using RIPA buffer and protein concentrations were 
measured with the BCA protein assay reagent (Pierce). Equal amounts of protein (20 μg) 
were loaded onto NuPAGE-Novex 4 to 12% Bis-Tris electrophoresis gels (Invitrogen) and 
blotted onto nitrocellulose membranes (GE Healthcare, Little Chalfont, Buckinghamshire, 
UK). Membranes were blocked in Tris-buffered saline/0.1% Tween 20 containing 5% nonfat 
dry milk and incubated overnight with appropriate antibodies for the detection of HO-1 (cat. 
no. sc-10789, 1:1000; Santa Cruz Biotechnology, Santa Cruz, CA) and β-tubulin (cat. no. 
ab6046, 1:1000; Abcam, Cambridge, UK). Horseradish peroxidase-linked secondary 
antibodies (Cell Signaling Technology Inc., Danvers, MA) were visualized by use of Amersham 
ECL Prime Substrate (GE Healthcare Life Sciences). Densitometry of the bands was 
performed using Image J software (National Institutes of Health, Bethesda, MD). 
III.3.9 Statistical analysis 
All data were expressed as mean ± SEM. Comparison of the means was performed 
using the Student’s t-test for two groups of data and ANOVA followed by Bonferroni’s 
multiple comparison test for comparison of more than two groups. Differences were 
considered to be significant at P < 0.05. 
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III.4 Results 
III.4.1 Influence of TNF-α/CHX on cell viability 
The aim of the first set of experiments was to assess the sensitivity of MODE-K cells 
to the cytotoxic effect of TNF-α by testing its influence on cell viability. TNF-α is a cytokine 
inducing apoptosis but many cell lines only undergo apoptosis when TNF-α is combined with 
an agent such as CHX. Previous observations in MODE-K cells showed that TNF-α per se in 
concentrations up to 10 ng/ml and incubated for up to 24 h did not induce cell death 
(Bharhani et al., 2006). We therefore first tested the apoptotic stimulus used in other 
intestinal epithelial cell lines (20 ng/ml TNF-α plus 25 µg/ml CHX) (Bhattacharya et al., 2003; 
Naugler et al., 2008; Greenspon et al., 2009). Incubation of MODE K-cells for 6 h with this 
combination decreased cell viability to 10% of untreated cells, while neither agent alone 
influenced cell viability, the latter corresponding to data with the same concentrations of 
both agents in rat IEC-6 cells (Bhattacharya et al., 2003). As preliminary experiments showed 
that the very pronounced effect of 20 ng/ml TNF-α plus 25 µg/ml CHX on cell viability was 
not influenced by any of the HO-1 related products, lower concentrations of TNF-α were 
investigated, in combination with either 25 or 10 µg/ml CHX, as 10 µg·/ml CHX is also often 
used in combination with TNF-α in cell lines (Johnson & Boise, 1999; Basuroy et al., 2006; 
Birbes et al., 2006). This showed a high sensitivity of MODE-K cells to TNF-α/CHX as 0.1-1 
ng/ml TNF-α together with 10 µg/ml CHX induced a concentration-dependent decrease in 
cell viability (to 54 ± 3% at 0.1 ng/ml and 22 ± 1% at 1 ng/ml TNF-α, Fig. III.1A), the effect 
with 1 ng/ml TNF-α plus 10 µg/ml CHX being close to that of 20 ng/ml TNF-α plus 25 µg/ml 
CHX. The concentration range of 0.1-1 ng/ml TNF-α was therefore studied in the assays for 
caspase-3/7 activity, apoptosis and oxidative stress. 
III.4.2 Influence of TNF-α/CHX on caspase-3/7 activity and apoptotic cell death 
The combination of TNF-α/CHX for 6 h induced an increase in caspase-3/7 activity in a 
concentration-dependent manner (Fig. III.1B). TNF-α (0.1 ng/ml) plus CHX (10 µg/ml) 
increased caspase-3/7 activity by 3.6 fold when compared to control while TNF-α (1 ng/ml) 
plus CHX (10 µg/ml) increased the caspase-3/7 activity by nearly 5 fold. Concomitantly,  
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Fig. III.1   Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX and of 20 ng/ml TNF-α plus 25 µg/ml CHX, 
incubated for 6 h, on cell viability (as % of control; A), caspase-3/7 activity (as % of control; B), and apoptosis 
(C). Control cells were incubated with serum free medium alone. Mean ± SEM of six independent experiments. 
*P < 0.05 versus control. D: Influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 0-6 h, on apoptosis. 
Mean ± SEM of three independent experiments. *P < 0.05 versus untreated (0 h) control group. 
flow cytometric analysis of PI-stained cells for apoptosis showed that TNF-α induced a 
concentration-dependent apoptotic cell death (Fig. III.1C). In both assays, the result with  
1 ng/ml TNF-α plus 10 µg/ml CHX approached that obtained with 20 ng/ml TNF-α plus  
25 µg/ml CHX studied in comparison. To evaluate the kinetics of TNF-α/CHX-induced 
apoptosis, MODE-K cells were incubated with 1 ng/ml TNF-α plus 10 µg/ml CHX for 0-6 h. 
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Induction of apoptosis began after exposure to TNF-α/CHX for 2 h and increased further in a 
time-dependent manner (Fig. III.1D). 
III.4.3 Influence of TNF-α/CHX on reduced glutathione (GSH) and reactive oxygen species 
(ROS) levels 
As a sequential pathway of “ROS production → caspase-3 activity → apoptosis” has 
been proposed for TNF-α/CHX-induced cell death in rat IEC-6 cells (Jin et al., 2008),  
TNF-α/CHX-induced oxidative stress in MODE-K cells was assessed by measurement of 
intracellular ROS generation and of the classic antioxidant GSH. Incubation of MODE-K cells 
with 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX for 3 h did not influence GSH levels, while 20 
ng/ml TNF-α plus 25 µg/ml CHX significantly decreased the GSH level to 62 ± 2% of untreated 
cells (Fig. III.2A). However, after 6 h of exposure, TNF-α/CHX reduced cellular GSH levels in a 
concentration-dependent manner, with 0.1 and 1 ng/ml TNF-α decreasing GSH levels to 69 ± 
3% and 44 ± 2%, respectively. TNF-α (20 ng/ml) plus CHX (25 µg/ml) added for 6 h decreased 
the GSH level to 21 ± 1%. 
Incubation of cells with TNF-α/CHX for 3 h also induced a concentration-dependent 
increase in ROS production (Fig. III.2B). When co-incubated with 10 µg/ml CHX, 0.1 and  
1 ng/ml TNF-α increased ROS production to 2.73 fold and 4.52 fold, respectively, compared 
to control. A time-course experiment with 1 ng/ml TNF-α plus 10 µg/ml CHX showed an 
increase in ROS production starting at 2 h (Fig. III.2C) illustrating that the increase in ROS 
production paralleled the induction of apoptosis. 
III.4.4 Effects of HO-1 and antioxidant-related products on TNF-α/CHX-induced decrease in 
cell viability 
To determine the highest concentration of the HO-1 and antioxidant-related products 
that was not cytotoxic per se, MODE-K cells were incubated with increasing concentrations 
of each compound for 12 h (n = 3 for each compound, data not shown). This concentration 
was then tested on the decrease in cell viability by 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX to 
screen for the protective effects versus the cytotoxic action of TNF-α/CHX. 
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Fig. III.2   Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX and of 20 ng/ml TNF-α plus 25 µg/ml CHX, 
incubated for 3 h (A, B) or 6 h (A), on cellular glutathione (GSH; as % of control; A) and intracellular ROS levels 
(B). Control cells were incubated with serum free medium alone. Mean ± SEM of six (A) or two (B) independent 
experiments. #P < 0.05 versus control (for 3 h). *P < 0.05 versus control (for 6 h). C: Influence of 1 ng/ml TNF-α 
plus 10 µg/ml CHX, incubated for 0-3 h, on intracellular ROS levels. Mean ± SEM of two independent 
experiments. *P < 0.05 versus untreated (0 h) control group. 
As for the HO-1 related products, 100 µM of bilirubin and 3 µM of biliverdin did not 
influence TNF-α/CHX-induced decrease in cell viability (data not shown), but 1 µM of 
bilirubin partially protected against 0.1 and 0.25 ng/ml TNF-α/CHX (Fig. III.3A). CORM-A1 
(100 µM) and CORM-3 (100 µM) induced significant partial protection from cell death at all 
concentrations of TNF-α/CHX tested (Fig. III.3B and C). The most effective CORM (CORM-A1) 
and the low concentration of bilirubin were selected for further study. 
With regard to the antioxidant-related products, apocynin (250 µM), Mito-TEMPO  
(1 µM) and DMOG (500 µM) did not influence the decrease in cell viability by TNF-α/CHX 
(data not shown). However, DPI (100 µM) showed prevention from TNF-α-induced 
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cytotoxicity at 0.1-0.5 ng/ml TNF-α/CHX, while nitrite (10 mM) showed cytoprotection at all 
tested concentrations of TNF-α/CHX (Fig. III.3D and E). The most effective agent was 
resveratrol (75 µM), which completely prevented cell death by 0.1 ng/ml TNF-α/CHX and 
restored cell viability in the presence of 1 ng/ml TNF-α/CHX from 22 ± 1% to 65 ± 3% (Fig. 
III.3F). On the basis of these results, nitrite (10 mM) and resveratrol (75 µM) were selected 
to further examine the relation between their influence on TNF-α/CHX-induced oxidative 
stress and on TNF-α/CHX-induced apoptosis. 
III.4.5 Effects of bilirubin, CORM-A1, nitrite and resveratrol on TNF-α/CHX-induced changes 
in caspase-3/7 activity and apoptosis 
Treatment with 1 µM bilirubin, 100 µM CORM-A1, 10 mM nitrite or 75 µM 
resveratrol significantly attenuated the TNF-α/CHX-induced increase in caspase-3/7 activity 
at all tested concentrations of TNF-α (Fig. III.4A-D). Among these agents, nitrite and 
resveratrol showed a more pronounced decrease of the induced caspase activities compared 
to bilirubin or CORM-A1. 
The anti-apoptotic effect was tested versus 0.1 and 1 ng/ml TNF-α/CHX. Bilirubin was 
not effective in preventing the apoptotic cell death at both tested TNF-α concentrations, 
while CORM-A1, nitrite and resveratrol partially prevented the apoptotic cell death induced 
by the two tested concentrations of stimulus (Fig. III.5A-D). The results with bilirubin 
illustrate that inhibition of TNF-α/CHX-induced caspase-3/7 activity does not necessarily 
result in a reduction of TNF-α/CHX-induced apoptosis. 
III.4.6 Effects of bilirubin, CORM-A1, nitrite and resveratrol on TNF-α/CHX-induced changes 
in GSH levels and ROS production 
The effect of the various agents on cellular levels of GSH were measured in the presence of 
TNF-α/CHX for 6 h. TNF-α (0.1-1 ng/ml) plus CHX significantly reduced cellular GSH levels 
while pretreatment with 1 µM bilirubin, 100 µM CORM-A1, 10 mM nitrite or 75 µM 
resveratrol partially prevented this effect (Fig. III.6A-D). We next investigated whether any of 
these agents could suppress TNF-α/CHX-induced ROS production by direct measurement of 
carboxy-H2DCFDA-derived fluorescence. TNF-α (1 ng/ml) plus CHX increased the ROS  
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Fig. III.4   Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, on caspase-3/7 activity (as % of 
control) in the absence and presence of 1 µM bilirubin (BR, A), 100 µM CORM-A1 (B), 10 mM nitrite (Nit, C) or 
75 µM resveratrol (Res, D). Control cells were incubated with serum free medium alone. Mean ± SEM of six 
independent experiments. *P < 0.05 versus control. #P < 0.05 versus corresponding group with TNF-α/CHX 
alone. 
 
 
Fig. III.3   Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, on cell viability (as % of control) 
in the absence and presence of 1 µM bilirubin (BR, A), 100 µM CORM-A1 (B), 100 µM CORM-3 (C), 100 µM 
diphenylene iodonium (DPI, D), 10 mM nitrite (Nit, E) or 75 µM resveratrol (Res, F). Control cells were 
incubated with serum free medium alone. Mean ± SEM of six independent experiments. *P < 0.05 versus 
control. #P < 0.05 versus corresponding group with TNF-α/CHX alone. 
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production by 4.63 fold compared to control, which was reduced to 3.51 fold by bilirubin, 
2.93 fold by CORM-A1, and 3.57 fold by nitrite (Fig. III.7). On the other hand, resveratrol 
completely abolished the TNF-α/CHX-induced increase in ROS production. The results with 
CORM-A1, nitrite and resveratrol suggest that inhibition of TNF-α/CHX-induced ROS 
production can contribute to the anti-apoptotic effects of these compounds in MODE-K cells. 
III.4.7 Effects of bilirubin, CORM-A1, nitrite and resveratrol on TNF-α/CHX-induced changes 
in HO-1 protein expression 
As induction of the expression of endogenous HO-1 has been suggested to contribute to the 
cytoprotective effects of CO-RMs and resveratrol (Kim et al., 2007; Sakata et al., 2010), the 
expression of HO-1 was assessed by Western blotting. In MODE-K cells, the baseline HO-1 
protein level was significantly decreased by 1 ng/ml TNF-α/CHX (Fig. III.8). The HO-1 inducer 
CoPP (10 µM) (Tsoyi et al., 2009), used as a positive control, increased HO-1 expression 
markedly both in the absence and presence of TNF-α/CHX. Treatment with 1 µM bilirubin, 
100 µM CORM-A1 or 10 mM nitrite did not affect basal HO-1 expression; in co-presence with 
TNF-α/CHX, the HO-1 level was not significantly different from that with TNF-α/CHX alone. 
Notably, 75 µM resveratrol per se induced HO-1 expression significantly to 1.63 fold as 
compared to the basal level. However, pretreatment of 75 µM resveratrol did not prevent 
the TNF-α/CHX-induced decrease in HO-1 protein expression. The results illustrate that HO-1 
expression does not contribute to the cytoprotective effect of CORM-A1, nitrite and 
resveratrol in MODE-K cells. 
III.5 Discussion 
The aim of this study was 1) to investigate the oxidative and apoptotic effects of  
TNF-α/CHX in the murine MODE-K epithelial cell line and 2) to evaluate the influence of HO-1 
and antioxidant-related products on the oxidative/apoptotic response to TNF-α/CHX in 
MODE-K cells. 
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Fig. III.5   Influence of 0.1 and 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, on apoptosis in the absence 
and presence of 1 µM bilirubin (BR, A), 100 µM CORM-A1 (B), 10 mM nitrite (Nit, C) or 75 µM resveratrol (Res, 
D). Control cells were incubated with serum free medium alone. Mean ± SEM of three independent 
experiments. *P < 0.05 versus control. #P < 0.05 versus corresponding group with TNF-α/CHX alone. 
III.5.1 Induction of oxidative stress and cell death in MODE-K cells by TNF-α 
The study showed that the MODE-K IEC line is highly sensitive to the cytotoxic effects of  
TNF-α with CHX, 0.1 ng/ml TNF-α plus 10 µg/ml CHX halving cell viability and 1 ng/ml TNF-α  
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Fig. III.6   Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, on cellular glutathione (GSH; as 
% of control) in the absence and presence of 1 µM bilirubin (BR, A), 100 µM CORM-A1 (B), 10 mM nitrite (Nit, 
C) or 75 µM resveratrol (Res, D). Control cells were incubated with serum free medium alone. Mean ± SEM of 
six independent experiments. *P < 0.05 versus control. #P < 0.05 versus corresponding group with TNF-α/CHX 
alone. 
plus 10 µg/ml CHX reducing cell viability to values close to that by 20 ng/ml TNF-α plus 25 
µg/ml CHX. The concentration range 0.1-1 ng/ml corresponds to TNF-α concentrations 
observed in mice under pathophysiological conditions of sepsis or postoperative ileus. After 
injection of endotoxin, circulatory peak levels of 0.78 and 2.11 ng/ml TNF-α have been 
reported (Copeland et al., 2005; Königsrainer et al., 2011); in mesenteric lymph derived from 
the gastrointestinal tract, still higher and more sustained TNF-α levels of approximately 3 
ng/ml were observed (Königsrainer et al., 2011). After intestinal manipulation, a TNF-α level  
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Fig. III.7   Influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 3 h, on intracellular ROS levels (as 
measured by DCF fluorescence) in the absence and presence of 1 µM bilirubin (BR), 100 µM CORM-A1, 10 mM 
nitrite (Nit) or 75 µM resveratrol (Res). Control cells were incubated with serum free medium alone. Mean ± 
SEM of four independent experiments. *P < 0.05 versus control. #P < 0.05 versus 1 ng/ml TNF-α plus 10 µg/ml 
CHX alone. 
of 0.08 ng/ml was obtained in peritoneal lavage fluid (Lubbers et al., 2009) and of 2 
ng/ml/mg in the supernatant of exteriorized and cultured muscularis layer (Schmidt et al., 
2012). 
TNF-α/CHX-induced apoptosis occurred in parallel with ROS production. TNF-α (0.1-1 
ng/ml) plus CHX treatment for 6 h induced concentration-dependent apoptosis correlating 
with its influence on cell viability. When studying the time-dependency of 1 ng/ml TNF-α, 
apoptosis started from 2 h of TNF-α incubation on, and this corresponded with the 
occurrence of ROS production. The concentration-dependent induction of apoptosis by  
TNF-α at 6 h was accompanied by a corresponding increase in caspase-3/7 activity, so that 
the sequence “ROS production → caspase-3/7 activity → apoptosis” as reported in rat IEC-6  
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Fig. III.8   Influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 3 h, on HO-1 protein expression (relative 
to β-tubulin) in the absence and presence of 10 µM cobalt protoporphyrin (CoPP), 100 µM CORM-A1, 1 µM 
bilirubin (BR), 75 µM resveratrol (Res) or 10 mM nitrite (Nit). Control cells were incubated with serum free 
medium alone. The influence of 20 ng/ml TNF-α plus 25 µg/ml CHX and DMSO, the solvent of Res was also 
studied. Mean ± SEM of three independent experiments. *P < 0.05 versus control. #P < 0.05 versus 1 ng·mL-1 
TNF-α/10 µg·mL-1 CHX alone. Representative immunoblots are shown at the top of the figure. 
cells (Jin et al., 2008) might also occur in MODE-K cells. The concentration-dependent 
induction of ROS by TNF-α at 3 h was not paralleled by a decrease in GSH, which only 
occurred at 6 h. GSH is a potent intracellular antioxidant that attenuates oxidative stress, 
while cytochrome c is a protein located in the mitochondrial intermembrane space which 
becomes pro-apoptotic when triggered by increased and sustained ROS production (Yang et 
al., 1997). Oxidative stress, due to ROS, can cause depletion of GSH levels in the 
mitochondria leading to the release and oxidation of cytochrome c to the cytosol and 
subsequent caspase activation. Since reduced GSH in mitochondria is the only defense 
provided to metabolize peroxides generated from the electron transport chain through the 
GSH redox cycle (Fernandez-Checa et al., 1998), from our observation, it seems that the 
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production of ROS in the form of peroxides starts at a later time point (after 3 h) during  
TNF-α/CHX exposure, while other forms of ROS (hydroxyl radical and superoxide anion) 
might play a role in earlier apoptosis induction from 2 h of TNF-α/CHX exposure in MODE-K 
cells. 
III.5.2 Influence of HO-1 related products on TNF-α/CHX-induced oxidative stress and 
apoptosis 
At the highest non-cytotoxic concentration used, CORM-3 and more effectively 
CORM-A1 reduced the decrease of cell viability by TNF-α, while 100 µM bilirubin or 3 µM 
biliverdin had no effect. However, at much lower concentration (1 µM), bilirubin has been 
shown to elicit antioxidant effects with significant reduction in ROS production and cell 
proliferation in human airway smooth muscle cells (Taille et al., 2003). At this concentration, 
our studies revealed that bilirubin partially prevented cell death induced by the two lower 
concentrations of TNF-α tested; although partially preventing the 1 ng/ml TNF-α/CHX-
induced increase in ROS production and caspase-3/7 activity, bilirubin failed to show any 
prevention of TNF-α/CHX-induced apoptosis. This is in agreement with a study by Basuroy et 
al. (2006) showing that bilirubin had only a mild effect on TNF-α/CHX-induced apoptosis 
although it reduced caspase-3 expression in a pronounced way. The mild effect of bilirubin 
on TNF-α/CHX-induced ROS-production is thus not sufficient to reduce TNF-α/CHX-induced 
apoptosis; neither is its mild effect on caspase-3/7 activity. The latter can be related to 
caspase-independent pathways of TNF-α-induced apoptosis as TNF-α has been reported to 
also induce caspase-independent cell death in a variety of cells like macrophages (Tran et al., 
2009), neutrophils (Maianski et al., 2003) and, in particular, HT-29 human adenocarcinoma 
cells (Wilson & Browning, 2002). 
The reduction of TNF-α/CHX-induced caspase-3/7 activity by CORM-A1 was also very 
mild, but in contrast to bilirubin, CORM-A1 was able to clearly reduce TNF-α/CHX-induced 
apoptosis. This dissociation can be attributed again to caspase-independent pathways of 
TNF-α-induced apoptosis. The exact mechanism of the anti-apoptotic effect of CORM-A1 in 
MODE-K cells remains to be clarified, but our study shows that its anti-apoptotic effect 
correlates with a reduction in ROS production, which was more pronounced than that 
observed with bilirubin, as well as an increase in GSH levels. Indeed, caspase-independent 
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induction of apoptosis by ROS has been reported in PC12 pheochromocytoma cells so that 
inhibition of ROS production per se can be expected to reduce apoptosis (Yuyama et al., 
2003). The finding that CORM-A1 exerts significant protection against both TNF-α/CHX-
induced oxidative stress and apoptosis supports the notion that CO can mediate the well-
known anti-apoptotic effect of HO-1. 
CO-RMs were shown to induce HO-1 expression in different types of cells (Sawle et 
al., 2005; Lee et al., 2006) and this was suggested to contribute to their anti-apoptotic effect 
(Kim et al., 2007). In thyroid carcinoma cells, HO-1 induction by hemin was shown to protect 
against TNF-α/CHX-induced apoptosis (Chen et al., 2004). In MODE-K cells in the actual 
study, basal HO-1 levels were decreased by 3 h exposure to TNF-α plus the protein synthesis 
inhibitor CHX, although TNF-α alone can reduce endogenous HO-1 expression in some cells 
(Chae et al., 2006). CoPP, a well-known HO-1 inducer as also confirmed in control MODE-K 
cells, still clearly induced HO-1 when cells were also incubated with TNF-α/CHX. However, 
this was not the case with CORM-A1, excluding the possibility that endogenous HO-1 
induction contributes to the anti-apoptotic effect of CORM-A1 in MODE-K cells. 
Correspondingly, exogenous CO protected pancreatic β-cells against TNF-α-induced 
apoptosis even when HO-1 activity was blocked (Gunther et al., 2002). 
III.5.3 Influence of antioxidant related products on TNF-α/CHX-induced oxidative stress and 
apoptosis 
Apocynin is widely used as an NADPH oxidase inhibitor (Stolk et al., 1994) and in 
Caco-2 cells, it was shown to inhibit polychlorinated biphenyls-induced NADPH oxidase 
activation and disruption of epithelial integrity (Choi et al., 2010). However, in the present 
study we found that apocynin did not protect at all MODE-K cells from TNF-α/CHX-induced 
cytotoxicity. This does not discard the possibility that NADPH oxidase is participating to  
TNF-α/CHX-induced ROS production in MODE-K cells since the inhibitory effect of apocynin 
on NADPH oxidase activity has been questioned (Heumüller et al., 2008). Another NADPH 
oxidase inhibitor, DPI (O'Donnell et al., 1993), partially protected MODE-K cells from  
TNF-α/CHX-induced cell death at lower concentrations of TNF-α, but not at 1 ng/ml TNF-α. 
Mitochondrial ROS has also been implicated in TNF-α-induced cytotoxicity (Schulze-
Osthoff et al., 1993). In our study, nitrite but not the mitochondrial-targeted antioxidant 
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Mito-TEMPO influenced TNF-α/CHX-induced decrease in cell viability of MODE-K cells. The 
concentration of nitrite (10 mM) used was shown to provide complete rescue of UVA-
induced apoptotic cell death in rat aortic endothelial cells (Suschek et al., 2003). We also 
found that nitrite reduced TNF-α/CHX-induced caspase-3/7 activation. It had a similar 
influence on TNF-α/CHX-induced ROS production as bilirubin, but in contrast to bilirubin, it 
also reduced TNF-α/CHX-induced apoptosis. In ischemia/reperfusion injury, nitrite has been 
shown to act by decreasing mitochondrial ROS generation through inhibition of complex I 
activity (Shiva et al., 2007). The fluorescent probe, carboxy-H2DCFDA, used in this study as an 
indicator of generalized oxidative stress is not specific for a single type of ROS like H2O2, 
peroxynitrite and peroxides (Possel et al., 1997; Afri et al., 2004). Consequently, this probe 
can detect different ROS types from mitochondria, lipid oxidation and other sources, and the 
similar degree of ROS reduction by nitrite and bilirubin does not necessarily mean that the 
same source of ROS is influenced by both agents. A more important role of mitochondrial 
ROS, rather than ROS from other sources, in the induction of apoptosis, might then explain 
why nitrite, preferentially reducing mitochondrial ROS production, is able to reduce 
apoptosis while bilirubin is not. 
Despite the fact that hydroxylase inhibitor DMOG has been reported to protect 
intestinal epithelial cells against TNF-α-induced apoptosis in vitro (Cummins et al., 2008) and 
to decrease hypoxia-induced ROS production in human synovial cells (Biniecka et al., 2011), 
it failed to prevent TNF-α/CHX-induced cell death in MODE-K cells. Resveratrol, a bioactive 
polyphenol from red wine, has shown cytoprotection in many models related to interaction 
with multiple targets, such as, for example, induction of silent mating type information 
regulator 2 homolog 1 (SIRT-1) (Petrovski et al., 2011). Its attenuating effect on dextran 
sulfate sodium-induced colitis was also related to SIRT-1 induction (Singh et al., 2010). 
Recently, induction of HO-1 was implied in the neuroprotective effect of resveratrol against 
stroke (Sakata et al., 2010). In our study, resveratrol per se increased basal HO-1 protein 
expression in MODE-K cells, but it did not prevent the decrease by TNF-α/CHX excluding  
HO-1 induction as the mechanism of action for its protective effect versus TNF-α/CHX. In 
MODE-K cells, resveratrol was by far the most effective cytoprotective agent as it fully 
abolished TNF-α/CHX-induced ROS production and caspase-3/7 activation; surprisingly, it 
only reduced apoptosis by approximately 50%. This suggests that TNF-α/CHX-induced 
apoptosis of MODE-K cells can occur in a ROS- and caspase-3/7-independent way. 
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In conclusion, these data indicate that mouse intestinal epithelial MODE-K cells are 
highly sensitive to TNF-α-induced apoptosis in the presence of CHX. TNF-α/CHX-induced 
apoptosis was accompanied by increased intracellular ROS generation and caspase-3/7 
activation. CORM-A1, nitrite and most importantly resveratrol attenuated TNF-α/CHX-
induced ROS production, caspase-3/7 activation and apoptosis. These agents might 
therefore be useful to prevent epithelial damage during ischemia/reperfusion injury. 
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Chapter IV 
Mitochondria and NADPH oxidases are the major sources of 
TNF-α/cycloheximide-induced oxidative stress in murine intestinal epithelial 
MODE-K cells 
 
IV.1  Abstract 
Background. TNF-α/cycloheximide (CHX)-induced apoptosis of the mouse intestinal 
epithelial cell line MODE-K corresponds with the production of reactive oxygen species 
(ROS). The aim of the study is to investigate the sources of ROS production contributing to 
apoptotic cell death during TNF-α/CHX-induced oxidative stress in MODE-K cells. 
Methods. Total ROS or mitochondrial superoxide anion production was measured 
simultaneously with cell death in the absence or presence of pharmacological inhibitors of 
various ROS-producing systems, and of ROS scavengers/antioxidants. The influence of  
TNF-α/CHX on mitochondrial membrane potential (Ψm) and cellular oxygen consumption 
was also studied. 
Key results. TNF-α/CHX time-dependently increased intracellular total ROS and 
mitochondrial superoxide anion production in MODE-K cells, starting from 2 h. Inhibition of 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) by a pan-NOX 
inhibitor (VAS-2870) and a specific inhibitor of Rac1 (NSC23766) significantly reduced  
TNF-α/CHX-induced total ROS and cell death levels. The mitochondrial electron transport 
chain inhibitors, amytal (IQ site of complex I) and TTFA (QP site of complex II) showed a 
pronounced decrease in TNF-α/CHX-induced total ROS, mitochondrial superoxide anion and 
cell death levels. TNF-α/CHX treatment caused an immediate decrease in mitochondrial 
respiration, and a loss of Ψm and increase in mitochondrial dysfunction from 1 h on. 
Conclusions. The results suggest that mitochondria and NOX are the two major 
sources of ROS overproduction during TNF-α/CHX-induced cell death in MODE-K cells, with 
superoxide anions being the major ROS species. Particularly, the quinone-binding sites of 
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mitochondrial complex I (site IQ) and complex II (site QP) seem to be the major sites of 
mitochondrial ROS production. 
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IV.2  Introduction 
Several acute and chronic intestinal inflammatory conditions such as necrotizing 
enterocolitis, postoperative ileus and inflammatory bowel disease (IBD) are accompanied 
with impairment of the intestinal epithelial barrier (Sharma & Tepas, 2010; Snoek et al., 
2012; Pastorelli et al., 2013). Upon the systemic inflammatory reaction during sepsis, 
disruption of the intestinal epithelial barrier can promote the progression towards multiple 
organ failure (Deitch, 2002). Amongst the pro-inflammatory cytokines produced in the 
inflamed intestine, tumor necrosis factor (TNF)-α is considered to play an important role in 
disrupting the intestinal epithelial barrier by induction of intestinal epithelial cell (IEC) 
apoptosis and shedding. Already in 1998, Piguet et al. showed in mice that acute intravenous 
administration of exogenous TNF-α leads to apoptosis of the IEC layer in a TNF type I 
receptor (TNFR1)-dependent manner and TNF was recently shown to be the crucial mediator 
of IEC apoptosis and shedding upon intraperitoneal injection of lipopolysaccharide in mice 
(Piguet et al., 1998; Williams et al., 2013). Apoptosis and IEC shedding in mouse is 
histologically analogous to that in humans (Bullen et al., 2006). 
Reactive oxygen species (ROS) have been implicated as second messengers during 
TNF-α-induced cell death in various cell systems (for review, see (Shen & Pervaiz, 2006)). The 
major ROS-producing enzyme systems are the nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase family, the mitochondrial electron transport chain (ETC) with complex I and 
III as major superoxide producers, xanthine oxidase and dysfunctional uncoupled endothelial 
nitric oxide (NO) synthase (eNOS) (Li et al., 2013a). The contribution of ROS to TNF-α-
induced IEC apoptosis has been mainly investigated in rat IECs. ROS production from NADPH 
oxidase (NOX) was implicated in TNF-α-induced apoptosis of the rat IEC line IEC-6 (Jin et al., 
2008), while mitochondrial dysfunction including enhanced mitochondrial ROS production 
was proposed for TNF-α-induced apoptosis in rat IEC line RIE-1 (Baregamian et al., 2009). 
Additionally, in rat enterocytes isolated 1 h after opening of the abdominal wall and 
intestinal handling, a condition inducing postoperative ileus where TNF-α is one of the 
inflammatory cytokines involved (Kalff et al., 2003), xanthine oxidase activity was 
significantly increased (Anup et al., 1999) and correspondingly, exposure of a human IEC 
monolayer to xanthine/xanthine oxidase significantly increased permeability (Mukojima et 
al., 2009). eNOS is not expressed in IECs (Chen et al., 2002; Konig et al., 2002) so that 
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uncoupled eNOS is unlikely as a ROS source in IECs. For the mouse IEC line MODE-K, we have 
previously reported that TNF-α/cycloheximide (CHX)-induced apoptosis corresponds with 
the production of ROS (Babu et al., 2012). The aim of the actual study was therefore to 
investigate the intracellular sources of TNF-α-induced ROS production in this model with 
particular attention for the mitochondrial sites of ROS production. Mitochondrial ROS are 
primarily superoxide anions and at least seven distinct sites of mitochondrial superoxide 
production have been described (Brand, 2010). A basal level of mitochondrial superoxide 
anions is present during normal respiration and its generation from complex I and III of the 
ETC is accepted to occur under physiologic conditions (Chen et al., 2003; Muller et al., 2004). 
Additionally, emerging evidence shows that complex II could also contribute to significant 
ROS production during pathological conditions like ischemia/reperfusion (Drose, 2013). In 
this study in MODE-K cells, total or mitochondrial ROS production by TNF-α/CHX was 
measured in parallel with induced cell death via flow cytometry in the absence or presence 
of pharmacological inhibitors of the various ROS-producing systems. Additionally, the 
influence of TNF-α/CHX on mitochondrial membrane potential (Ψm) and cellular oxygen 
consumption was studied. 
 
IV.3 Materials and methods 
IV.3.1 Chemicals and reagents 
Recombinant murine TNF-α was purchased from R&D system (Minneapolis, MN, 
USA). Reagents for cell culture, including Dulbecco’s modified Eagle’s medium (DMEM), 
penicillin/streptomycin, glutamax and fetal bovine serum were obtained from Gibco BRL 
(Grand Island, NY, USA). 2-(2,2,6,6-tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl) 
triphenylphosphonium chloride monohydrate (Mito-TEMPO) and JC-10 were purchased 
from Enzo Life Sciences (Zandhoven, Belgium). APC Annexin V, carboxylated (carboxy-
H2DCFDA) and chloromethyl (CM-H2DCFDA) analogues of 2′7′-dichlorodihydrofluorescein 
diacetate acetyl ester (H2DCFDA), Hoechst blue 33342, MitoTracker Deep Red FM, 
MitoTracker Green FM, MitoSOX Red, Sytox Red, Sytox Green and tetramethyl rhodamine 
methyl ester (TMRM) were purchased from Molecular Probes – Invitrogen (Carlsbad, CA, 
USA). The cell permeable lipophilic iron chelator, salicylaldehyde isonicotinoyl hydrazone 
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(SIH) was a kind gift from Prof. Dr. U Brunk. All other chemicals were obtained from Sigma 
(St. Louis, MO, USA). 
IV.3.2 Cell culture 
The mouse small IEC line, MODE-K (a generous gift from Dr. Ingo B. Autenrieth, 
University of Tübingen, Germany) was used in our study. This is a cell line derived from the 
duodenum-jejunum from normal young C3H/HeJ mouse immortalized by simian virus (SV)-
40 large T gene transfer. The cells are undifferentiated but still exhibit morphological and 
phenotypic characteristics of normal enterocytes (Vidal et al., 1993). MODE-K cells (passage 
10–35) were cultured in high-glucose DMEM supplemented with 10% fetal bovine serum, 2 
mM L-glutamine, and 5% penicillin/streptomycin. Cultures were maintained in a humidified 
5% CO2 atmosphere at 37°C and experiments were conducted on cells at approximately 80-
90% confluence. MODE-K cells were seeded at specified cell density in various experiments, 
grown for 36 h and then serum starved overnight (except when used for the cellular oxygen 
consumption assay). On day 3, cells were treated with various concentrations of TNF-α/CHX 
for 0-6 h. All the drugs tested for possible interference with TNF-α/CHX-induced effects were 
pre-incubated from 1 h before exposure to TNF-α/CHX, followed by co-incubation of drugs 
with various concentrations of TNF-α/CHX for 6 h, with the exception of the hydrophilic iron 
chelator desferrioxamine (DFO), which needs 3 h pre-incubation before exposure to  
TNF-α/CHX. The influence of drugs per se on cell viability was studied on day 3 by incubating 
MODE-K cells with a concentration dilution series for 12 h. The drugs were tested for 
possible interference with TNF-α/CHX-induced effects at the highest possible concentration 
without an effect per se on cell viability based on quantitation of ATP in MODE-K cells. 
IV.3.3 Cellular ATP measurement and determination of cell viability 
Cell viability was assessed using the CellTiter-Glo Luminescent Cell Viability Assay 
(Promega, Madison, WI, USA) according to the manufacturer's protocol. This assay 
determines the number of viable cells in culture based on quantitation of ATP present, an 
indicator of metabolically active cells. Briefly, MODE-Κ cells were plated at 1 x 104 cells per 
200 µL of culture medium per well in a 96-well microtiter plate. At the end of the 12 h 
incubation period with drugs on day 3, an equivolume of the luminescent substrate and lysis 
buffer mix from the assay kit was added. The mixture was transferred to an opaque 96-well 
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plate and luminescence was recorded using a GloMax Microplate Luminometer (Promega). 
The index of cellular viability was calculated as percentage of luminescence with respect to 
untreated control cells. 
IV.3.4 Flow cytometric analysis of mode of cell death 
We have previously reported that TNF-α/CHX induces apoptotic cell death in MODE-K 
cells as evidenced by increase in caspase-3/7 activity and DNA fragmentation (assessed as 
hypodiploid DNA content by flow cytometry) (Babu et al., 2012). The mode and kinetics of 
cell death was further characterized by annexin V and propidium iodide (PI) staining by using 
FITC Annexin V Apoptosis Detection Kit I (BD Pharmingen). One of the earliest events during 
apoptosis, the exposure of phosphatidylserine to the outer cell surface, is measured by its 
binding to FITC annexin V. Briefly, 2.5 x 105 cells per well were seeded in 6-well plates. After 
exposure of cells to TNF-α/CHX for 0-6 h, floating and adherent cells were collected, washed 
with PBS and then resuspended in 1x annexin V binding buffer at 1 x 106 cells/ml. To 0.1 ml 
of solution containing 1 x 105 cells, 5 μl of FITC Annexin V and 5 μl PI (10 µg/ml in PBS) were 
added; the cell suspension was gently vortexed and left incubated for 30 min at RT in the 
dark. A volume of 400 μl of 1x annexin V binding buffer was then added to each sample. 
Within 1 h, the cells were analyzed by flow cytometry (FACSCalibur, BD Bioscience, NJ) and 
quantified using CellQuest software (Becton Dickinson, San Jose, CA, USA). FITC Annexin V 
fluorescence was measured using a 530/30 nm bandpass filter (FL1) and PI fluorescence 
using a 670 nm longpass filter (FL3). At least 30,000 cells were acquired from each sample. 
Quadrant statistics were performed to determine viable (Annexin V-/PI-), early apoptotic 
(Annexin V+/PI-), late apoptotic/necrotic (Annexin V+/PI+) and dead cells (Annexin V-/PI+). 
IV.3.5 Measurement of intracellular ROS generation 
IV.3.5.1 Simultaneous determination of intracellular total ROS generation and cell 
death 
The intracellular total ROS production was detected using carboxy-H2DCFDA. 
Carboxy-H2DCFDA is a cell-permeable indicator for ROS that is nonfluorescent until the 
acetate groups are removed by intracellular esterases and oxidation occurs within the cell. 
When oxidized by various active oxygen species, it is irreversibly converted to the 
fluorescent form, DCF. The fluorescence generated by DCF is proportional to the rate of 
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carboxy-H2DCFDA oxidation, which is in turn indicative of the cellular oxidizing activity and 
intracellular ROS levels. For ROS measurements, briefly, 2.5 x 105 cells per well were seeded 
in 6-well plates. Following exposure of cells to TNF-α/CHX for 0-6 h with/without drugs, 
carboxy-H2DCFDA (10 μM) was loaded to the cells for 40 min before the end of the 
treatment period in the dark at 37°C. The floating and adherent cells were collected by 
trypsinization, washed twice with Hanks’ balanced salt solution (HBSS) with calcium and 
magnesium. Sytox Red (2.5 nM) dead cell stain was added to the cell suspension and 
simultaneous detection of ROS production and cell death was performed in a single 
experimental setup by flow cytometry using 488 nm excitation wavelength with 530/30 nm 
(FL1; DCF) and 670/30 (FL4; Sytox Red) emission filters. The green fluorescence of the ROS 
probes was measured only in the viable (Sytox Red-negative) cell population. Cells treated 
with hydrogen peroxide (H2O2) for either 40 min or 3 h were used as a positive control. 
IV.3.5.2 Simultaneous determination of mitochondrial superoxide anion, apoptosis and 
cell death 
MitoSOX Red was used to detect mitochondrial superoxide production anion. This 
modified cationic dihydroethidium dye is localized to the mitochondria where it is oxidized 
by superoxide anion to generate bright red fluorescence. Mitochondrial superoxide anion 
generation, apoptosis and cell death were determined in a single experimental setup as 
previously described (Mukhopadhyay et al., 2007). Briefly, the cells were loaded with 5 µM 
MitoSOX Red and 5 µl APC Annexin V (the latter only for the time kinetic assay) for 30 min 
before the end of treatment period, collected, washed twice with HBSS and then stained 
with 2 nM Sytox Green. The samples were run on a flow cytometer with 488 nm excitation 
to measure oxidized MitoSOX Red in the FL2 channel, APC Annexin V (FL4) and Sytox Green 
(FL1). Cell debris with low FSC (forward scatter) and SSC (side scatter) was excluded from the 
analysis. The cells were then analyzed for APC Annexin V (FL4) and Sytox Green (FL1). Cells 
that exhibited apoptosis (FL4-positive) or were dead (FL1-positive) were excluded from the 
analysis, and viable cells (Annexin V-/Sytox Green-) were gated and the mean fluorescence 
intensity (MFI) of MitoSOX Red staining was analyzed. Thus, MitoSOX Red of the cells 
analyzed excluded any non-specific interferences from apoptotic and dead cells. Cells 
treated for 30 min with 10 µM antimycin-A, an agent well known to generate superoxide 
anions by binding to the Qi site of cytochrome c reductase in the mitochondrial complex III, 
were used as a positive control. 
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For all ROS experiments, (a) the fluorescence properties of at least 30,000 cells were 
acquired from each sample, (b) the samples were analyzed immediately and strictly 
protected from light, (c) basal ROS generation in the cells treated without the stimulus 
(either medium alone or solvent-treated medium) was used as a control, (d) mean 
fluorescence intensities (MFIs) were expressed as percentage of control level set as 100%. 
IV.3.5.3 Imaging of intracellular total ROS/mitochondrial superoxide anion production 
and cell death 
The ROS production in MODE-K cells was also analyzed by imaging using laser 
scanning confocal microscopy (LSCM). Imaging of intracellular total ROS and cell death was 
performed after co-staining with CM-H2DCFDA and Sytox Red while imaging of mitochondrial 
superoxide anion production and cell death was performed after co-staining with MitoSOX 
Red and Sytox Green. Additionally, the cell-permeable DNA dye Hoechst 33342 was used in 
both experiments for nuclear staining. CM-H2DCFDA is a chloromethyl derivative of 
H2DCFDA, but it is much better retained in live cells than carboxy-H2DCFDA. CM-H2DCFDA 
passively diffuses into cells, where its acetate groups are cleaved by intracellular esterases 
and its thiol-reactive chloromethyl group reacts with intracellular glutathione and other 
thiols. Subsequent oxidation yields fluorescent DCF that is trapped inside the cell, which 
facilitates long-term studies. In brief, MODE-K cells were grown on 20 mm-culture dishes at a 
density of 2.3 x 105 cells per dish. On day three, the cells were stimulated with TNF-α  
(1 ng/ml) plus CHX (10 µg/ml) for 1-6 h at 37°C; the combination of dyes (1 µM CM-H2DCFDA 
and 1 µM Sytox Red or 1.25 µM MitoSOX Red and 2 µM Sytox Green, together with 10 µg/ml 
Hoechst 33342) was incubated from 40 min before the end of the incubation period. The 
cells were then washed once and confocal images were captured with a Zeiss LSM780 
confocal microscope (Zeiss, Jena, Germany) every hour from 0 to 6 h. Images were taken by 
using a Plan-Neofluar 25×/0.8 Imm Korr DIC M27 objective (1024 x 1024, pixel size: 332 nm x 
332 nm). Hoechst was excited with the Ti:Sa Laser MaiTai at 780 nm (1.2%). DCF and Sytox 
Green were excited using the 488 nm line of an Argon laser (0.5%). MitoSOX and Sytox Red 
were excited using a 633 nm diode laser (15%). Hoechst signals were collected from 415 to 
499 nm, DCF and Sytox Green from 499 to 569 nm, and MitoSOX and Sytox Red from 605 to 
690 nm. Z-sections were made every 2 µm. Image processing was performed using Fiji 
software. 
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IV.3.6 Detection of mitochondrial membrane potential (Ψm) 
IV.3.6.1 Estimation of mitochondrial membrane potential (Ψm) 
Estimation of mitochondrial membrane potential (Ψm) was performed using JC-10, a 
membrane permeable fluorescent probe. JC-10 is a cationic fluorophore, which is rapidly 
taken up by cells and mitochondria due to their negative charge. Inside mitochondria, JC-10 
forms J-aggregates which emit fluorescence at 590 nm (FL2; red fluorescence). Remaining 
JC-10 in cytosol maintains the monomeric form and emits fluorescence at 525 nm (FL1; 
green fluorescence). Uptake levels of JC-10 in mitochondria depend on the polarization state 
of the mitochondrial membrane. Depolarized mitochondria have lower uptake of JC-10 
compared to polarized mitochondria of a normal healthy cell. Briefly, 2.5 x 105 cells per well 
were seeded in 6-well plates. Following the treatment, cells were washed twice with HBSS 
and then incubated with 5 μM JC-10 solution prepared in DMEM media for 30 min. 
Subsequently, the cells were quickly washed with HBSS prior to measurement. The 
fluorescence intensities of JC-10 monomers and aggregates were quantified, respectively, by 
FL1 (530/30 nm) and FL2 (585/42 nm) detectors of the flow cytometer. The JC-10 
aggregate/monomer ratio is directly proportional to mitochondrial membrane potential 
intensity. This ratiometric method was used with this dye to provide a semi-quantitative 
measurement of Ψm. 
IV.3.6.2 Simultaneous determination of mitochondrial membrane potential (Ψm), 
apoptosis and cell death 
Determination of the changes in mitochondrial membrane potential (Ψm) was also 
performed using TMRM along with staining of APC Annexin V (for apoptosis, only for the 
time kinetic assay) and Sytox Green (for cell death). TMRM is a cell-permeant, lipophilic 
cationic, red-orange fluorescent dye that is readily sequestered by active mitochondria. 
Unlike JC-10, TMRM is a single wavelength dye that can be combined with a cell death 
marker to measure fluorescence exclusively in the live cells. Briefly, following the treatment, 
the cells were washed twice with HBSS and then incubated with 200 nM TMRM solution and 
5 µl APC Annexin V (the latter only for time kinetic assay) prepared in DMEM media for 30 
min. Subsequently, the cells were quickly washed twice with HBSS and stained with 2 nM 
Sytox Green prior to measurement. The percentage of TMRM, Annexin V APC and Sytox 
Green stained cells was calculated from at least 30,000 cells of each sample in comparison to 
Chapter IV 
Sources of ROS during TNF-α/CHX-induced oxidative stress and apoptosis 
 
138 
 
the control. TMRM was excited at 488 nm, and fluorescence emitted at 588 nm (FL2) was 
measured only in the viable (Annexin V-/Sytox Green-) cells by flow cytometry. Cells treated 
for 30 min with 50 µM carbonyl cyanide 3-chlorophenylhydrazone (CCCP), a potent 
uncoupler of oxidative phosphorylation which causes rapid loss of Ψm (loss of TMRM 
fluorescence), was used as a positive control. 
IV.3.7 Measurement of mitochondrial dysfunction 
Determination of respiratory chain damage was performed by double staining with 
two different mitochondria-specific dyes, MitoTracker Green FM and MitoTracker Deep Red 
FM to distinguish total and respiring mitochondria, respectively. Mitochondria in cells 
stained with MitoTracker Green FM dye exhibit bright green fluorescein-like fluorescence 
(FL1; fluorescence emission at 516 nm) as this dye accumulates in the lipid environment of 
mitochondria and becomes fluorescent. MitoTracker Deep Red FM is a red fluorescence 
probe (FL4; fluorescence emission at 665 nm) that does not fluoresce until it enters an 
actively respiring cell, where it is oxidized to the corresponding fluorescent mitochondrion-
selective probe and then sequestered in the mitochondria. The treated cells were incubated 
with 200 nM MitoTracker Green FM and 25 nM MitoTracker Deep Red FM in the dark at 
37°C for 30 min before the end of the treatment period. Next, the cells were harvested and 
the pellets were suspended in 0.5 ml of PBS. The samples were analyzed immediately by 
flow cytometry. The percentage of MitoTracker Green-positive/MitoTracker Deep Red-
negative cells is an important parameter of accumulation of cells with non-respiring 
(dysfunctional) mitochondria (Zhou et al., 2011). 
 
For ROS, Ψm and mitochondrial dysfunction assays, the samples were acquired and 
analyzed using a FACSCalibur using CellQuest software or with an LSR II using DIVA software 
(BD Biosciences). 
IV.3.8 Mitochondrial respiration 
Cellular oxygen consumption in the DMEM XF assay medium containing 1% FCS was 
measured in a Seahorse XF96 Analyzer (Seahorse Bioscience, Billerica, MA, USA). Oxygen 
consumption rate (OCR) and extracellular acidification rate (ECAR) were analyzed following 
the manufacturer’s protocols. Measurements are based on oxygen-dependent quenching of 
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a built-in fluorescent sensor. Briefly, MODE-K cells were seeded at 6.5 x 104 cells per well in 
Seahorse XF96 specialized cell culture plates. Approximately 24 h later, media was replaced 
with DMEM XF assay medium (unbuffered DMEM supplemented with 25 mM glucose, 2 mM 
L-glutamax and 1 mM sodium pyruvate) and cells were incubated for 1 h at 37°C without 
CO2. Then, basal OCR and ECAR were measured simultaneously in the Seahorse XF96 
extracellular flux analyzer for 2 h 30 min. Reagents and chemicals for respiratory stress 
testing were loaded onto XF96 extracellular flux assay plate. TNF-α/CHX, CCCP or 
rotenone/antimycin-A were diluted in DMEM running medium and loaded into port-A,  
port-B and port-C, respectively. Titrations were preliminarily performed to determine the 
optimal concentration of CCCP. In all cell groups, CCCP (50 µM) was added at 115 min to 
determine maximal respiration. Then rotenone (2.5 µM) and antimycin-A (5 µM) were added 
at 130 min to block mitochondrial respiration and non-mitochondrial respiration was 
determined. To test the influence of TNF-α/CHX, it was added at 30 min after five 
measurements of basal respiration. After measuring OCR and ECAR for 2 h 30 min, the 
amount of dead cells in the microchamber of each well was determined on a BD PathwayTM 
855 instrument as described previously (Duprez et al., 2011). This allows normalization of 
the respiratory rates in function of the amount of cells in each microchamber. Cells were 
plated with at least 5 replicate wells for each treatment group. The OCR and ECAR values 
were expressed as percentage of control versus basal measurements. 
IV.3.9 Statistical analysis 
All data were expressed as mean ± SEM. Comparison of the means was performed 
using the Student’s t-test for two groups of data and ANOVA followed by Bonferroni’s 
multiple comparison test for comparison of more than two groups. Differences were 
considered to be significant at P < 0.05. 
IV.4 Results 
IV.4.1 ROS is an important contributor to TNF-α/CHX-induced cell death in MODE-K cells 
We previously reported that TNF-α/CHX-induces ROS production in MODE-K cells 
(Babu et al., 2012). In the current study, simultaneous measurement of intracellular total 
ROS production and cell death was performed by flow cytometric analysis with carboxy-
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H2DCFDA as ROS indicator and Sytox Red as a marker for dead cells. ROS production 
measurements were performed exclusively in the live cell population. As shown in Fig. IV.1A 
(left panel), incubation of the cells with 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX for 6 h induced 
a concentration-dependent increase in MFI of DCF as compared with the control group, 
originating from an increasing percentage of DCF-positive live cells (Fig. IV.2A). The increase 
in ROS production is paralleled by an increase in cell death as measured by Sytox Red 
positivity (Fig. IV.1A, right panel). The increase in DCF MFI by 1 ng/ml TNF-α plus 10 µg/ml 
CHX is maximal as higher concentrations of TNF-α (up to 20 ng/ml) in combination with  
10 µg/ml CHX induced the same degree of DCF MFI (Fig. IV.2B); the response is close to that 
by 20 ng/ml TNF-α plus 25 µg/ml CHX, a classic apoptotic stimulus used in other intestinal 
epithelial cell lines (Bhattacharya et al., 2003; Jin et al., 2008; Naugler et al., 2008; 
Greenspon et al., 2009). To evaluate the time kinetics of TNF-α/CHX-induced ROS production 
and cell death, MODE-K cells were incubated with 1 ng/ml TNF-α plus 10 µg/ml CHX for  
0.5-6 h. As assessed by flow cytometry, significant induction of both ROS generation and cell 
death began after 2 h of exposure to TNF-α/CHX and increased further in a time-dependent 
manner (Fig. IV.1B); this was confirmed by laser scanning confocal microscopy (LSCM) (Fig. 
IV.3). The cell death modality followed apoptotic cell death kinetics as observed by the onset 
of annexin positivity at the same time where ROS production started, i.e., 2 h, with further 
increase upon time (Fig. IV.1C and 2C). Incubation for 40 min with hydrogen peroxide (H2O2), 
a positive control for total ROS production, also increased DCF fluorescence concentration-
dependently (0.5-3 mM), only causing a minor increase in cell death at 3 mM (Fig. IV.4A). 
Increasing the incubation time of H2O2 to 3 h increased both total ROS production and cell 
death in a concentration-dependent manner (Fig. IV.4B). 
To understand the role of ROS production in TNF-α/CHX-induced cell death in  
MODE-K cells, a set of antioxidants and ROS scavengers was tested versus 1 ng/ml TNF-α 
plus 10 µg/ml CHX (Table IV.1). With regard to the effects of hydrophilic antioxidants, the 
superoxide anion scavenger tiron completely abolished TNF-α/CHX-induced ROS production 
with significant partial reduction of cell death (Fig. IV.5A) while N-acetylcysteine (NAC), a 
precursor of the antioxidant reduced glutathione (GSH), significantly reduced both ROS 
production and cell death induced by TNF-α/CHX (Fig. IV.5B). The lipophilic antioxidants, 
butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) both as good as 
abolished TNF-α/CHX-induced ROS production and cell death, suggesting a possible causal 
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relationship between intracellular ROS generation and cell death in this cell system  
(Fig. IV.5C and 6A). On the other hand, the iron chelators, desferrioxamine (DFO) and 
salicylaldehyde isonicotinoyl hydrazone (SIH) also abolished TNF-α/CHX-induced ROS 
production but without any effect on cell death (Fig. IV.5D and 6B). In contrast, when using 
DFO or SIH versus 3 mM H2O2 (incubated for 3 h), they abolished both H2O2-induced total 
ROS production and cell death (Fig. IV.4C and D). 
IV.4.2 NOX and mitochondrial ETC complex enzymes, but not xanthine oxidase, contribute to 
TNF-α/CHX-induced total ROS production and cell death in MODE-K cells 
To determine the sources of ROS generation in response to TNF-α/CHX in MODE-K 
cells, we systematically used pharmacological inhibitors of various ROS producing systems 
within the IECs. Neither the xanthine oxidase inhibitor allopurinol (Fig. IV.7A) nor 
diphenylene iodonium (DPI; Fig. IV.7B), the most commonly used NOX inhibitor which acts 
on flavoproteins, influenced TNF-α/CHX-induced ROS production or cell death. However, a 
well-validated selective pan-NOX inhibitor, VAS-2870, partially reduced TNF-α/CHX-induced 
ROS accompanied by partial reduction in cell death suggesting that NOX is a possible source 
of ROS production in MODE-K cells (Fig. IV.7C). Furthermore, treatment with NSC23766, a 
Rac1 inhibitor known to block NOX activation, also significantly mitigated the ROS 
production and cell death to a similar level as VAS-2870 (Fig. IV.7D). 
Next, various mitochondrial respiration inhibitors blocking a complex enzyme of the 
ETC were tested (Fig. IV.8). Amytal, an inhibitor of the downstream quinone-binding site in 
complex I (IQ) greatly decreased TNF-α/CHX-induced ROS production with near abolishment 
of cell death (Fig. IV.9A). The ubiquinone binding (QP) site inhibitor of complex II, 
theonyltrifluoroacetone (TTFA) completely blocked TNF-α/CHX-induced total ROS 
 
Fig. IV.1   ROS production (assessed with carboxy-H2DCFDA) and cell death (assessed with Sytox Red) in  
TNF-α/CHX-treated MODE-K cells measured by flow cytometry. (A) Influence of 0.1-1 ng/ml TNF-α plus 10 
µg/ml CHX and of 20 ng/ml TNF-α plus 25 µg/ml CHX, incubated for 6 h, on intracellular total ROS levels 
(expressed as % of control DCF MFI; left panel) and cell death (expressed as % Sytox Red positivity; right panel). 
Control cells were incubated with serum-free medium alone. Mean ± SEM of six independent experiments. *P < 
0.05 versus control. (B) Time course study of the influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 
0.5-6 h, on intracellular total ROS levels (left panel) and cell death (right panel). Mean ± SEM of three 
independent experiments. *P < 0.05 versus untreated (0 h) control group. (C) Influence of 1 ng/ml TNF-α plus 
10 µg/ml CHX, incubated for 1-6 h, on FITC-Annexin V/propidium iodide (PI) positivity. Mean ± SEM of three 
independent experiments. *P < 0.05 versus untreated (0 h) control group. 
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Fig. IV.3   Time-dependent induction of ROS production (assessed with CM-H2DCFDA) and cell death (assessed 
with Sytox Red) by TNF-α/CHX in MODE-K cells as imaged with laser scanning confocal microscopy. Time course 
study of influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 0-6 h, on intracellular total ROS 
production and cell death after staining with the ROS probe CM-H2DCFDA (for total ROS production; green, first 
row), the cell-impermeable DNA dye Sytox Red (cell death; red, second row) and chromatin decondensation 
using the cell-permeable DNA dye Hoechst 33365 (for nuclei; blue, third row) imaged in separate channels and 
processed as merged image (fourth row). Results are representative of at least two independent experiments 
imaged at every one-hour time point. 
 
 
Fig. IV.2   ROS production (assessed with carboxy-H2DCFDA) and cell death (assessed with Sytox Red) in  
MODE-K cells. (A) Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX and of 20 ng/ml TNF-α plus 25 µg/ml CHX, 
incubated for 6 h, on intracellular total ROS production expressed as the percentage of DCF-positive live cells 
(left panel). Control cells were incubated with serum-free medium alone. Mean ± SEM of six independent 
experiments. *P < 0.05 versus untreated control group. Representative histogram of control and 1 ng/ml TNF-α 
plus 10 µg/ml CHX-treated group after carboxy-H2DCFDA staining in live cell population. The cells in M1 region 
represents the DCF-positive cells (right panel). (B) Influence of 1-20 ng/ml TNF-α plus 10 µg/ml CHX and of 20 
ng/ml TNF-α plus 25 µg/ml CHX, incubated for 6 h, on intracellular total ROS production after carboxy-H2DCFDA 
staining (expressed as % of control DCF MFI; left panel) and cell death (expressed as % Sytox Red positivity; 
right panel). Mean ± SEM of six independent experiments. *P < 0.05 versus untreated control group. (C) Time 
course study of TNF-α/CHX-induced apoptotic cell death in MODE-K cells. Representative dot plots of flow 
cytometric analysis showing the influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 0.25-6 h, on FITC 
Annexin V/propidium iodide (PI) positivity. Membrane changes leading to phosphatidylserine exposure 
occurring with the onset of apoptosis is measured by its binding with FITC Annexin V. Viable cells with intact 
membranes exclude PI, whereas the membranes of dead and damaged cells are permeable to PI. The shift of 
cells from the lower left quadrant (FITC Annexin V−/PI−) to the lower right quadrant (FITC Annexin V+/PI−) is 
clearly visible from 2 h on, while the shift to the upper right quadrant (FITC annexin V+/PI+) is visible from 3 h 
on. 
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Effect of commonly used antioxidants or inhibitors of ROS-generating enzymes on TNF-α/CHX-induced 
intracellular total ROS level and cell death 
 Percentage reduction of TNF-α/CHX-induced 
Antioxidants or inhibitors 
ROS level 
(DCF fluorescence) 
Cell death 
(Sytox Red positivity) 
Tiron 2.5 mM 95.2 ± 2.6* 46.6 ± 5.6* 
N-acetylcysteine (NAC) 20 mM 66.9 ± 2.7* 44.2 ± 1.2* 
Butylated hydroxyanisole (BHA) 200 µM 98.7 ± 0.7* 108.6 ± 2.8* 
Butylated hydroxytoluene (BHT) 50 µM 94.6 ± 1.7* 90.1 ± 2.1* 
Desferrioxamine (DFO) 1 mM 98.3 ± 1.4* 8.5 ± 2.3 
Salicylaldehyde isonicotinoyl hydrazone (SIH) 
100 µM 
86.7 ± 1.6* 2.9 ± 5.1 
Allopurinol 200 µM 3.4 ± 13.3 1.2 ± 4.2 
Diphenylene iodonium (DPI) 100 µM 1.3 ± 4.2 0.6 ± 2.1 
VAS-2870 10 µM 61.9 ± 2.9* 36.1 ± 3.3* 
NSC23766 50 µM 75.4 ± 4.0* 34.7 ± 5.5* 
Amytal 5 mM 76.3 ± 2.6* 90.5 ± 1.3* 
Theonyltrifluoroacetone (TTFA) 0.25 mM 97.5 ± 0.9* 75.8 ± 5.6* 
Malonate 1 mM 60.6 ± 1.1* -0.4 ± 4.0 
Antimycin-A 10 µM -29.2 ± 34.9 -9.1 ± 12.2 
Myxothiazole 1 µM 25.9 ± 1.8* 44.0 ± 2.9* 
Potassium cyanide (KCN) 2 mM 90.7 ± 1.1* 81.5 ± 1.2* 
Oligomycin 1 µM 38.0 ± 12.0* 42.0 ± 0.8* 
Carbonylcyanide m-chlorophenylhydrazone (CCCP)  
1 µM 
52.2 ± 7.7* 47.0 ± 9.3* 
Carbonyl cyanide p-trifluoro 
methoxyphenylhydrozone (FCCP) 0.5 µM 
23.5 ± 1.7* 57.7 ± 1.9* 
Mito-TEMPO 5 µM 9.6 ± 4.1 8.0 ± 7.9 
 
Mean ± SEM, n = 3, *: Significant reduction of the increase in intracellular total ROS level or cell death, induced 
by TNF-α (1 ng/ml)/CHX (10 µg/ml) (P < 0.05) 
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production with concomitant reduction of cell death (Fig. IV.9B). On the other hand, 
malonate, a competitive carboxylate (succinate) site inhibitor of complex II at the flavin 
binding domain, significantly reduced the ROS level but without any influence on cell death 
(Fig. IV.9C). Antimycin-A and myxothiazole, acting at different sites within complex III, are 
known to increase or decrease ROS, respectively. Accordingly, antimycin-A (Qi site inhibitor) 
per se induced ROS production but did not modulate TNF-α/CHX-induced ROS and cell death 
levels (Fig. IV.9D). On the other hand, myxothiazole (Qo site inhibitor) at the concentration 
used per se mildly induced ROS production; but it also mildly reduced TNF-α/CHX-induced 
ROS with pronounced recovery of cell death (Fig. IV.10A). The complex IV inhibitor 
potassium cyanide (KCN) nearly abolished TNF-α/CHX-induced ROS production and cell 
death (Fig. IV.10B). The complex V (F0F1-ATP synthase) inhibitor, oligomycin moderately 
reduced both TNF-α/CHX-induced ROS production and cell death, even though at the used 
concentration it per se mildly induced ROS production without affecting cell death as 
compared to control (Fig. IV.10C). The proton ionophore uncouplers, CCCP and carbonyl 
cyanide p-trifluoromethoxyphenylhydrozone (FCCP) both decreased TNF-α/CHX-induced 
ROS production and cell death partially but with variable effects, where FCCP resulted in less 
pronounced reduction of ROS levels and in higher cell death prevention as compared to 
CCCP (Fig. IV.10D and 11A). It should be noted however that FCCP per se increased ROS 
production mildly as compared to control. The mitochondria-targeted antioxidant Mito-
TEMPO did not show any effect on ROS generation or cell death induced by TNF-α/CHX (Fig. 
IV.11B). 
These results suggest that NOX and mitochondria, but not xanthine oxidase, 
contribute to ROS production and cell death after TNF-α/CHX challenge in MODE-K cells. 
 
 
Table IV.1 Effect of commonly used antioxidants or inhibitors of ROS-generating enzymes on TNF-α  
(1 ng/ml) plus CHX (10 µg/ml)-induced intracellular total ROS level and cell death in MODE-K cells stained with 
carboxy-H2DCFDA and Sytox Red (expressed as % reduction of the increase induced by TNF-α/CHX; a negative 
value indicates that the response to TNF-α/CHX increased in the presence of the compound).  
DCF: dichlorofluorescein. Mean ± SEM of three independent experiments. *: Significant reduction of the 
response to TNF-α/CHX (P < 0.05). 
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IV.4.3 TNF-α/CHX induces mitochondrial superoxide anion production in MODE-K cells 
In mitochondria, superoxide anion is generated as a byproduct during the flow of 
electrons through the four ETC complexes to molecular oxygen and is considered as the 
primary ROS originating from mitochondria. MitoSOX Red, a novel sensitive probe for highly 
selective detection of superoxide anion generated in the mitochondria of live cells (Robinson 
et al., 2006) was thus tested. Incubation of MODE-K cells with 0.1-1 ng/ml TNF-α plus  
10 µg/ml CHX for 6 h increased MitoSOX Red-detectable superoxide levels in a 
concentration-dependent manner, corresponding with the concentration-dependent 
increase in cell death (Fig. IV.12A). Moreover, 1 ng/ml TNF-α plus 10 µg/ml CHX for 0.5-6 h 
induced a time-dependent increase in mitochondrial superoxide anion production (Fig. 
IV.12B, left panel) starting at 2 h, which was paralleled by apoptosis (annexin positivity; data 
not shown) and cell death (Sytox Green positivity; Fig. IV. 12B, right panel). The 
mitochondrial superoxide level induced by 6 h of incubation with 1 ng/ml TNF-α plus 10 
µg/ml CHX was nearly 3 fold higher as the control level. Laser scanning confocal microscopic 
(LSCM) analysis confirmed the time-dependent increase in mitochondrial superoxide level 
(MitoSOX Red fluorescence) and cell death (Sytox Green fluorescence) by 1 ng/ml TNF-α plus 
10 µg/ml CHX (Fig. IV.13). Antimycin-A also increased generation of mitochondrial 
superoxide in a concentration-dependent manner further confirming the specificity of 
detection of mitochondrial superoxide generation by MitoSOX Red (data not shown). 
The mitochondrial complex I and II inhibitors amytal and TTFA, that nearly abolished 
total ROS production and cell death by TNF-α/CHX, were then tested on TNF-α/CHX-induced 
mitochondrial superoxide anion generation. Treatment with amytal significantly decreased 
TNF-α (1 ng/ml) plus CHX (10 µg/ml)-induced mitochondrial superoxide level by 72.9 ± 3.3% 
and cell death by 83.6 ± 4.9% (n = 3; Fig. IV.12C). TTFA abolished TNF-α/CHX-induced  
 
Fig. IV.4   ROS production and cell death in H2O2-treated MODE-K cells. (A and B) Influence of 0.25-3 mM H2O2, 
incubated for 40 min (A) or 3 h (B), on intracellular total ROS levels (expressed as % of control DCF MFI; left 
panel) and cell death (expressed as % Sytox Red positivity; right panel). Control cells were incubated with 
serum-free medium alone. Mean ± SEM of six (A) and three (B) independent experiments are given. *P < 0.05 
versus control. (C and D) Effect of desferrioxamine (DFO) or salicylaldehyde isonicotinoyl hydrazone (SIH) on 
H2O2-induced intracellular total ROS production and cell death in MODE-K cells measured by flow cytometry. 
Influence of 1 mM H2O2, incubated for 3 h, on intracellular total ROS levels (left panel) and cell death (right 
panel) in the absence and presence of 1 mM DFO (C) or 100 µM SIH (D). Control cells were incubated with 
serum-free medium alone; the effect of DFO or SIH per se was also tested. Mean ± SEM of three independent 
experiments. *P < 0.05 versus control. #P < 0.05 versus 1 mM H2O2 alone. 
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Fig. IV.6   Effect of a lipophilic antioxidant or of an iron chelator on TNF-α/CHX-induced total ROS production 
(assessed with carboxy-H2DCFDA) and cell death (assessed with Sytox Red) in MODE-K cells measured by flow 
cytometry. Influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, on intracellular total ROS levels 
(left panel) and cell death (right panel) in the absence and presence of 200 µM butylated hydroxyanisole (BHA; 
A) or 100 µM salicylaldehyde isonicotinoyl hydrazone (SIH; B). Control cells were incubated with serum-free 
medium alone; the effect of BHT or SIH per se was also tested. Mean ± SEM of three independent experiments. 
*P < 0.05 versus control. #P < 0.05 versus 1 ng/ml TNF-α plus 10 µg/ml CHX alone. 
 
 
mitochondrial superoxide production and reduced TNF-α/CHX-induced cell death by 77.5 ± 
3.8% (n = 3; Fig. IV.12D). This suggests that complex I (ubiquinone binding IQ site) and II (QP 
site) might be the major contributors of mitochondrial superoxide production. 
 
Fig. IV.5   Effect of antioxidants on TNF-α/CHX-induced total ROS production and cell death in MODE-K cells. 
Influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, on intracellular total ROS levels (left panel) 
and cell death (right panel) in the absence and presence of 2.5 mM tiron (A), 20 mM N-acetylcysteine (NAC; B), 
50 µM butylated hydroxytoluene (BHT; C) or 1 mM desferrioxamine (DFO; D). Control cells were incubated with 
serum-free medium alone; the effect of each antioxidant per se was also tested. Mean ± SEM of three 
independent experiments. *P < 0.05 versus control. #P < 0.05 versus 1 ng/ml TNF-α plus 10 µg/ml CHX alone. 
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Fig. IV.8   Graphical representation of different ROS producing sites in the mitochondria and the site of action 
of mitochondrial complex inhibitors. Flavin mononucleotide (FMN); Coenzyme Q (CoQ); Ubiquinone binding 
site of complex I (IQ); Flavin adenine dinucleotide (FAD); Proximal ubiquinone binding site of complex II (QP); 
Ubiquinol oxidation site of complex III (Qo site); Ubiquinone reduction site of complex III (Qi site); Cytochrome 
c (Cyt c). 
 
IV.4.4 Influence of TNF-α/CHX on mitochondrial membrane potential (Ψm), mitochondrial 
dysfunction and respiratory rate of MODE-K cells 
As ROS generation and depolarization of mitochondrial membrane potential (Ψm) can 
contribute to apoptosis (Ricci et al., 2003), we next examined the changes in Ψm in MODE-K 
cells. Treatment of MODE-K cells with 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX induced a 
concentration-dependent increase in cells with depolarized mitochondria (TMRM assay,  
 
Fig. IV.7   Effect of inhibitors of xanthine oxidase, NOX or Rac1 on TNF-α/CHX-induced total ROS production and 
cell death in MODE-K cells. Influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, on intracellular 
total ROS levels (left panel) and cell death (right panel) in the absence and presence of 200 µM allopurinol 
(Allo; A), 100 µM diphenylene iodonium (DPI; B), 10 µM VAS-2870 (VAS; C) or 50 µM NSC23766 (NSC; D). 
Control cells were incubated with serum-free medium alone; the effect of each inhibitor per se was also tested. 
Mean ± SEM of three independent experiments. *P < 0.05 versus control. #P < 0.05 versus 1 ng/ml TNF-α plus 
10 µg/ml CHX alone. 
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Fig. IV.14A, left panel and JC-10 assay, Fig. IV.15A) with concomitant increase in cell death 
(as assessed with Sytox Green in combination with the TMRM assay, Fig. IV.14A, right panel). 
About 60% of the cells treated with TNF-α (1 ng/ml) plus CHX (10 µg/ml) showed a reduction 
in Ψm, suggesting that a decrease in their respiratory chain activity or mitochondrial 
uncoupling might play an important role in cell death. The positive control CCCP dissipated 
the mitochondrial membrane potential in a concentration-dependent manner (JC-10 assay, 
Fig. IV.15B). The time kinetic assay with TNF-α (1 ng/ml) plus CHX (10 µg/ml) for 0.25-6 h 
showed that the depolarization of mitochondria started as early as 1 h and increased further 
in a time-dependent manner while annexin positivity and cell death started at 2 h (Fig. 
IV.14B). This suggests that collapse of the Ψm occurred as an early event during TNF-α/CHX-
induced apoptotic cell death in MODE-K cells. The most effective tested antioxidant, BHA, 
nearly abolished TNF-α/CHX-induced mitochondrial depolarization and cell death (Fig. 
IV.15C) implying that the changes in mitochondrial membrane potential might be a crucial 
event during cell death in MODE-K cells. Additionally, as an indicator of dysfunction of 
mitochondria, two types of mitochondria-specific dyes were used to distinguish actively 
respiring (MitoTracker Deep Red FM-positive) and total (MitoTracker Green FM-positive) 
mitochondria. TNF-α (0.1-1 ng/ml) plus CHX (10 µg/ml) increased the amount of respiration-
interrupted mitochondria in a concentration- and time-dependent (tested with 1 ng/ml; 
increase starting at 1 h) manner suggesting that mitochondrial dysfunction plays a crucial 
role in apoptotic cell death of MODE-K cells (Fig. IV.16 and 17). These data together suggest 
that dysfunctional mitochondria with reduced integrity might allow leakage of ROS from the 
mitochondria contributing to cell death. 
We next investigated whether the observed increase in ROS production and decrease 
in mitochondrial transmembrane potential could be related to modulation of mitochondrial 
energy metabolism. To this end, we measured cellular oxygen consumption and glycolysis 
rate using a Seahorse XF96 analyzer. Addition of TNF-α (1 ng/ml) plus CHX (10 µg/ml)  
 
Fig. IV.9   Effect of inhibitors of mitochondrial electron transport chain complex I, II or III on TNF-α/CHX-induced 
total ROS production and cell death in MODE-K cells. Influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated 
for 6 h, on intracellular total ROS levels (left panel) and cell death (right panel) in the absence and presence of  
5 mM amytal (Amy; A), 0.25 mM theonyltrifluoroacetone (TTFA; B), 1 mM malonate (Mal; C) or 10 µM 
antimycin-A (Ant-A; D). Control cells were incubated with serum-free medium alone; the effect of each 
inhibitor per se was also tested. Mean ± SEM of three independent experiments. *P < 0.05 versus control. #P < 
0.05 versus 1 ng/ml TNF-α plus 10 µg/ml CHX alone. 
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Fig. IV.11   (A and B) Effect of a proton ionophore uncoupler or of a mitochondria-targeted antioxidant on  
TNF-α/CHX-induced total ROS production and cell death in MODE-K cells. Influence of 1 ng/ml TNF-α plus  
10 µg/ml CHX, incubated for 6 h, on intracellular total ROS levels (left panel) and cell death (right panel) in the 
absence and presence of 0.5 µM carbonyl cyanide p-trifluoromethoxyphenylhydrozone (FCCP; A) or 5 µM Mito-
TEMPO (Mito; B). Control cells were incubated with serum-free medium alone; the effect of the compounds 
per se was also tested. Mean ± SEM of three independent experiments. *P < 0.05 versus control. #P < 0.05 
versus 1 ng/ml TNF-α plus 10 µg/ml CHX alone. 
 
 
Fig. IV.10   Effect of inhibitors of mitochondrial electron transport chain complex III, IV or V or of a proton 
ionophore uncoupler on TNF-α/CHX-induced total ROS production and cell death in MODE-K cells. Influence of 
1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, on intracellular total ROS levels (left panel) and cell death 
(right panel) in the absence and presence of 1 µM myxothiazole (Myxo; A), 2 mM potassium cyanide (KCN; B),  
1 µM oligomycin (Oligo; C) or 1 µM carbonylcyanide m-chlorophenylhydrazone (CCCP; D). Control cells were 
incubated with serum-free medium alone; the effect of each inhibitor per se was also tested. Mean ± SEM of 
three independent experiments. *P < 0.05 versus control. #P < 0.05 versus 1 ng/ml TNF-α plus 10 µg/ml CHX 
alone. 
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Fig. IV.13   Time-dependent induction of mitochondrial superoxide anion production (assessed with MitoSOX 
Red) and cell death (assessed with Sytox Green) by TNF-α/CHX in MODE-K cells as imaged with laser scanning 
confocal microscopy. Time course study of influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 0-6 h, 
on mitochondrial superoxide anion production and cell death after staining with the mitochondrial superoxide 
probe MitoSOX Red (for superoxide production; red, first row), the cell-impermeable DNA dye Sytox Green (cell 
death; green, second row) and chromatin decondensation using the cell-permeable DNA dye Hoechst 33365 
(for nuclei; blue, third row) imaged in separate channels and processed as merged image (fourth row). Results 
are representative of at least two independent experiments imaged at every one-hour time point. 
 
 
Fig. IV.12   TNF-α/CHX-induced mitochondrial superoxide anion production (assessed with MitoSOX Red) and 
cell death (assessed with Sytox Red) in MODE-K cells measured by flow cytometry. (A) Influence of 0.1-1 ng/ml 
TNF-α plus 10 µg/ml CHX and of 20 ng/ml TNF-α plus 25 µg/ml CHX, incubated for 6 h, on mitochondrial 
superoxide anion levels (expressed as % of control MitoSOX Red MFI; left panel) and cell death (expressed as % 
Sytox Red positivity; right panel). Control cells were incubated with serum-free medium alone. Mean ± SEM of 
six independent experiments. (B) Time course study of the influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, 
incubated for 0.5-6 h, with simultaneous determination of mitochondrial superoxide anion production 
(expressed as % of control MitoSOX Red MFI; left panel), annexin positivity (data not shown) and cell death 
(expressed as % Sytox Green positivity; right panel). Mean ± SEM of three independent experiments. *P < 0.05 
versus untreated control group in all panels. (C and D) Effect of inhibitors of mitochondrial electron transport 
chain complex I or complex II on TNF-α/CHX-induced mitochondrial superoxide anion production and cell death 
in MODE-K cells measured by flow cytometry. Influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 6 h, 
on mitochondrial superoxide anion levels (left panel) and cell death (right panel) in the absence and presence 
of 5 mM amytal (Amy; C) or 0.25 mM theonyltrifluoroacetone (TTFA; D). Control cells were incubated with 
serum-free medium alone; the effect of each inhibitor per se was also tested. Mean ± SEM of three 
independent experiments. *P < 0.05 versus control. #P < 0.05 versus 1 ng/ml TNF-α plus 10 µg/ml CHX alone. 
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induced a significant decrease in basal oxygen consumption rate (OCR; a measure of 
mitochondrial respiration) of MODE-K cells within a few minutes of its administration. The 
first value of OCR in the presence of TNF-α/CHX dropped by 21% compared to the value just 
before its addition; in the corresponding control group (medium treatment only), the drop 
was only 4% (P < 0.05 versus control). This drop in OCR after TNF-α/CHX addition persisted 
over the period of observation (until 115 min) with concurrent decrease of the basal 
extracellular acidification rate (ECAR; a measure of lactate release; data not shown) as 
compared to control (Fig. IV.18A and B). TNF-α/CHX also increased the maximal respiration 
induced by CCCP, however without any influence on the minimal non-mitochondrial 
respiratory rate. 
IV.5 Discussion 
IV.5.1 ROS overproduction plays a major role in TNF-α/CHX-induced cell death of MODE-K 
cells 
In the present study, we have utilized the well-characterized DCF fluorescence assay 
for measurement of total ROS production and observed that TNF-α/CHX-induced ROS only 
appears after 2 h in MODE-K cells. In contrast, TNF-α induced a rapid and transient increase 
in ROS production (rising as early as 15 min and already again decreasing in the 1 h exposure 
period) in rat RIE-1 cells (Baregamian et al., 2009), while TNF-α/CHX induced a rapid increase 
in ROS production from 20 min on (that was maintained for the 2 h exposure period) in rat 
IEC-6 cells (Jin et al., 2008). Interestingly, MODE-K cells showed a significant increase in DCF 
fluorescence only upon treatment with a high concentration of exogenous H2O2 (0.5 mM) for 
40 min while, contrarily, the same concentration of H2O2 for 15 min increased DCF 
fluorescence in the rat IEC-6 cells to the same ROS level as induced by TNF-α (20 ng/ml) plus 
 
Fig. IV.14   TNF-α/CHX-induced depolarization of mitochondrial membrane potential and apoptotic cell death in 
MODE-K cells measured by flow cytometry. (A) Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX and of  
20 ng/ml TNF-α plus 25 µg/ml CHX, incubated for 6 h, on mitochondrial membrane potential (expressed as % of 
cells with depolarized mitochondria after TMRM staining; left panel) and cell death (expressed as % Sytox 
Green positivity; right panel). Control cells were incubated with serum-free medium alone. Mean ± SEM of six 
independent experiments. *P < 0.05 versus control. (B) Time course study of influence of 1 ng/ml TNF-α plus  
10 µg/ml CHX, incubated for 0.25-6 h, on mitochondrial membrane potential (% of cells with depolarized 
mitochondria after TMRM staining), apoptosis (annexin positivity) and cell death (Sytox Green positivity). Mean 
± SEM of three independent experiments. *P < 0.05 versus untreated (0 h) control group. 
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CHX (25 µg/ml) treatment for 30 min (Jin et al., 2008). This suggests that MODE-K cells are 
highly resistant to the initial burst of oxidative stress by H2O2. Moreover, the time-
dependent ROS and cell death generation by TNF-α/CHX starting at 2 h suggests that the 
mouse intestinal epithelial cells are able to counteract the initial burst of oxidative stress up 
to a certain time point, after which the antioxidant defense can no longer be maintained. 
From then on, ROS signaling might lead to apoptotic cell death, as evidenced by annexin 
positivity. 
The reduction of both total ROS and cell death by a variety of antioxidants implies 
that ROS production might contribute to TNF-α/CHX-induced cell death in MODE-K cells. 
Moreover, the more pronounced effect of lipophilic BHT and BHA as compared to NAC in 
reducing TNF-α/CHX-induced ROS level and cell death suggests that the cytotoxic ROS 
produced is less accessible to NAC, which is a hydrophilic antioxidant, and thus might be 
released predominantly in the hydrophobic domain of the mitochondrial membrane. This is 
corroborated by the inability of the water-soluble mitochondria-targeted antioxidant mito-
TEMPO to suppress ROS generation or cell death. Therefore, we additionally assessed the 
contribution of mitochondrial ROS by direct measurement of the primary species of intra-
mitochondrial ROS, the superoxide anion with MitoSOX Red and we have shown, for the first 
time, an increase in the levels of mitochondrial superoxide anion with TNF-α/CHX in IECs. 
Our observation that mitochondria are an important source of ROS generation during TNF-α-
induced cell death in mouse MODE-K IECs is in agreement with previous reports in rat IECs, 
where the involvement of mitochondrial ROS in TNF-α-induced ROS production was studied 
 
 
Fig. IV.15   Influence of TNF-α/CHX and CCCP on mitochondrial membrane depolarization and effect of the 
antioxidant butylated hydroxyanisole (BHA) versus TNF-α/CHX in MODE-K cells as assessed by flow cytometry. 
(A) Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX and of 20 ng/ml TNF-α plus 25 µg/ml CHX, incubated for 6 
h, on mitochondrial membrane potential measured after JC-10 staining by flow cytometry (expressed as % of 
cells with polarized and depolarized mitochondria; left panel). (B) Influence of 1-5 µM·CCCP, incubated for 6 h, 
on mitochondrial membrane potential measured after JC-10 staining (expressed as % of cells with polarized 
and depolarized mitochondria; left panel). Control cells were incubated with serum-free medium alone. Mean 
± SEM of three independent experiments. *P < 0.05 versus control. In both (A) and (B), the right panels show 
representative dot plots of the flow cytometric analysis for the different concentrations of TNF-α/CHX or CCCP 
on the distribution of JC-10 aggregates (cells emitting red fluorescence in the FL-2 channel; R2 gate) and JC-10 
monomers (cells emitting green JC-10 detected in the FL-1 channel; R3 gate). (C) Influence of 1 ng/ml TNF-α 
plus 10 µg/ml CHX, incubated for 6 h, on mitochondrial membrane potential (expressed as % of cells with 
depolarized mitochondria after TMRM staining; left panel) and cell death (expressed as % Sytox Green 
positivity; right panel) in the absence and presence of 200 µM butylated hydroxyanisole (BHA). Control cells 
were incubated with serum-free medium alone; the effect of BHA per se was also tested. Mean ± SEM of three 
independent experiments. *P < 0.05 versus control. #P < 0.05 versus 1 ng/ml TNF-α plus 10 µg/ml CHX alone. 
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Fig. IV.16   TNF-α/CHX-induced concentration-dependent mitochondrial dysfunction in MODE-K cells. (A) 
Influence of 0.1-1 ng/ml TNF-α plus 10 µg/ml CHX and of 20 ng/ml TNF-α plus 25 µg/ml CHX, incubated for 6 h, 
on the amount of respiring mitochondria assessed with Mitotracker Green FM (FL1; FITC) and Mitotracker 
Deep Red FM (FL4; APC) staining. Representative dot plots of the flow cytometric analysis showing the effect of 
various concentrations of TNF-α/CHX on the population of cells (gated on live cells) losing mitochondrial 
potential and with respiration-interrupted mitochondria (shift of cell population towards P2 gated region). (B) 
Quantification of flow cytometric measurements (expressed as % of cells with dysfunctional mitochondria). 
Mean ± SEM of three independent experiments. *P < 0.05 versus untreated control group. 
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Fig. IV.17   TNF-α/CHX-induced time-dependent mitochondrial dysfunction in MODE-K cells. (A) Time course 
study of influence of 1 ng/ml TNF-α plus 10 µg/ml CHX, incubated for 0-6 h, on the amount of respiring 
mitochondria assessed with Mitotracker Green FM (FL1; FITC) and Mitotracker Deep Red FM (FL4; APC) 
staining. Representative dot plots of the flow cytometric analysis showing the effect of 1 ng/ml TNF-α plus 10 
µg/ml CHX upon time on the population of cells (gated on live cells) losing mitochondrial potential and with 
respiration-interrupted mitochondria (shift of cell population towards P2 gated region). (B) Quantification of 
flow cytometric measurements (expressed as % of cells with dysfunctional mitochondria). Mean ± SEM of three 
independent experiments. *P < 0.05 versus untreated (0 h) control group. 
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by use of mitochondrial DNA (mtDNA)-depleted rho zero (ρ°) cells (RIE-1 cells) (Baregamian 
et al., 2009) and using dihydrorhodamine 123 (IEC-6 cells) (Jin et al., 2008). However, our 
result with the novel fluorogenic probe MitoSOX Red certifies both species (superoxide 
anion) and organelle specificity (mitochondria) of ROS generation in living cells retaining a 
functional mitochondrial respiratory chain. The kinetic measurement of mitochondrial 
superoxide levels indicates the onset of mitochondrial ROS production at 2 h after exposure 
to TNF-α/CHX, when also apoptotic cell death starts. 
The abolishment of TNF-α/CHX-induced total ROS production by iron chelators 
without any influence on cell death excludes the contribution of iron-mediated oxidative 
stress in TNF-α/CHX-induced cell death of MODE-K cells. Iron mediates the Fenton reaction, 
transferring hydrogen peroxide to the highly toxic hydroxyl radical. The latter can thus 
indeed not contribute to TNF-α/CHX-induced cell death in MODE-K cells in the presence of 
the iron chelators (Vanden Berghe et al., 2010). Although non-specific and measuring all 
types of ROS, DCF shows more pronounced reactivity with hydroxyl radical than with 
hydrogen peroxide (39 fold difference) and superoxide anion (110 fold difference) 
(Setsukinai et al., 2003). In the presence of iron chelators, other ROS than hydroxyl radical, 
such as superoxide anion and hydrogen peroxide, might still be generated and contribute to 
cell death, but not be measurable with DCF. In contrast, the influence of DFO versus a 
cytotoxic concentration of H2O2 illustrates that H2O2-induced cytotoxicity is mainly due to 
the hydroxyl radical. Similar to the iron chelators, tiron abolished TNF-α/CHX-induced ROS 
production, but in contrast to them, it partially reduced TNF-α/CHX-induced cell death. Tiron 
is known to exert its antioxidant effect by metal chelation in addition to its superoxide anion  
 
Fig. IV.18   TNF-α/CHX-induced decrease in mitochondrial respiration in MODE-K cells. (A) Influence of 1 ng/ml 
TNF-α plus 10 µg/ml CHX, incubated for 2 h, on cellular oxygen consumption rate (OCR, expressed as % of 
basal). OCR was measured at different time points for 2.5 h. First, five consecutive measurements of baseline 
respiration during incubation with medium alone for 30 min were done. Then, 1 ng/ml TNF-α plus 10 µg/ml 
CHX was injected or not (control) followed by six consecutive measurements. Subsequently, the protonophore 
CCCP was added (50 μM) to measure maximal oxygen consumption for three measurements. Finally, the 
complex I inhibitor rotenone (2.5 μM) plus the complex III inhibitor antimycin-A (5 μM) were injected, followed 
by three consecutive measurements to determine the minimal mitochondrial respiration. Finally, the amount 
of viable cells (HOECHST+/PI- cells) in the microchamber of each well was determined by automated imaging. 
Data are expressed as percentage relative to the basal OCR measured just before TNF-α/CHX injection. The 
data represent the average of five replicates for each condition. (B) Absolute values for basal, maximal and 
minimal OCR after addition of medium (control) or TNF-α/CHX in MODE-K cells were analyzed as described 
above in (A). The data represent the oxygen consumption rate (pmol O2 per minute) per 1000 cells ± S.E.M 
(n=4). 
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scavenger and superoxide dismutase mimetic properties (Krishna et al., 1992). Thus, the 
reduction of TNF-α/CHX-induced cell death by tiron in contrast to the lack of effect of the 
iron chelators could be attributed to the latter effects at the cytoplasmic level. 
IV.5.2 NOXs contribute to ROS production during TNF-α/CHX-induced cell death in MODE-K 
cells 
The contribution of mitochondria as a major source of ROS production however does 
not exclude other ROS sources in the cell. Allopurinol failed to modulate TNF-α/CHX-induced 
ROS levels and cell death excluding xanthine oxidase as a possible source of ROS production 
in MODE-K cells. The NOX isozymes present in the mouse small intestinal epithelium are 
NOX1 and dual oxidase (DUOX)1/2 (Bedard & Krause, 2007; Jones et al., 2013). DPI, the most 
commonly used classical inhibitor of NOX enzymes, did not modulate the ROS level or the 
cell death induced by TNF-α/CHX. DPI is a specific flavoprotein inhibitor that not only inhibits 
the flavin component of NOX, but also inhibits the flavin site in mitochondrial complex I, 
which leads to increased mitochondrial ROS generation from complex I at a concentration as 
low as 1 µM (Li et al., 2003; Riganti et al., 2004; Liu & Schubert, 2009). However, in our study 
DPI at 100 µM per se did not induce total ROS generation. These results suggest that the ROS 
production site of TNF-α/CHX-treated MODE-K cells is not a DPI-inhibitable flavin site. 
However, the recently developed pan-NOX inhibitor VAS-2870 (Altenhofer et al., 2012) 
moderately decreased TNF-α/CHX-induced increase in ROS, suggesting that part of ROS 
generation could be attributed to NOX enzymes. Additionally, a relatively similar effect of 
NSC23766 to that of VAS-2870 implies that Rac1 mediated activation of NOX isozymes partly 
contributes to TNF-α/CHX-induced ROS production in MODE-K cells, corresponding to the 
role of Rac1 regulation in NOX-derived ROS production by TNF-α/CHX treatment of rat IEC-6 
cells (Jin et al., 2008). TNF-α has also been reported to lead to NOX-induced ROS production 
in cell systems other than IECs (Li et al., 2005; Kim et al., 2007; Lai et al., 2012). Moreover, 
activation of TNFR1 has been shown to lead to recruitment of NOX1, involving riboflavin 
kinase (Yazdanpanah et al., 2009). Thus, NOX is clearly one of the enzymatic ROS production 
systems involved during TNF-α/CHX-induced cell death of MODE-K cells. 
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IV.5.3 Mitochondrial complex I and II are the major contributors of ROS production during 
TNF-α/CHX-induced cell death in MODE-K cells 
Mitochondrial ROS has previously also been implicated in TNF-α-induced cytotoxicity 
(Jin et al., 2008; Kim et al., 2010). The investigation of the relative contribution of the 
respiratory chain complexes to TNF-α/CHX-induced ROS production by use of various 
inhibitors revealed the complex nature of ROS production in living MODE-K cells. Amytal, an 
inhibitor of the quinone-binding site in complex I (IQ) reduced TNF-α/CHX-induced ROS by 
76% and cell death by 91%. In contrast to malonate that inhibits complex II at the flavin 
binding domain, the pronounced effect of TTFA in mitigating TNF-α/CHX-induced ROS and 
cell death strongly suggests that the Qp site of complex II might be a major mitochondrial 
contributor of ROS production during TNF-α/CHX-induced cell death. The mitochondrial 
respiratory chain complexes I and III have been suggested to be the major mitochondrial ROS 
sources in the physiological state with normal oxygen levels (Chen et al., 2003; Turrens, 
2003). However, complex II has been implicated in hypoxia-induced ROS generation 
(Paddenberg et al., 2003) and tissue damage associated with oxidative stress (Ralph et al., 
2011). As treatment of MODE-K cells with TNF-α/CHX quickly induces decreased 
mitochondrial oxygen consumption (based on mitochondrial respiration analysis), 
mechanisms as occurring during hypoxia could develop so that it is plausible that complex II 
might also contribute to ROS production. Under such a condition, blockade of complex II at 
the Qp site by TTFA leads to a reduction of complex I related ROS production, generated by 
the reverse electron transfer from complex II into complex I. The partial reduction of  
TNF-α/CHX-induced ROS and cell death by myxothiazole, a Qo site inhibitor of complex III, 
implies that complex III is also involved in ROS production by TNF-α in MODE-K cells. 
Cyanide is a well-known inhibitor of cytochrome c oxidase (complex IV), by binding to 
heme a3; the effect of potassium cyanide shows that complex IV also in some way 
participates in ROS production by TNF-α/CHX-treated MODE-K cells. Oligomycin, an inhibitor 
of the proton-translocating ATP-synthase, also showed a protective effect in MODE-K cells, 
which is in agreement with a report in Hela cancer cells where oligomycin inhibited TNF-α-
induced ROS overproduction and cell death (Shchepina et al., 2002) suggesting a possible 
involvement of energy-coupled mechanisms in TNF-α-induced effects. Complex IV (involved 
in the reduction of molecular oxygen to water) and complex V (involved in the production of 
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ATP) are probably not direct sites of ROS production, but probably indirectly regulate ROS 
production from the mitochondria. The major sources of TNF-α/CHX-induced ROS 
production indeed seem complexes I, II and III at their interaction sites with the coenzyme Q 
(CoQ) in the Q cycle pool : IQ in complex I, QP in complex II and Qo in complex III. Superoxide 
released from complex III via Qo is released towards the intermembrane space, while 
complex I and II release superoxide towards the matrix. Superoxide released from complex 
III towards the matrix via the Qi site does not seem to contribute to TNF-α/CHX-induced ROS 
production in MODE-K cells, as antimycin-A had no protective influence. The effect of amytal 
and TTFA in mitigating TNF-α/CHX-induced MitoSOX Red fluorescence further underlines 
that complexes I (at the IQ site) and II (at the QP site) are major mitochondrial ROS 
production sites during TNF-α/CHX-induced cell death in MODE-K cells. Indeed, reverse 
electron transport from complex II to complex I is proposed to be a major pathway for 
mitochondrial ROS production (Drose, 2013). 
As the electrons are passed between the complexes from I to IV, complexes I, III and 
IV pump protons out of the mitochondrial matrix into the intermembrane space creating an 
electrochemical gradient across the mitochondrial inner membrane, the proton-motive 
force, consisting of a transmembrane electric potential and a transmembrane pH gradient. 
ROS production in the mitochondria is highly sensitive to changes in proton-motive force 
with slight increases intensifying ROS production and vice versa (Mailloux & Harper, 2012). 
Mild mitochondrial uncoupling with reduction of the mitochondrial membrane potential 
could thus effectively limit ROS generation (Produit-Zengaffinen et al., 2007) and this has 
been implicated as a negative feedback mechanism, counteracting elevated ROS (Papa & 
Skulachev, 1997; Echtay et al., 2003). Under conditions of oxidative stress, reduction of the 
proton gradient across the mitochondrial membrane by mild uncoupling is known to reduce 
mitochondrial ROS production particularly during reverse electron transport (Miwa et al., 
2003; Lambert & Brand, 2004; Giardina et al., 2008). In addition to reducing mitochondrial 
superoxide anion production, “mild” mitochondrial uncoupling has been hypothesized to be 
a protective mechanism against excessive ROS production by invoking the antioxidant 
defense system preventing cell death (“uncoupling to survive”) (Skulachev, 1996; Brand, 
2000; Mailloux & Harper, 2011). The addition of the proton ionophore uncouplers 1 h before 
exposure of MODE-K cells to TNF-α/CHX lowers the proton-motive force, and can thus be 
expected to attenuate mitochondrial superoxide production. The proton ionophore-induced 
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uncoupling might also induce the protective antioxidant defense system, contributing to the 
reduction of TNF-α/CHX-induced cell death with FCCP and CCCP. 
Mitochondrial function is crucial in maintaining the cellular integrity as mitochondria 
are the main cellular sites controlling energy metabolism and the redox state. Moreover, 
mitochondrial membrane potential (Ψm), metabolic state of mitochondria, and oxygen levels 
are the major factors regulating ROS production in mitochondria (Li et al., 2013b). The effect 
of the potent antioxidant BHA in restoring mitochondrial membrane polarization necessary 
for oxidative phosphorylation with concomitant recovery of cell death further underlines the 
importance of mitochondrial integrity to prevent TNF-α/CHX-induced cell death. Our 
observation that treatment of MODE-K cells with TNF-α/CHX causes a rapid decrease in 
cellular oxygen consumption creating a hypoxic state (within 5 min of addition) and a 
decrease in Ψm (occurring within 60 min) and mitochondrial dysregulation (starting at 60 
min) at earlier time points than ROS production and cell death (starting at 2 h), suggests that 
there could be a sequential link between these events. Taken together, targeted therapies to 
mitigate mitochondrial ROS could be of potential therapeutic benefit in reducing intestinal 
epithelial cell death and barrier dysfunction. 
IV.5.4 Possible interplay between NOX and mitochondria during TNF-α/CHX-induced cell 
death in MODE-K cells 
More recently, the possible existence of interplay between the NOX and 
mitochondrial sources of ROS has been proposed, where an increase in mitochondrial ROS 
can lead to NOX activation and vice versa (Dikalov, 2011). Interestingly, an increase in 
cellular ROS level originating from mitochondria was observed during serum starvation of 
human 293T cells; the mitochondrial ROS then trigger NOX1 activation by stimulating 
phospho-inositide 3-kinase and Rac1 and this pathway maintains ROS production in a later 
phase. Moreover, mitochondrial ROS are essential to initiate the process leading to cell 
death, but need the sustained accumulation of ROS by NOX activation to effectively induce 
cell death, as both inhibition of mitochondrial- or NOX-related ROS production prevented 
cell death (Lee et al., 2006). In agreement with that, the more pronounced effect in 
decreasing total cellular ROS and cell death by some of the mitochondrial complex inhibitors 
as compared to the moderate effect of the NOX inhibitor VAS-2870 in MODE-K cells, 
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suggests that TNF-α/CHX treatment of serum-starved MODE-K cells might trigger an initial 
phase of mitochondria-derived ROS production followed by a late phase of ROS production 
from NOX, whereby Rac1 might mediate the late (but not early) stage of ROS accumulation 
by interacting with NOX1. Additionally, a report in pulmonary artery smooth muscle cells 
showed more direct evidence for a role of hypoxia-induced mitochondrial ROS formation in 
NOX activation and further ROS production mediated via PKCε activation (Rathore et al., 
2008). So, it seems plausible that a similar ROS-derived cell death mechanism might occur 
upon TNF-α/CHX exposure of serum-deprived MODE-K cells, as this results in a state of low 
oxygen level as observed by the decrease in cellular oxygen consumption. However, this 
warrants further investigation to better understand the cross-talk between mitochondria 
and NOX during cellular stress response in IECs. 
 
In summary, this study presents evidence that mitochondria and NOX are the two 
major sources of ROS overproduction during TNF-α/CHX-induced cell death in MODE-K cells 
with superoxide anions being the major ROS species. In particular, the quinone-binding sites 
of mitochondrial complex I (site IQ) and complex II (site QP) seem to be the major sites of 
mitochondrial ROS production. Moreover, with TNF-α/CHX treatment, the decrease in 
mitochondrial respiration and loss of Ψm occurring as early events followed by subsequent 
ROS production might lead to apoptotic cell death in MODE-K cells. These findings might 
advance our understanding of the role of ROS production during cytokine-induced epithelial 
cell death involved in many acute gastrointestinal inflammatory conditions for the 
development of selective targeted therapy towards mitigating mitochondrial oxidative 
stress. 
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Chapter V 
Antioxidant potential of CORM-A1 and resveratrol during  
TNF-α/cycloheximide-induced oxidative stress and apoptosis in murine 
intestinal epithelial MODE-K cells 
 
V.1  Abstract 
Background. Targeting excessive production of reactive oxygen species (ROS) could 
be an effective therapeutic strategy to prevent oxidative stress-associated gastrointestinal 
inflammation. NADPH oxidase (NOX) and mitochondrial complexes (I and II) are the major 
sources of ROS production contributing to TNF-α/cycloheximide (CHX)-induced apoptosis in 
the mouse intestinal epithelial cell line, MODE-K. 
Methods. In the current study, the influence of a polyphenolic compound 
(resveratrol) and a water-soluble carbon monoxide (CO)-releasing molecule (CORM-A1) on 
the different sources of TNF-α/CHX-induced ROS production in MODE-K cells was assessed. 
This was compared with H2O2-, rotenone- or antimycin-A-induced ROS-generating systems. 
Intracellular total ROS, mitochondrial-derived ROS and mitochondrial superoxide anion 
(O2) production levels were assessed. Additionally, the influence on TNF-α/CHX-induced 
changes in mitochondrial membrane potential (Ψm) and mitochondrial function was studied. 
Key results. In basal conditions, CORM-A1 did not affect intracellular total or 
mitochondrial ROS levels, while resveratrol increased intracellular total ROS but reduced 
mitochondrial ROS production. TNF-α/CHX- and H2O2-mediated increase in intracellular total 
ROS production was reduced by both resveratrol and CORM-A1, whereas only resveratrol 
attenuated the increase in mitochondrial ROS triggered by TNF-α/CHX. CORM-A1 decreased 
antimycin-A-induced mitochondrial O2 production without any influence on TNF-α/CHX- 
and rotenone-induced mitochondrial O2 levels, while resveratrol abolished all three effects. 
Finally, resveratrol greatly reduced and abolished TNF-α/CHX-induced mitochondrial 
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depolarization and mitochondrial dysfunction, while CORM-A1 only mildly affected these 
parameters. 
Conclusions. These data indicate that the cytoprotective effect of resveratrol is 
predominantly due to mitigation of mitochondrial ROS, while CORM-A1 acts solely on NOX-
derived ROS to protect MODE-K cells from TNF-α/CHX-induced cell death. This might explain 
the more pronounced cytoprotective effect of resveratrol. 
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V.2  Introduction 
Disturbance of the intestinal epithelial barrier function is observed with the 
development of mucosal inflammation during acute and chronic enteropathies (Sharma & 
Tepas, 2010; Snoek et al., 2012; Pastorelli et al., 2013). Reactive oxygen species (ROS) are 
one of the major key players involved in the initiation and progression of inflammation 
(Mittal et al., 2014). Oxidative stress-induced epithelial cell damage leading to increased 
intestinal permeability and translocation of intraluminal endotoxins might trigger muscular 
inflammation during various conditions involving acute gastrointestinal (GI) inflammation 
such as postoperative ileus, septic ileus, necrotizing enterocolitis and acute intestinal 
ischemia/reperfusion (I/R) (Anup et al., 1999; de Winter et al., 2005; Baregamian et al., 
2009; De Backer et al., 2009; Guan et al., 2009). Moreover, overproduction of ROS with 
extensive mucosal injury has also been observed for chronic GI inflammation in animal 
models of inflammatory bowel disease (IBD) (Ahn et al., 2001; Reifen et al., 2004; Cetinkaya 
et al., 2005) and in colonic samples of ulcerative colitis patients (Oshitani et al., 1993; 
Nishikawa et al., 2005). Antioxidant treatment appears to reduce oxidative stress and 
associated inflammation in animal models of colitis (Millar et al., 1996; Damiani et al., 2007; 
Vasina et al., 2010) and in patients with ulcerative colitis (Aghdassi et al., 2003; Barbosa et 
al., 2003; Seidner et al., 2005). 
An array of pro-inflammatory cytokines is released within the intestinal mucosa 
during various GI inflammatory disorders (Kim et al., 2012) and, among others, tumor 
necrosis factor (TNF)-α is an early inflammatory mediator in inflamed intestine (Holtmann et 
al., 2002). Induction of intestinal epithelial cell (IEC) apoptosis and cell shedding by TNF-α is 
thought to play an important role in epithelial barrier dysfunction. We and others have 
reported that ROS play an important role in TNF-α-induced apoptotic cell death of IECs (Jin 
et al., 2008; Baregamian et al., 2009; Babu et al., 2012). In rat IEC-6 cells, the nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase (NOX) family and the mitochondrial 
electron transport chain (ETC) are the two major ROS-producing sources involved in  
TNF-α/cycloheximide (CHX)-induced cell death (Jin et al., 2008). The same accounts for 
murine MODE-K cells; particularly, in addition to NOX, complexes I and II of the 
mitochondrial ETC were found to be the main sites of superoxide anion (O2) production 
from the mitochondria, the primary ROS species originating from this organelle (Babu et al., 
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2015). These data indicate that the endogenous antioxidant defence system might not be 
sufficient to counteract TNF-α-induced ROS production, suggesting that mitigating excessive 
ROS production might be of therapeutic value to reduce intestinal barrier dysfunction during 
GI inflammation. 
Among the endogenous intracellular antioxidant pathways, heme oxygenase-1  
(HO-1) has a prominent role in the adaptation of tissues against oxidative stress since this 
redox-sensitive inducible enzyme generates biliverdin, a powerful antioxidant, and carbon 
monoxide (CO), which acts as a crucial signaling factor mediating a variety of important 
pharmacological effects (Ryter et al., 2006). CO-releasing molecules (CO-RMs), a class of 
organometallic compounds liberating CO in biological systems in a controllable manner, have 
been developed to mimic the antioxidant, anti-inflammatory and cytoprotective effects of 
CO (Motterlini et al., 2002; Sawle et al., 2005; Motterlini & Otterbein, 2010). The inhibitory 
effect of CO and CO-RMs on cytokine-induced changes in IECs might contribute to their 
beneficial effect in acute GI inflammation (Babu et al., 2014). The exact mechanism(s) of 
action of CO is still under scrutiny but emerging evidence indicates that the beneficial 
properties of CO may be linked to its ability to bind to heme-containing proteins such as NOX 
and mitochondrial complexes in different tissues (Taille et al., 2005; Bilban et al., 2008). The 
cytoprotective properties of CO/CO-RMs in IECs and their effect on cellular targets mediating 
ROS production in comparison to classical antioxidants have not been investigated so far. 
Resveratrol, a bioactive polyphenolic antioxidant present in red wine has been extensively 
studied with regard to cardiovascular and neuronal protection (Foti Cuzzola et al., 2011; 
Wang et al., 2012). Experimental data show that it also significantly ameliorates acute 
intestinal inflammation, such as induced by I/R (Ozkan et al., 2009) or by oral infection with 
Toxoplasma gondii (Bereswill et al., 2010). We previously showed that CORM-A1 as well as 
resveratrol reduced both TNF-α/CHX-induced ROS production and apoptosis in MODE-K IECs 
(Babu et al., 2012). The aim of the present study was therefore to investigate the influence 
of CORM-A1 and resveratrol on the different sources of TNF-α/CHX-induced ROS production 
in MODE-K cells. We also examined the effects of CORM-A1 and resveratrol on 
mitochondrial function by assessing TNF-α/CHX-induced changes in mitochondrial 
membrane potential (Ψm) and cellular oxygen consumption. 
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V.3 Materials and methods 
V.3.1 Chemicals and reagents 
Reagents for cell culture, including Dulbecco’s modified Eagle’s medium (DMEM), 
penicillin/streptomycin, glutamax and fetal bovine serum were obtained from Gibco BRL 
(Grand Island, NY, USA). JC-10 was purchased from Enzo Life Sciences (Zandhoven, Belgium). 
Carboxylated analogue of 2′7′-dichlorodihydrofluorescein diacetate acetyl ester (carboxy-
H2DCFDA), dihydrorhodamine 123 (DHR123), Hoechst blue 33342, MitoTracker Deep Red 
FM, MitoTracker Green FM, MitoSOX Red, Sytox Green, Sytox Red and 
tetramethylrhodamine methyl ester (TMRM) were purchased from Molecular Probes – 
Invitrogen (Carlsbad, CA, USA). Recombinant murine TNF-α was purchased from R&D system 
(Minneapolis, MN, USA). The cell permeable lipophilic iron chelator, salicylaldehyde 
isonicotinoyl hydrazone (SIH), was a kind gift from Prof. Dr. U Brunk. CORM-A1 was 
synthesized as previously described (Motterlini et al., 2005). All other chemicals were 
obtained from Sigma (St. Louis, MO, USA). All chemicals were dissolved in DMSO, except 
CORM-A1 and desferrioxamine (DFO), that were dissolved in water, and TNF-α, that was 
dissolved in phosphate buffered saline. 
V.3.2 Cell culture 
The mouse small IEC line, MODE-K (a generous gift from Dr. Ingo B. Autenrieth, 
University of Tübingen, Germany) was used in our study. This is a cell line derived from the 
duodenum-jejunum from normal young C3H/HeJ mouse immortalized by simian virus (SV)-
40 large T gene transfer. The cells are undifferentiated but still exhibit morphological and 
phenotypic characteristics of normal enterocytes (Vidal et al., 1993). MODE-K cells (passage 
10–35) were cultured in high-glucose DMEM supplemented with 10% fetal bovine serum,  
2 mM L-glutamine, and 5% penicillin (10,000 units/ml)/streptomycin (10 mg/ml). Cultures 
were maintained in a humidified 5% CO2 atmosphere at 37°C and experiments were 
conducted on cells at approximately 80-90% confluence. MODE-K cells were seeded at 
specified cell density in various experiments, grown for 36 h and then serum starved 
overnight (except when used for the cellular oxygen consumption assay). On day 3, cells 
were treated with 1 ng/ml TNF-α plus 10 µg/ml CHX for 6 h. All the drugs tested for possible 
interference with TNF-α/CHX-induced effects were pre-incubated from 1 h before exposure 
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to TNF-α/CHX followed by co-incubation of drugs with TNF-α/CHX for 6 h, with the exception 
of the hydrophilic iron chelator DFO, which needs 3 h pre-incubation before exposure to 
TNF-α/CHX. Except otherwise indicated, the drugs used in the actual study (allopurinol, 
CORM-A1, DFO, NSC23766, resveratrol, SIH and VAS-2870) were applied in the highest 
possible concentration without an effect per se on cell viability of MODE-K cells when 
incubated for 12 h, based on quantitation of ATP (see Babu et al., 2012; Babu et al., 2015). 
V.3.3 Simultaneous determination of intracellular total or mitochondrial ROS generation 
and cell death 
In our previous study in MODE-K cells, CORM-A1 and resveratrol reduced both  
TNF-α/CHX-induced ROS production and apoptosis as assessed in two separate assays, i.e. 
fluorescence measurement of carboxy-H2DCFDA with a microtiter plate reader, and flow 
cytometric analysis of DNA hypoploidy upon staining with propidium iodide (PI), respectively 
(Babu et al., 2012). In the actual study, ROS production and cell death were measured 
simultaneously by flow cytometry, allowing measurement of ROS production in gated viable 
cells. 
Carboxy-H2DCFDA is a cell-permeable indicator for ROS that is nonfluorescent until 
the acetate groups are removed by intracellular esterases and oxidation occurs within the 
cell. When oxidized by various active oxygen species, it is irreversibly converted to the 
fluorescent form, DCF. The fluorescence generated by DCF is proportional to the rate of 
carboxy-H2DCFDA oxidation, which is in turn indicative of the cellular oxidizing activity and 
intracellular ROS levels. DHR123 has been reported as a marker for mitochondrial ROS 
production (Jin et al., 2008; Basu Ball et al., 2011; Tiede et al., 2011). It is an uncharged and 
non-fluorescent ROS indicator that can passively diffuse across membranes where it is 
oxidized to cationic rhodamine 123 (R123) which localizes in the mitochondria and exhibits 
green fluorescence. For ROS measurements, briefly, 2.5 x 105 cells per well were seeded in  
6-well plates. Following exposure of cells to 1 ng/ml TNF-α plus 10 µg/ml CHX for 6 h 
with/without drugs, carboxy-H2DCFDA (10 μM) or DHR123 (1 μM) was loaded to the cells for 
40 min before the end of the treatment period in the dark at 37°C. The floating and adherent 
cells were collected by trypsinization and washed twice with Hanks’ balanced salt solution 
(HBSS) with calcium and magnesium. Sytox Red (2.5 nM) dead cell stain was added to the 
cell suspension and simultaneous detection of ROS production and cell death was performed 
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in a single experimental setup by flow cytometry using 488 nm excitation wavelength with 
530/30 nm (FL1; DCF or R123) and 670/30 (FL4; Sytox Red) emission filters. Viable (Sytox 
Red-negative) cells were gated and the green fluorescence of the ROS probes was analyzed 
in these cells. Cells treated with 1 mM hydrogen peroxide (H2O2) for 40 min were used as a 
positive control. 
V.3.4 Simultaneous determination of mitochondrial O2 and cell death 
MitoSOX Red was used to detect mitochondrial O2 production. This modified 
cationic dihydroethidium dye is localized to the mitochondria where it is oxidized by O2 to 
generate bright red fluorescence (Robinson et al., 2006). Mitochondrial O2 generation and 
cell death were determined in a single experimental setup by treating the cell samples with 
MitoSOX Red and Sytox Red. Briefly, the cells were loaded with 5 µM MitoSOX Red for 30 
min before the end of treatment period, collected, washed twice with HBSS and then stained 
with 2.5 nM Sytox Red. The samples were run on a flow cytometer with 488 nm excitation to 
measure oxidized MitoSOX Red in the FL2 channel and Sytox Red in the FL4 channel. Cell 
debris with low FSC (forward scatter) and SSC (side scatter) was excluded from the analysis. 
Dead cells (FL4-positive) were also excluded from the analysis and the mean fluorescence 
intensity (MFI) of MitoSOX Red staining was analyzed in the gated viable cell population 
(Sytox Red-negative). Thus, MitoSOX Red of the cells analyzed excluded any non-specific 
interferences from dead cells. Cells treated for 30 min with 10 µM antimycin-A, an agent 
well known to generate O2 by binding to the Qi site of cytochrome c reductase in the 
mitochondrial complex III, were used as a positive control. 
 
For all ROS experiments, (a) the fluorescence properties of at least 30,000 cells were 
acquired from each sample, (b) the samples were analyzed immediately and strictly 
protected from light, (c) basal ROS generation in cells not exposed to TNF-α/CHX, in culture 
medium alone or in medium containing the solvent of the drug to be studied versus  
TNF-α/CHX, was used as a control, and (d) mean fluorescence intensities (MFIs) were 
expressed as percentage of control level set as 100%. 
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V.3.5 Detection of mitochondrial membrane potential (Ψm) 
Estimation of mitochondrial membrane potential (Ψm) was performed using JC-10, a 
membrane permeable fluorescent probe. JC-10 is a cationic fluorophore, which is rapidly 
taken up by cells and mitochondria due to their negative charge. Inside mitochondria, JC-10 
forms J-aggregates which emit fluorescence at 590 nm (FL2; red fluorescence). Remaining 
JC-10 in cytosol maintains the monomeric form and emits fluorescence at 525 nm (FL1; 
green fluorescence). Uptake levels of JC-10 in mitochondria depend on the polarization state 
of the mitochondrial membrane. Depolarized mitochondria have lower uptake of JC-10 
compared to polarized mitochondria of a normal healthy cell. Briefly, 2.5 x 105 cells per well 
were seeded in 6-well plates. Following the treatment, cells were washed twice with HBSS 
and then incubated with 5 μM JC-10 solution prepared in DMEM media for 30 min. 
Subsequently, the cells were quickly washed with HBSS prior to measurement. The 
fluorescence intensities of JC-10 monomers and aggregates were quantified, respectively, by 
FL1 (530/30 nm) and FL2 (585/42 nm) detectors of the flow cytometer. The JC-10 
aggregate/monomer ratio is directly proportional to mitochondrial membrane potential 
intensity. This ratiometric method was used with this dye to provide a semi-quantitative 
measurement of Ψm. 
V.3.6 Simultaneous determination of mitochondrial membrane potential (Ψm) and cell 
death 
Determination of the changes in mitochondrial membrane potential (Ψm) was also 
performed using TMRM along with staining of Sytox Green (for cell death). TMRM is a cell-
permeant, lipophilic cationic, red-orange fluorescent dye that is readily sequestered by 
active mitochondria. Unlike JC-10, TMRM is a single wavelength dye that can be combined 
with a cell death marker to measure fluorescence exclusively in the live cells. Briefly, 
following the treatment, the cells were washed twice with HBSS and then incubated with 
200 nM TMRM solution prepared in DMEM media for 30 min. Subsequently, the cells were 
quickly washed twice with HBSS and stained with 2 nM Sytox Green prior to measurement. 
The percentage of TMRM and Sytox Green stained cells was calculated from at least 30,000 
cells of each sample in comparison to the control. TMRM was excited at 488 nm, and 
fluorescence emitted at 588 nm (FL2) was measured in gated viable (Sytox Green-negative) 
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cells by flow cytometry. Cells treated for 30 min with 50 µM carbonyl cyanide 3-
chlorophenylhydrazone (CCCP), a potent uncoupler of oxidative phosphorylation which 
causes rapid loss of Ψm (loss of TMRM fluorescence), were used as a positive control. 
V.3.7 Measurement of mitochondrial dysfunction 
Determination of respiratory chain damage was performed by double staining with 
two different mitochondria-specific dyes, MitoTracker Green FM and MitoTracker Deep Red 
FM to distinguish total and respiring mitochondria, respectively. Mitochondria in cells 
stained with MitoTracker Green FM dye exhibit bright green fluorescein-like fluorescence 
(FL1; fluorescence emission at 516 nm) as this dye accumulates in the lipid environment of 
mitochondria and becomes fluorescent. MitoTracker Deep Red FM is a red fluorescence 
probe (FL4; fluorescence emission at 665 nm) that does not fluoresce until it enters an 
actively respiring cell, where it is oxidized to the corresponding fluorescent mitochondrion-
selective probe and then sequesters in the mitochondria. The treated cells were incubated 
with 200 nM MitoTracker Green FM and 25 nM MitoTracker Deep Red FM in the dark at 
37°C for 30 min before the end of the treatment period. Next, the cells were harvested and 
the pellets were suspended in 0.5 mL of PBS. The samples were analyzed immediately by 
flow cytometry. The percentage of MitoTracker Green-positive/MitoTracker Deep Red-
negative cells is an important parameter of accumulation of cells with non-respiring 
(dysfunctional) mitochondria (Zhou et al., 2011). 
 
For ROS, Ψm and mitochondrial dysfunction assays, the samples were acquired and 
analyzed using a FACSCalibur using CellQuest software or with an LSR II using DIVA software 
(BD Biosciences). 
V.3.8 Mitochondrial respiration 
Cellular oxygen consumption in the DMEM XF assay medium containing 1% FCS was 
measured in a Seahorse XF96 Analyzer (Seahorse Bioscience, Billerica, MA, USA). Oxygen 
consumption rate (OCR) and extracellular acidification rate (ECAR) were analyzed following 
the manufacturer’s protocols. Measurements are based on oxygen-dependent quenching of 
a built-in fluorescent sensor. Briefly, MODE-K cells were seeded at 6.5 x 104 cells per well in 
Seahorse XF96 specialized cell culture plates. Approximately 24 h later, media were replaced 
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with DMEM XF assay medium (unbuffered DMEM supplemented with 25 mM glucose, 2 mM 
L-glutamax and 1 mM sodium pyruvate) and cells were incubated at 37°C without CO2. OCR 
and ECAR were measured simultaneously in the Seahorse XF96 extracellular flux Analyzer for 
2.5 h. Reagents and chemicals for respiratory stress testing were loaded onto XF96 
extracellular flux assay plate. TNF-α/CHX, CCCP or rotenone/antimycin-A were diluted in 
DMEM running medium and loaded into port-A, port-B and port-C, respectively. Titrations 
were preliminarily performed to determine the optimal concentration of CCCP. In all cell 
groups, CCCP (50 µM) was added at 115 min to determine maximal respiration, then 
rotenone (2.5 µM) and antimycin-A (5 µM) were added at 130 min to block mitochondrial 
respiration, determining non-mitochondrial respiration. To test the influence of TNF-α/CHX, 
it was added at 30 min after five measurements of basal respiration. Experiments without 
and with TNF-α/CHX administration, were also performed in the continuous presence of 
CORM-A1 or resveratrol, starting their incubation at 37°C without CO2 from 1 h before 
analysis of OCR and ECAR. After measuring OCR and ECAR for 2.5 h, the number of live and 
dead cells in the microchamber of each well was determined on a BD PathwayTM 855 
imaging instrument as described previously (Duprez et al., 2011). Nuclei of all cells were 
stained by the nuclear dye Hoechst blue 33342, while nuclei of dead cells were stained by 
both Hoechst blue 33342 and PI. The number of live cells was used for normalization of the 
respiratory rate in each microchamber. Cells were plated with at least 5 replicate wells for 
each treatment group. The OCR and ECAR values were expressed as absolute values of 
measurements. 
V.3.9 Statistical analysis 
All data were expressed as mean ± SEM. Comparison of the means was performed 
using the Student’s t-test for two groups of data and ANOVA followed by Bonferroni’s 
multiple comparison test for comparison of more than two groups. Differences were 
considered to be significant at P < 0.05. 
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V.4 Results 
V.4.1 Effects of CORM-A1 and resveratrol on TNF-α/CHX-induced changes in intracellular 
total ROS production and cell death 
To determine whether the modulation of ROS production by CORM-A1 and 
resveratrol could contribute to their corresponding cytoprotective activities, TNF-α/CHX-
induced intracellular total ROS production and cell death were simultaneously measured by 
flow cytometry analysis. Treatment of MODE-K cells with CORM-A1 (100 µM) per se was 
without effect but CORM-A1 significantly reduced both TNF-α/CHX-induced ROS production 
(Fig. V.1A and C) and dead cells (Fig. V.1D). In contrast, resveratrol (75 µM) per se increased 
total ROS production to similar levels induced by TNF-α/CHX but without affecting cell 
survival. Interestingly, treatment of cells with resveratrol significantly reduced both  
TNF-α/CHX-induced ROS production and cell death (Fig. V.1B, E and F). These results 
together imply that the cytoprotective effects of CORM-A1 and resveratrol in MODE-K cells 
can be attributed at least in part to their ability to mitigate oxidative stress as evidenced by 
their direct influence on intracellular ROS production. 
V.4.2 Effects of CORM-A1 and resveratrol on H2O2-induced changes in intracellular total 
ROS production 
The antioxidant capacity of CORM-A1 and resveratrol was further investigated in vitro 
using the model of H2O2-induced oxidative stress in MODE-K cells. For these experiments, 
incubation of cells with 1 mM H2O2 for 40 min was selected as this condition induced a level 
of intracellular total ROS production similar to that induced by TNF-α/CHX for 6 h, albeit 
without inducing cell death. H2O2 increased ROS production by 170% as compared to control 
and CORM-A1 significantly attenuated this effect (Fig. V.2A and C). Resveratrol per se 
increased ROS production to similar levels as induced by H2O2, but still could abolish H2O2-
induced increase in total ROS production (Fig. V.2B and E). Treatment with a hydrophilic 
(DFO) and a lipophilic (SIH) iron chelator abolished H2O2-induced ROS production, with SIH 
also significantly reducing basal ROS production (Fig. V.3A and C). 
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Fig. V.1   Effects of CORM-A1 or resveratrol on TNF-α/CHX-induced intracellular total ROS production and cell 
death in MODE-K cells. MODE-K cells were treated with TNF-α (1 ng/ml) plus CHX (10 µg/ml) in the absence or 
presence of CORM-A1 (100 μM) or resveratrol (75 μM). A-B Effect of CORM-A1 (A) or resveratrol (B) on  
TNF-α/CHX-induced intracellular total ROS levels assessed with carboxy-H2DCFDA (DCF), and gated on the 
viable, Sytox Red-negative population. Representative overlay histogram plots of DCF fluorescence are shown. 
The cells in M1 region represent the DCF-positive cells contributing to the shift in fluorescence. C-F Influence of 
TNF-α/CHX, incubated for 6 h, on intracellular total ROS levels (expressed as % of control DCF MFI) and cell 
death (expressed as % Sytox Red positivity) in the absence and presence of CORM-A1 (C, D) or resveratrol (Res; 
E, F). Control cells were incubated with serum free medium alone; the effect of CORM-A1 or resveratrol per se 
was also tested. Mean ± SEM of three independent experiments. *P < 0.05 vs. control. #P < 0.05 vs. TNF-α/CHX 
alone. 
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Fig. V.2   Effects of CORM-A1 or resveratrol on H2O2-induced intracellular total ROS production and cell death in 
MODE-K cells. MODE-K cells were treated with H2O2 (1 mM) in the absence or presence of CORM-A1 (100 μM) 
or resveratrol (75 μM). A-B Effect of CORM-A1 (A) or resveratrol (B) on H2O2-induced intracellular total ROS 
levels assessed with carboxy-H2DCFDA (DCF), and gated on the viable, Sytox Red-negative population. 
Representative overlay histogram plots of DCF fluorescence are shown. The cells in M1 region represent the 
DCF-positive cells contributing to the shift in fluorescence. C-F Influence of H2O2, incubated for 40 min, on 
intracellular total ROS levels (expressed as % of control DCF MFI) and cell death (expressed as % Sytox Red 
positivity) in the absence and presence of CORM-A1 (C, D) or resveratrol (Res; E, F). Control cells were 
incubated with serum free medium alone; the effect of CORM-A1 or resveratrol per se was also tested (not 
shown in the histograms of A and B for clarity). Mean ± SEM of three independent experiments. *P < 0.05 vs. 
control. #P < 0.05 vs. H2O2 alone. 
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Fig. V.3   Effects of the iron chelators desferrioxamine (DFO; 1 mM) and salicylaldehyde isonicotinoyl hydrazone 
(SIH; 100 μM) on H2O2 (1 mM)-induced intracellular total ROS production (assessed with carboxy-H2DCFDA) and 
cell death (assessed with Sytox Red) in MODE-K cells measured by flow cytometry. A-D Influence of H2O2, 
incubated for 40 min, on intracellular total ROS levels (expressed as % of control DCF MFI) and cell death 
(expressed as % Sytox Red positivity) in the absence and presence of DFO (A, B) or SIH (C, D). Control cells were 
incubated with serum free medium alone; the effect of DFO or SIH per se was also tested. Mean ± SEM of three 
independent experiments. *P < 0.05 vs. control. #P < 0.05 vs. H2O2 alone. 
V.4.3 Effects of CORM-A1 and resveratrol on TNF-α/CHX-induced changes in mitochondrial 
ROS production and cell death 
In rat IEC-6 cells, some supporting evidence that DHR123 marks mitochondrial ROS 
has been reported (Jin et al., 2008). The DHR123 fluorescent probe was therefore used to 
assess the effects of CORM-A1 and resveratrol on TNF-α/CHX-induced ROS production by 
mitochondria. Treatment with TNF-α/CHX resulted in a significant increase in mitochondrial 
ROS production compared to control cells (Fig. V.4A, B, C and E). CORM-A1 did not have any  
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Fig. V.4   Effects of CORM-A1 or resveratrol on TNF-α/CHX-induced mitochondrial ROS production and cell 
death in MODE-K cells. MODE-K cells were treated with TNF-α (1 ng/ml) plus CHX (10 µg/ml) in the absence or 
presence of CORM-A1 (100 μM) or resveratrol (75 μM). A-B Effect of CORM-A1 (A) or resveratrol (B) on  
TNF-α/CHX-induced mitochondrial ROS levels assessed with DHR123 (R123), and gated on the viable, Sytox 
Red-negative population. Representative overlay histogram plots of R123 fluorescence are shown. The cells in 
M1 region represent the R123-positive cells contributing to the shift in fluorescence. C-F Influence of  
TNF-α/CHX, incubated for 6 h, on mitochondrial ROS levels (expressed as % of control R123 MFI) and cell death 
(expressed as % Sytox Red positivity) in the absence and presence of CORM-A1 (C, D) or resveratrol (Res; E, F). 
Control cells were incubated with serum free medium alone; the effect of CORM-A1 or resveratrol per se was 
also tested. Mean ± SEM of three independent experiments. *P < 0.05 vs. control. #P < 0.05 vs. TNF-α/CHX 
alone. 
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effect on this parameter (Fig. V.4A and C) despite being able to markedly reduce TNF-α/CHX-
induced cell death (Fig. V.4D). In contrast, resveratrol reduced basal mitochondrial ROS 
levels but also abolished TNF-α/CHX-induced increase in mitochondrial ROS production with 
a concomitant decrease in TNF-α/CHX-induced cell death (Fig. V.4B, E and F). 
V.4.4 Effects of CORM-A1 and resveratrol on TNF-α/CHX-induced changes in mitochondrial 
O2 production and cell death 
The influence of CORM-A1 and resveratrol on TNF-α/CHX-induced mitochondrial O2 
production was assessed by using the fluorescent probe MitoSOX Red in conjunction with 
Sytox Red, to discriminate viable versus dead cells, in a single experimental setup. Treatment 
with TNF-α/CHX increased mitochondrial O2 production by approximately 3 fold as 
compared to control. Although CORM-A1 significantly reduced TNF-α/CHX-induced cell 
death (Fig. V.5D), it did not influence TNF-α/CHX-induced mitochondrial O2 production (Fig. 
V.5A and C). In contrast, treatment with resveratrol significantly reduced basal mitochondrial 
O2 levels and prevented the TNF-α/CHX-induced increase in mitochondrial O2 levels (Fig. 
V.5B and E), with concomitant decrease in TNF-α/CHX-induced cell death (Fig. V.5F). 
V.4.5 Influence of higher concentrations of CORM-A1 and resveratrol on intracellular total 
ROS and mitochondrial O2 production in MODE-K cells 
Results till now showed that in MODE-K cells 100 µM CORM-A1, incubated for 7 h, 
per se did not influence intracellular total ROS or mitochondrial O2 levels (Fig. V.1C, 2C and 
5C). Similar results were obtained with higher concentrations of CORM-A1 (150 and 200 µM) 
(Fig. V.6A and C). Treatment of cells with 100 µM CORM-A1 did not change mitochondrial 
O2 production even at earlier time points (0.25 to 3 h) (Fig. V.6E). However, a higher 
concentration of CORM-A1 (200 µM) promoted a significant increase in mitochondrial O2 
when incubated for 1 or 2 h (Fig. V.6E). Resveratrol at 75 µM for 7 h was shown to increase 
intracellular total ROS and decrease mitochondrial O2 (Fig. V.1E, 2E and 5E). Higher 
concentrations of resveratrol (100 µM and 125 µM) induced a concentration-dependent 
increase in total ROS production (Fig. V.7A) and decrease in mitochondrial O2 production 
(Fig. V.7C) which was accompanied by a significant increase in cell death occurring at 125 µM  
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Fig. V.5   Effects of CORM-A1 or resveratrol on TNF-α/CHX-induced mitochondrial O2 production and cell 
death in MODE-K cells. MODE-K cells were treated with TNF-α (1 ng/ml) plus CHX (10 µg/ml) in the absence or 
presence of CORM-A1 (100 μM) or resveratrol (75 μM). A-B Effect of CORM-A1 (A) or resveratrol (B) on  
TNF-α/CHX-induced mitochondrial O2 levels assessed with MitoSOX Red, and gated on the viable, Sytox Red-
negative population. Representative overlay histogram plots of MitoSOX Red fluorescence are shown. The cells 
in M1 region represent the MitoSOX Red-positive cells contributing to the shift in fluorescence. C-F Influence of 
TNF-α/CHX, incubated for 6 h, on mitochondrial O2 levels (expressed as % of control MitoSOX Red MFI) and 
cell death (expressed as % Sytox Red positivity) in the absence and presence of CORM-A1 (C, D) or resveratrol 
(Res; E, F). Control cells were incubated with serum free medium alone; the effect of CORM-A1 or resveratrol 
per se was also tested. Mean ± SEM of three independent experiments. *P < 0.05 vs. control. #P < 0.05 vs.  
TNF-α/CHX alone. 
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Fig. V.6   Effects of CORM-A1 (100, 150 and 200 μM) on intracellular total ROS production (assessed with 
carboxy-H2DCFDA), mitochondrial O2 production (assessed with MitoSOX Red) and cell death (assessed with 
Sytox Red) in MODE-K cells measured by flow cytometry. A-D Influence of CORM-A1, incubated for 7 h, on 
intracellular total ROS levels (expressed as % of control DCF MFI; A), mitochondrial O2 levels (expressed as % 
of control MitoSOX Red MFI; C) and cell death (expressed as % Sytox Red positivity; B and D). E Influence of 
CORM-A1 (100 and 200 µM), incubated for 0.25-3 h, on mitochondrial O2 levels. Mean ± SEM of three 
independent experiments. *P < 0.05 vs. control (0 h). 
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Fig. V.7   Effects of resveratrol (75, 100 and 125 μM) on intracellular total ROS production (assessed with 
carboxy-H2DCFDA), mitochondrial O2 production (assessed with MitoSOX Red) and cell death (assessed with 
Sytox Red) in MODE-K cells measured by flow cytometry. A-D Influence of resveratrol, incubated for 7 h, on 
intracellular total ROS levels (expressed as % of control DCF MFI; A), mitochondrial O2 levels (expressed as % 
of control MitoSOX Red MFI; C) and cell death (expressed as % Sytox Red positivity; B and D). E-F Effects of 
inhibitors of xanthine oxidase, NOX or Rac-1 on resveratrol-induced total ROS production in MODE-K cells 
measured by flow cytometry. Influence of resveratrol (75 µM), incubated for 7 h, on intracellular total ROS 
levels (E) and cell death (F) in the absence and presence of allopurinol (Allo; 100 µM), VAS-2870 (VAS; 10 µM) 
or NSC23766 (NSC; 50 µM). Control cells were incubated with serum free medium alone. Mean ± SEM of three 
independent experiments. *P < 0.05 vs. control. #P < 0.05 vs. resveratrol alone. 
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(Fig. V.7B and D). The increase in intracellular total ROS by 75 µM resveratrol was not 
influenced by the xanthine/xanthine oxidase inhibitor allopurinol, but was abolished by the 
pan-NOX inhibitor VAS-2870 and the Rac1 inhibitor NSC23766 (Fig. V.7E). 
V.4.6 Effects of CORM-A1 and resveratrol on mitochondrial complex I- and complex III-
induced changes in mitochondrial O2 and cell death 
The effect of CORM-A1 and resveratrol on O2 production at the level of 
mitochondrial complex I and complex III was investigated. Rotenone (7.5 µM), an inhibitor of 
mitochondrial complex I, induced a robust increase in mitochondrial O2 level comparable 
to that induced by TNF-α/CHX (Fig. V.8A, B, C and E) without affecting cell survival  
(Fig. V.8D and F). The concentration of 7.5 µM rotenone was selected based on a 
concentration-response study of the effect of rotenone on mitochondrial O2, when 
incubated for 6 h to mimic the exposure time to TNF-α/CHX (Fig. V.9A). Treatment with 
CORM-A1 did not affect rotenone-induced mitochondrial O2 production while resveratrol 
completely abolished this effect (Fig. V.8A, B, C and E). 
The influence of CORM-A1 and resveratrol on mitochondrial O2 production at the 
level of mitochondrial complex III was investigated by use of the complex III inhibitor 
antimycin-A, an agent well-known to induce O2 production at this site. Antimycin-A was 
used at 10 µM for 6 h as this concentration did not induce cell death in MODE-K cells, but 
increased mitochondrial O2 production to a level comparable to that induced by  
TNF-α/CHX (Fig. V.9C and D). Interestingly, CORM-A1 significantly decreased (Fig. V.10A and 
C) while resveratrol completely abolished (Fig. V.10B and E) antimycin-A-induced 
mitochondrial O2 production. 
V.4.7 Effects of CORM-A1 and resveratrol on TNF-α/CHX-induced changes in mitochondrial 
membrane potential (Ψm), mitochondrial dysfunction and cellular oxygen consumption of 
MODE-K cells 
We next studied the influence of CORM-A1 and resveratrol on TNF-α/CHX-induced 
changes in Ψm. Two different potentiometric dyes, TMRM and JC-10, were used. TMRM  
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Fig. V.8   Effects of CORM-A1 or resveratrol on mitochondrial complex I (rotenone)-induced mitochondrial O2 
production and cell death in MODE-K cells. MODE-K cells were treated with rotenone (7.5 µM) in the absence 
or presence of CORM-A1 (100 μM) or resveratrol (75 μM). A-B Effect of CORM-A1 (A) or resveratrol (B) on 
rotenone-induced mitochondrial O2 levels assessed with MitoSOX Red, and gated on the viable, Sytox Red-
negative population. Representative overlay histogram plots of MitoSOX Red fluorescence are shown. The cells 
in M1 region represent the MitoSOX Red-positive cells contributing to the shift in fluorescence. C-F Influence of 
rotenone (Rot), incubated for 6 h, on mitochondrial O2 levels (expressed as % of control MitoSOX Red MFI) 
and cell death (expressed as % Sytox Red positivity) in the absence and presence of CORM-A1 (C, D) or 
resveratrol (Res; E, F). Control cells were incubated with serum free medium alone; the effect of CORM-A1 or 
resveratrol per se was also tested (not shown in the histograms of A and B for clarity). Mean ± SEM of three 
independent experiments. *P < 0.05 vs. control. #P < 0.05 vs. rotenone alone. 
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Fig. V.9   Mitochondrial O2 production (assessed with MitoSOX Red) and cell death (assessed with Sytox Red) 
in rotenone (1-15 µM)- and antimycin-A (5-20 µM)-treated MODE-K cells measured by flow cytometry. A-D 
Influence of rotenone (A, B) or antimycin-A (C, D), incubated for 6 h, on mitochondrial O2 levels (expressed as 
% of control MitoSOX Red MFI) and cell death (expressed as % Sytox Red positivity). Control cells were 
incubated with serum free medium alone. Mean ± SEM of three independent experiments. *P < 0.05 vs. 
control. 
 
enables the possibility of analyzing cell death simultaneously in combination with the cell 
death marker Sytox Green. About 7-8% of control cells showed depolarized mitochondria. 
Treatment of cells with TNF-α/CHX caused a 60% depolarization of mitochondria as 
measured with both TMRM (Fig. V.11A and C) and JC-10 staining (Fig. V.12A and B).  
CORM-A1 decreased the number of depolarized cells to 43% and 48% (Fig. V.11A and 12A) 
while resveratrol decreased it to 17% and 19% (Fig. V.11C and 12B) for TMRM and JC-10, 
respectively. 
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Fig. V.10   Effects of CORM-A1 or resveratrol on mitochondrial complex III (antimycin-A)-induced mitochondrial 
O2 production and cell death in MODE-K cells. MODE-K cells were treated with antimycin-A (10 µM) in the 
absence or presence of CORM-A1 (100 μM) or resveratrol (75 μM). A-B Effect of CORM-A1 (A) or resveratrol (B) 
on antimycin-A-induced mitochondrial O2 levels assessed with MitoSOX Red, and gated on the viable, Sytox 
Red-negative population. Representative overlay histogram plots of MitoSOX Red fluorescence are shown. The 
cells in M1 region represent the MitoSOX Red-positive cells contributing to the shift in fluorescence. C-F 
Influence of antimycin-A (Ant-A), incubated for 6 h, on mitochondrial O2 levels (expressed as % of control 
MitoSOX Red MFI) and cell death (expressed as % Sytox Red positivity) in the absence and presence of  
CORM-A1 (C, D) or resveratrol (Res; E, F). Control cells were incubated with serum free medium alone; the 
effect of CORM-A1 or resveratrol per se was also tested (not shown in the histograms of A and B for clarity). 
Mean ± SEM of three independent experiments. *P < 0.05 vs. control. #P < 0.05 vs. antimycin-A alone. 
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Fig. V.11   Effects of CORM-A1 (100 μM) or resveratrol (75 μM) on TNF-α (1 ng/ml)/CHX (10 µg/ml)-induced 
changes in mitochondrial membrane potential (assessed with TMRM) and cell death (assessed with Sytox 
Green) in MODE-K cells measured by flow cytometry. A-D Influence of TNF-α/CHX, incubated for 6 h, on 
mitochondrial membrane potential (expressed as % of cells with depolarized mitochondria after TMRM 
staining) and cell death (expressed as % Sytox Green positivity) in the absence and presence of CORM-A1 (A, B) 
or resveratrol (Res; C, D). Control cells were incubated with serum free medium alone; the effect of CORM-A1 
or resveratrol per se was also tested. Mean ± SEM of three independent experiments. *P < 0.05 vs. control. #P < 
0.05 vs. TNF-α/CHX alone. 
 
Double staining of MODE-K cells with two different mitochondria-specific dyes to distinguish 
actively respiring (MitoTracker Deep Red FM-positive) and total (MitoTracker Green FM-
positive) mitochondria showed an increase in the amount of respiration-interrupted  
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Fig. V.12   Effects of CORM-A1 (100 μM) or resveratrol (75 μM) on TNF-α (1 ng/ml)/CHX (10 µg/ml)-induced 
mitochondrial membrane depolarization (assessed with JC-10) in MODE-K cells measured by flow cytometry. 
Influence of TNF-α/CHX, incubated for 6 h, on mitochondrial membrane potential measured by flow cytometry 
(expressed as % of cells with polarized and depolarized mitochondria after JC-10 staining) in the absence and 
presence of CORM-A1 (A) or resveratrol (Res; B). Control cells were incubated with serum free medium alone; 
the effect of CORM-A1 or resveratrol per se was also tested. Mean ± SEM of three independent experiments. 
*P < 0.05 vs. control. #P < 0.05 vs. TNF-α/CHX alone. 
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mitochondria upon treatment of cells with TNF-α/CHX as compared to untreated control 
cells (46 ± 2% versus 4% ± 1% in P2 gated region; Fig. V.13B and D; third panel in Fig. V.13A 
and C). Treatment with CORM-A1 (Fig. V.13A and B) significantly decreased, while treatment 
with resveratrol (Fig. V.13C and D) abolished the TNF-α/CHX-induced increase in 
dysfunctional mitochondria, the level becoming lower than in control cells. 
Cellular oxygen consumption rate (OCR) was measured using a Seahorse XF96 
Analyzer to study the influence of CORM-A1 and resveratrol on TNF-α/CHX-treated MODE-K 
cells. Addition of TNF-α/CHX significantly decreased basal OCR within a few minutes of its 
administration and this decrease was maintained over time. Moreover, TNF-α/CHX increased 
the maximal respiration induced by the uncoupling agent CCCP without affecting non-
mitochondrial respiratory rate (Fig. V.14A and B; V.15A and B). CORM-A1 per se significantly 
decreased basal OCR but from 1.5 h after its administration OCR slowly recuperated. Just 
before adding CCCP the OCR was still lower than in control cells; both maximal respiration 
and non-mitochondrial respiration were decreased compared to control cells. In MODE-K 
cells, treated with TNF-α/CHX in the presence of CORM-A1, the OCR remained low till 
administration of CCCP; the maximal respiration was lower than in controls and in cells 
treated with TNF-α/CHX alone (Fig. V.14A and 15A). Resveratrol per se decreased basal OCR 
to a similar extent as CORM-A1 but this decrease was stable till administration of CCCP; 
maximal respiration was not influenced by resveratrol but minimal respiration was 
decreased compared to controls. In MODE-K cells, treated with TNF-α/CHX in the presence 
of resveratrol, OCR values were similar to those in cells treated with TNF-α/CHX alone, 
except that maximal respiration was now decreased compared to controls (Fig. V.14B and 
15B). 
V.5 Discussion 
Treatment of MODE-K cells with TNF-α/CHX induces apoptosis, which is associated 
with increased production of ROS. We previously found that CORM-A1 and resveratrol 
reduce both these effects (Babu et al., 2012). We have also recently identified that NOX and 
mitochondrial ETC complexes (I and II) are the major sources of ROS production during  
TNF-α/CHX-induced apoptosis (Babu et al., 2015). Here, we investigated the influence of  
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CORM-A1 and resveratrol on these pathways. The principal finding of this study is that 
CORM-A1 and resveratrol act on different sources of intracellular ROS production during 
their protection against TNF-α/CHX-induced cell death of MODE-K cells (see Table V.1 for a 
qualitative summary of the effects of CORM-A1 and resveratrol in basal conditions and 
versus TNF-α/CHX). 
V.5.1 Mechanism of action of CORM-A1 during TNF-α/CHX-induced oxidative stress in 
MODE-K cells 
Incubating MODE-K cells with 100 µM CORM-A1 from 1 h before exposure to  
TNF-α/CHX for 6 h partially reduced TNF-α/CHX-induced cell death. We previously reported 
that treatment of MODE-K cells with TNF-α/CHX induces a decrease in cellular oxygen 
consumption within 5 min of addition, a decrease in Ψm and an increase in mitochondrial 
dysregulation within 1 h of addition and an increase in intracellular total ROS and 
mitochondrial O2 within 2 h of addition, the latter coinciding with the occurrence of 
apoptotic cell death (Babu et al., 2012; Babu et al., 2015). In several papers, the protection 
of cells by CO against oxidative insults has been related to inhibition of cytochrome c 
oxidase, the terminal enzyme within complex IV of the ETC, by competitive binding with 
oxygen resulting in a significant transient burst of mitochondria-derived ROS. The latter 
would create a state of preconditioning, inducing adaptive signaling towards subsequent 
oxidative stress (Taille et al., 2005; Chin et al., 2007; Zuckerbraun et al., 2007; Kim et al., 
2008). However, in MODE-K cells, 100 µM CORM-A1 did not change mitochondrial ROS or 
O2 levels even in the first hours after administration; only a higher CORM-A1 concentration 
of 200 µM increased mitochondrial O2 levels temporarily at 1-2 h of incubation.  
 
 
Fig. V.13   Effects of CORM-A1 (100 μM) or resveratrol (75 μM) on TNF-α (1 ng/ml)/CHX (10 µg/ml)-induced 
mitochondrial dysfunction in MODE-K cells measured by flow cytometry. A-D Influence of TNF-α/CHX, 
incubated for 6 h, on the amount of respiring mitochondria assessed with Mitotracker Green FM (FL1; FITC) 
and Mitotracker Deep Red FM (FL4; APC) staining in the absence and presence of CORM-A1 (A, B) or resveratrol 
(C, D). Control cells were incubated with serum free medium alone; the effect of CORM-A1 or resveratrol per se 
was also tested. A and C Representative dot plots of the flow cytometric analysis showing the effect of CORM-
A1 (A) or resveratrol (Res; C) on the population of cells (gated on live cells) losing mitochondrial potential and 
with respiration-interrupted mitochondria (shift of cell population towards P2 gated region) after treatment 
with TNF-α/CHX. B and D Quantification of flow cytometric measurements (expressed as % of cells with 
dysfunctional mitochondria) of CORM-A1 (B) and resveratrol (Res; D). Mean ± SEM of three independent 
experiments. *P < 0.05 vs. control. #P < 0.05 vs. TNF-α/CHX alone. 
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Fig. V.14   Acute effects of CORM-A1 (100 μM) or resveratrol (75 μM) on TNF-α (1 ng/ml)/CHX (10 µg/ml)-
induced decrease in mitochondrial respiration in MODE-K cells. Influence of TNF-α/CHX, incubated for 2 h, on 
cellular oxygen consumption rate (OCR, expressed as pmoles/min) in the absence and presence of CORM-A1 
(A) or resveratrol (B). CORM-A1 or resveratrol was incubated from 1 h before analysis of OCR. OCR was 
measured at different time points for 2.5 h. First, five consecutive measurements of respiration during 
incubation with medium alone were done for 30 min. Then, TNF-α/CHX was injected or not (control) followed 
by six consecutive measurements. At 115 min, the protonophore CCCP (50 μM) was added to measure maximal 
oxygen consumption for three measurements. At 130 min, the complex I inhibitor rotenone (2.5 μM) and the 
complex III inhibitor antimycin-A (5 μM) were injected, followed by three consecutive measurements to 
determine the non-mitochondrial respiration. Finally, the amount of viable cells (Hoechst+/PI- cells) in the 
microchamber of each well was determined by automated imaging. The data represent the average of five 
replicates for each condition. 
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Fig. V.15   Acute effects of CORM-A1 (100 μM) or resveratrol (75 μM) on TNF-α (1 ng/ml)/CHX (10 µg/ml)-
induced decrease in mitochondrial respiration in MODE-K cells. Influence of TNF-α/CHX, incubated for 2 h, on 
cellular oxygen consumption rate (OCR, expressed as pmoles/min) in the absence and presence of CORM-A1 
(A) or resveratrol (B). CORM-A1 or resveratrol was incubated from 1 h before analysis of OCR. OCR was 
measured at different time points for 2.5 h. First, five consecutive measurements of respiration during 
incubation with medium alone were done for 30 min. Then, TNF-α/CHX was injected or not (control) followed 
by six consecutive measurements. At 115 min, the protonophore CCCP (50 μM) was added to measure maximal 
oxygen consumption for three measurements. At 130 min, the complex I inhibitor rotenone (2.5 μM) and the 
complex III inhibitor antimycin-A (5 μM) were injected, followed by three consecutive measurements to 
determine the non-mitochondrial respiration. Finally, the amount of viable cells (Hoechst+/PI- cells) in the 
microchamber of each well was determined by automated imaging. OCR values are given for the 
measurements just before and after TNF-α/CHX administration (25 min and 32 min), for the measurement just 
before CCCP administration (111 min), for the second measurement after CCCP administration (124 min) and 
for the second measurement after administration of antimycin-A plus rotenone (142 min). A/R: Antimycin-A 
plus rotenone; TNF: TNF-α/CHX. * Significantly different from control. 
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Table V.1 Qualitative summary of the effects of CORM-A1 and resveratrol in basal conditions and versus  
TNF-α/CHX. 
 
 
 
Still, 100 µM CORM-A1 decreased cellular OCR in MODE-K cells with partial recuperation 
from this decrease from 90 min after its administration. In a previous study, a decrease in 
OCR was observed in isolated heart mitochondria treated with 100 µM CORM-3, while lower 
concentrations (1-20 µM) triggered an actual increase in OCR. However, the decrease in OCR 
with 100 µM CORM-3 was accompanied by inhibition of cytochrome c oxidase (complex IV) 
and increase in mitochondrial ROS production (Lo Iacono et al., 2011). In contrast, we did 
not observe an increase in mitochondrial ROS production with 100 µM CORM-A1 in MODE-K 
cells. The difference in these results could be due to the chemical reactivity of CORM-3 and 
CORM-A1, the first being a transition metal carbonyl releasing CO with a fast rate, whereas 
the second being a boranocarbonate that generates spontaneously CO at physiological pH 
with a slow kinetic (Motterlini et al., 2002; Motterlini et al., 2005). In addition, we cannot 
exclude that the different results obtained are due to differences in technology, as Lo Iacono 
et al. (2011) measured OCR in isolated mitochondria using a Clark-type oxygen electrode and 
different substrates, compared to the intact cells in growth medium used in our study where 
OCR was measured using the Seahorse XF96 Analyzer. One has speculated that the 
cytoprotective effects of CO are independent of mitochondrial ROS generation, but related 
to partial or temporal inhibition of mitochondrial respiration (Almeida et al., 2015). In 
HEK293 cells, both exogenous and endogenous CO were shown to reduce cellular respiration 
(D'Amico et al., 2006) and it was suggested that this might contribute to its cytoprotective 
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effects, as reported for NO (Xu et al., 2004). This might also explain why CORM-A1 partially 
recovered the decrease in Ψm and the increase in mitochondrial dysfunction by TNF-α/CHX 
observed in this study. 
Although CORM-A1 is not preconditioning MODE-K cells by inducing per se 
mitochondrial ROS, it has antioxidant potential in the cells as illustrated by the partial 
reduction of TNF-α/CHX-induced and H2O2-induced intracellular total ROS. Modulation of 
ROS production is considered to be a main mechanism of CO-mediated cytoprotection 
(Motterlini et al., 2012), the O2 producing heme-containing proteins in mitochondria 
(cytochromes) and the NOX enzymes in the cells being the major targets of CO due to its 
higher affinity for heme (Foresti & Motterlini, 2010). In MODE-K cells, CORM-A1 was not able 
to reduce TNF-α/CHX-induced mitochondrial ROS or O2 levels, excluding that this 
contributes to its partial protection from TNF-α/CHX-induced cytotoxicity. We previously 
showed that mitochondrial complexes I and II are the major mitochondrial ROS production 
sites during TNF-α/CHX-induced cell death in MODE-K cells (Babu et al., 2015). CORM-A1 did 
not influence mitochondrial O2 induced by the complex I inhibitor rotenone probably 
because rotenone-induced mitochondrial ROS are released into the mitochondrial matrix 
(Chen et al., 2003; Rodriguez-Rocha et al., 2013). Still, CORM-A1 was able to reduce 
antimycin-A-induced mitochondrial O2. Antimycin-A-derived mitochondrial O2 is reported 
to be fully (St-Pierre et al., 2002) or at least partially (Han et al., 2003) released into the 
mitochondrial intermembrane space. As myxothiazole, the Qo site inhibitor of complex III, 
partially reduced TNF-α/CHX-induced total ROS and cell death in MODE-K cells (Babu et al., 
2015), part of TNF-α/CHX-induced ROS must also be released into the mitochondrial 
intermembrane space. The lack of any effect of CORM-A1 versus TNF-α/CHX-induced 
mitochondrial ROS might be related to near full use of CORM-A1 derived CO in the 
cytoplasm to counteract NOX-derived ROS upon exposure to TNF-α. The latter ROS 
production site is not activated by antimycin-A, so that sufficient CO might reach the 
mitochondrial intermembrane space upon exposure of MODE-K cells to antimycin-A. 
The partial reduction of TNF-α/CHX-induced intracellular total ROS by CORM-A1 is 
thus probably due to inhibition of NOX-derived ROS. In addition to mitochondrial complexes 
I and II, NOX are the second source of TNF-α/CHX-induced ROS, leading to apoptosis in 
MODE-K cells (Babu et al., 2015). CO has been reported to inhibit NOX and decrease 
cytoplasmic O2 production (Bilban et al., 2006; Srisook et al., 2006; Wang et al., 2007; 
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Kelsen et al., 2008), probably by binding to the heme-containing gp91phox (NOX2) subunit 
with subsequent decrease in NOX activity (Taille et al., 2005; Nakahira et al., 2006). Similarly, 
CORM-A1 inhibited TNF-α-induced NOX activation and apoptosis in cerebral microvascular 
endothelial cells (Basuroy et al., 2009). As NOX are only one of the two major sources of 
TNF-α/CHX-induced ROS in MODE-K cells, and NOX activation might be sequential to 
mitochondrial ROS production (Babu et al., 2015), the inhibitory effect of CORM-A1 on NOX 
can only lead to partial reduction of TNF-α/CHX-induced cell death. 
V.5.2 Mechanism of action of resveratrol during TNF-α/CHX-induced oxidative stress in 
MODE-K cells 
In contrast to CORM-A1, resveratrol decreased the basal levels of both mitochondrial 
ROS and mitochondrial O2 in MODE-K cells. Moreover, the more pronounced reduction in 
TNF-α/CHX-induced cell death by resveratrol accompanied by abolishment of mitochondrial 
ROS/O2 levels implies that the inhibitory action of this polyphenol on mitochondria-derived 
ROS contributes to its anti-apoptotic/cytoprotective effects in MODE-K cells. Attenuation of 
mitochondrial oxidative stress with resveratrol was also reported in coronary arterial 
endothelial cells (Ungvari et al., 2009). Cytoprotection related to reduction of mitochondrial 
ROS has already been reported for several drugs (Reddy, 2006; Szeto, 2006; Plotnikov et al., 
2013) and a mitochondrial-targeted antioxidant has recently been shown to be beneficial in 
reducing intestinal epithelial barrier dysfunction (Wang et al., 2014). In addition to 
decreasing mitochondrial O2 levels, resveratrol effectively prevented the TNF-α/CHX-
induced development of mitochondrial dysfunction and drop in Ψm in MODE-K cells. 
Resveratrol abolished both complex I- and complex III-induced ROS (as seen in experiments 
using rotenone and antimycin-A, respectively), which demonstrates the capacity of 
resveratrol in mitigating complex I and complex III-derived ROS. Owing to its lipophilicity, 
resveratrol might penetrate the mitochondrial matrix beyond the intermembrane space and 
thus could scavenge O2 produced inside the matrix being available at the close proximity of 
O2 generation. Additionally, resveratrol could induce an increased expression of 
mitochondrial superoxide dismutase (SOD)-2 as shown before in cultured neuronal cells 
(Fukui et al., 2010). 
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In contrast to decreasing mitochondrial ROS, resveratrol increased intracellular total 
ROS production in MODE-K cells. Although well known as an antioxidant, the pro-oxidant 
effects of resveratrol have been reported in some cell types (de la Lastral & Villegas, 2007) 
and it has been suggested that this can create an intracellular environment preventing 
apoptotic cell death (Ahmad et al., 2003). Resveratrol-induced ROS production in MODE-K is 
mediated through NOX1 (as evidenced by its abolishment in the presence of pan-NOX and 
Rac1 inhibitors), which is similar to its effect reported in endothelial cells (Schilder et al., 
2009). NOX-derived ROS production serves as a protective signal to increase the levels of 
intracellular antioxidant enzymes/scavenging molecules and has been implicated in stress-
induced preconditioning (Bell et al., 2005; Jiang et al., 2011; Frasier et al., 2013). The 
increase in the levels of NOX-derived ROS by pretreatment with resveratrol might exert such 
a “protective signaling” for MODE-K cells to raise their antioxidant defense to protect 
themselves from the successive cytokine (TNF-α) effect. Notably, resveratrol was shown in 
cultured hepatocytes to increase the activity of several antioxidant enzymes such as catalase 
and SOD via activation of nuclear factor-E2-related factor-2 (Rubiolo et al., 2008). NOX-
derived ROS has also been shown to play a role in epithelial cell proliferation (Brar et al., 
2002; Ranjan et al., 2006). The role of NOX1-dependent ROS generation during proliferation 
of mouse small intestinal (Jones et al., 2013) and colonic epithelium (Coant et al., 2010) has 
been recently proposed. Hence, it seems plausible that ROS generation resulting from pre-
treatment of MODE-K cells with resveratrol before exposure to TNF-α/CHX might have 
activated the proliferative machinery to defend against the successive stress insult. 
We suggested that treatment of MODE-K cells with TNF-α/CHX might involve an early 
phase of mitochondria-derived ROS production inducing a later phase of NOX-derived ROS 
production as mitochondrial complex inhibitors show a more pronounced decrease in total 
ROS levels and cell death as compared to the moderate effect of the NOX inhibitor,  
VAS-2870 (Babu et al., 2015). The pronounced cytoprotective effect of resveratrol 
concomitant with the abolishment of mitochondrial ROS/O2, as compared to the moderate 
NOX-dependent cytoprotection observed with CORM-A1, further strengthens the notion of a 
possible sequential communication from mitochondria to NOX for ROS production in  
MODE-K cells. 
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In conclusion, the cytoprotective effect of resveratrol is predominantly due to 
mitigation of mitochondrial ROS while CORM-A1 acts solely on NOX-derived ROS to protect 
MODE-K cells from TNF-α/CHX-induced cell death. These data infer that interference of 
CORM-A1 and resveratrol with particular intracellular ROS production sites could have some 
therapeutic value and therefore should be further tested for the treatment of acute GI 
inflammatory diseases. 
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Chapter VI   General discussion and conclusions 
 
Intestinal epithelial barrier dysfunction is involved in several acute GI inflammatory 
disease conditions such as POI and NEC. By intestinal epithelial barrier dysfunction, the gut 
can be a triggering factor in the progression of sepsis. The progression of sepsis to severe 
sepsis with MOF and to septic shock is related to an inflammatory/oxidative cascade 
involving production of inflammatory cytokines and ROS, I/R injury and mitochondrial 
dysfunction. Oxidative stress and inflammation can lead to disturbance of the intestinal 
epithelial barrier, accompanied by sepsis-induced ileus and allowing luminal bacterial 
content to penetrate in the body and aggravate the systemic inflammation. Several studies 
support that TNF-α, secreted by IECs themselves and by activated macrophages, is central to 
intestinal epithelial injury (Hausmann, 2010; Roulis et al., 2011). Apart from its pro-
inflammatory actions, there is also evidence that TNF-α increases oxidative stress in a variety 
of different cells (Shen & Pervaiz, 2006; Jin et al., 2008). In a murine model of POI, a 
condition classically related to a muscular inflammatory reaction to the manipulation of the 
intestine, our laboratory has shown an increase in oxidative stress after intestinal 
manipulation occurring both in the mucosa and in the muscular layer, the increase in the 
mucosa in the early phase being more pronounced than in the muscular layer (De Backer et 
al., 2009). This suggests that early epithelial oxidative stress, possibly inducing increased 
intestinal permeability, might contribute to the pathogenesis of POI. HO-1 is upregulated by 
oxidative stress and inflammatory mediators, and confers protection against oxidative stress 
and inflammation. This effect is mainly related to the products generated from the 
enzymatic activity of HO-1 i.e. biliverdin/bilirubin and still more CO. Several cytoprotective 
agents have been proposed to at least partially act via HO-1 induction; a frequently studied 
example between these agents is the polyphenol resveratrol. The aim of this thesis was 
therefore to establish an in vitro IEC model to assess the relation between TNF-α-induced 
oxidative stress and cell death, and to investigate the protective effects of HO-1-derived 
products, for CO using CO-RMs, and of resveratrol. 
The murine IEC line MODE-K was used as it is a non-cancerous cell line derived from 
duodenum-jejunum of a normal mice bearing the characteristic features of normal 
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enterocytes (Vidal et al., 1993). Additionally, data obtained with this cell line might be useful 
for targeted investigation in a murine in vivo model such as POI in subsequent projects. 
Preliminary experiments with TNF-α were done by testing its influence on cell viability. As in 
the case of many cell lines, including the GI ones (Beyaert et al., 1993; Bhattacharya et al., 
2003; Pajak et al., 2005; Minero et al., 2013), we have found that TNF-α requires the 
combination with CHX to reduce cell viability in MODE-K cells. TNF-α is a pleiotropic cytokine 
that not only rapidly accelerates cell death, but also induces survival signals probably via 
activating the transcription factor NF-kB (Hayden & Ghosh, 2014). Addition of CHX 
suppresses the synthesis of short-lived cytoprotective proteins and blocks these protein 
synthesis-mediated survival effects. Therefore, the combination TNF-α/CHX was selected for 
further investigation. 
Primary experiments involving treatment of MODE-K cells with 20 ng/ml TNF-α plus 
25 µg/ml CHX, a classic cytotoxic apoptotic stimulus used in other IEC lines (Bhattacharya et 
al., 2003; Naugler et al., 2008; Greenspon et al., 2009), decreased the cell viability to 10% of 
untreated cells. Moreover, this pronounced effect on cell viability was not influenced by any 
of the HO-1-related products. Treatment with 0.1 and 1 ng/ml TNF-α plus 10 µg/ml CHX 
decreased the cell viability to 50% and 20%, respectively. These results suggest that the 
MODE-K cell line is highly sensitive to the cytotoxic effects of TNF-α/CHX. 
VI.1  Relation between TNF-α/CHX-induced oxidative stress and apoptotic cell death in 
MODE-K cells 
Exposure of MODE-K cells to 0.1, 0.25, 0.5 and 1 ng/ml TNF-α plus 10 µg/ml CHX for  
6 h decreased cell viability, increased caspase-3/7 activity and increased the number of 
apoptotic cells in a concentration-dependent manner. When incubated for 3 h, 0.1-1 ng/ml 
TNF-α plus 10 µg/ml CHX increased the intracellular ROS levels in a concentration-dependent 
manner as assessed with the most commonly used oxidant-sensitive fluorescent probe 
carboxy-H2DCFDA. When investigating the time dependency of 1 ng/ml TNF-α plus 10 µg/ml, 
apoptosis started after 2 h of treatment with TNF-α/CHX corresponding with the onset of 
ROS production. The concentration-dependent induction of apoptosis by TNF-α/CHX at 6 h 
accompanied by a corresponding increase in caspase-3/7 activity suggests that a sequence of 
“ROS production → caspase-3/7 activity → apoptosis” might occur in MODE-K cells, similarly 
Chapter VI 
General discussion and conclusions 
 
227 
 
as reported in rat IEC-6 cells (Jin et al., 2008). The quantitation of apoptosis involved 
measurement of DNA hypoploidy after PI staining by flow cytometry while the quantitation 
of ROS production involved the measurement of fluorescence after carboxy-H2DCFDA 
staining in wells of a microtiter plate reader, the fluorescence being contributed by both live 
and dead cells. 
In the second project, intracellular ROS generation (by use of carboxy-H2DCFDA) and 
cell death (by use of Sytox Red) were therefore measured simultaneously by flow cytometry, 
allowing selective measurement of ROS fluorescence in viable cells. This assay confirmed the 
concentration-dependent effect of 0.1, 0.25, 0.5 and 1 ng/ml TNF-α plus 10 µg/ml CHX on 
ROS production and cell death, as well as the time dependency for 1 ng/ml TNF-α plus  
10 µg/ml CHX, with ROS increase and cell death both starting from 2 h of exposure. By use of 
annexin V and PI staining, it was illustrated again that TNF-α/CHX-induced cell death 
followed apoptotic kinetics, early apoptotic cells occurring from 2 h of exposure. 
The onset of ROS production by TNF-α at 2 h in MODE-K cells is in apparent contrast 
with the rapid onset of ROS production at earlier time points observed in IECs from rat 
origin, i.e., 15 min in RIE-1 (Baregamian et al., 2009) and 20 min in IEC-6 (Jin et al., 2008) 
cells. Of note, MODE-K cells showed a significant increase in ROS production only when 
treated with a high concentration of exogenous H2O2 (0.5 mM) for a period of 40 min 
suggesting that MODE-K cells are highly resistant to the initial burst of oxidative stress by 
H2O2. These results suggest that the mouse IECs have the capacity to counteract the initial 
burst of oxidative stress up to a threshold time, beyond which the antioxidant defense can 
no longer be maintained and apoptotic cell death starts. 
The significant reduction of both total ROS and cell death induced by TNF-α/CHX by a 
variety of antioxidants (like BHT, BHA, NAC and tiron) implies that ROS production 
contributes to TNF-α/CHX-induced cell death in MODE-K cells. The lipophilic antioxidants like 
BHT and BHA showed a more pronounced effect in decreasing TNF-α/CHX-induced ROS 
production and cell death as compared to the hydrophilic antioxidant NAC; these results 
suggest that the ROS produced might be predominantly released in the hydrophobic 
compartment of the mitochondrial membrane. This is corroborated by the lack of effect of 
the water-soluble mitochondria-targeted antioxidant Mito-TEMPO on both TNF-α/CHX-
induced ROS production and cell death. 
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Each of the ROS species is a distinct chemical entity with its own reaction 
preferences, kinetics, rate and site of production, degradation and diffusion characteristics in 
biological systems. So, in biomedical research investigations, specifying the particular ROS 
thought to be responsible for the observed biological effect(s) with the direct measurement 
of a particular ROS would help in better understanding of the redox signaling under 
consideration (Murphy et al., 2011). In this thesis, the abolishment of TNF-α/CHX-induced 
ROS production by iron chelators (DFO and SIH) without any effect on cell death excludes 
OH as the specific ROS causing TNF-α/CHX-induced cell death of MODE-K cells. The 
concentration-dependent increase in ROS production by TNF-α at 3 h was not paralleled by 
the decrease in the antioxidant GSH level; the latter occurred only at 6 h. Reduced GSH in 
mitochondria is the only antioxidant defense mechanism available to neutralize peroxides 
generated from the ETC through the GSH redox pool (Fernandez-Checa et al., 1998). The 
decrease in GSH levels occurring only at 6 h suggests that ROS production in the form of 
H2O2 only starts after 3 h of TNF-α/CHX exposure, with other forms of ROS in particular O2 
being involved in the earlier apoptosis observed already from 2 h of exposure to TNF-α/CHX 
in MODE-K cells. 
VI.2  Sources of TNF-α/CHX-induced oxidative stress in MODE-K cells 
Activation of NOX, dysregulation of mitochondrial oxidative phosphorylation, the 
interaction xanthine/xanthine oxidase and uncoupled eNOS are the endogenous sources of 
ROS production in eukaryotic cells. A contribution of eNOS to TNF-α/CHX-induced oxidative 
stress in MODE-K cells can be excluded as it is not expressed in IECs (Chen et al., 2002; Konig 
et al., 2002). The lack of effect of allopurinol on both the TNF-α/CHX-induced ROS 
production and cell death excludes xanthine oxidase as a possible source of ROS production 
in MODE-K cells. NOX1 and DUOX1/2 are the three NOX isozymes present in the mouse 
small intestinal epithelium (Bedard & Krause, 2007; Jones et al., 2013). During the screening 
study, the classical inhibitors of NOX (apocynin and DPI) showed differential effects on the 
TNF-α/CHX-induced decrease in cell viability. DPI reduced TNF-α-induced cytotoxicity at  
0.1-0.5 ng but not at 1 ng TNF-α/CHX, while apocynin failed to influence the decrease in cell 
viability at all tested concentrations of TNF-α. The differential effect of apocynin and DPI 
does not exclude the involvement of NOX during TNF-α/CHX-induced ROS production in 
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MODE-K cells as apocynin was not effective in inhibiting NOX activity in certain cell types 
(Aldieri et al., 2008). In the flow cytometric study, DPI was again found to not influence cell 
death (and also ROS production) by 1 ng TNF-α/CHX, but the decrease in the level of  
TNF-α/CHX-induced ROS production by the recently developed and well-validated pan-NOX 
inhibitor VAS-2870 indicates that NOX enzymes also contribute to ROS production by TNF-α 
in MODE-K cells. This is further corroborated by a relatively similar effect of NSC23766 to 
that of VAS-2870, implying that Rac1 mediated activation of NOX isozymes partly contributes 
to TNF-α/CHX-induced ROS production in MODE-K cells. This is in agreement with a study in 
rat IEC-6 cells (Jin et al., 2008). 
Mitochondria have been implicated as the principal source of ROS generation 
required for TNF-α-induced cytotoxicity of a variety of cells like mouse fibroblasts (Schulze-
Osthoff et al., 1993; Kamata et al., 2005), human cervical adenocarcinoma cells (Kim et al., 
2010), macrophages (Roca & Ramakrishnan, 2013), neonatal rat ventricular myocytes 
(Suematsu et al., 2003), liver cells (Kastl et al., 2014), endothelial cells (Deshpande et al., 
2000; Corda et al., 2001), cardiomyocytes (Roberge et al., 2014) and IECs (Jin et al., 2008; 
Baregamian et al., 2009). A growing body of evidence suggests that ROS are physiologically 
generated at the level of complexes I and III of the mitochondrial respiratory chain. The 
involvement of different complexes of the respiratory chain in ROS-dependent signaling is 
cell type-dependent and stimulus-specific (Liu & Schubert, 2009; Kastl et al., 2014). In the 
current study, the effects of the various inhibitors of the mitochondrial ETC complexes 
revealed the complex nature of ROS production in living MODE-K cells. The pronounced 
decrease in TNF-α/CHX-induced ROS production and cell death by amytal and TTFA suggests 
that the quinone binding sites of complexes I and II might be major mitochondrial 
contributors to ROS production during TNF-α/CHX-induced cell death. Interestingly, complex 
II was reported to contribute to hypoxia-induced ROS generation (Paddenberg et al., 2003) 
and oxidative stress with associated tissue damage (Ralph et al., 2011). Since treatment of 
MODE-K cells with TNF-α/CHX quickly induces decreased mitochondrial oxygen 
consumption, a similar mechanism as occurring during hypoxia could develop and 
contribution of complex II-induced ROS might come into play. Reverse electron transport 
from complex II to complex I is proposed to be a major pathway for mitochondrial ROS 
production during conditions involving oxidative stress (Drose, 2013). Correspondingly, in 
MODE-K cells, treatment of TTFA abolished TNF-α/CHX-induced ROS production suggesting 
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that the blockade of complex II at the Qp site by TTFA leads to a reduction of complex I 
related ROS production, generated by reverse electron transfer from complex II to complex I. 
Additionally, the partial reduction of TNF-α/CHX-induced ROS and cell death by myxothiazole 
indicates that the Qo site of complex III is also involved in TNF-α-induced ROS production. 
The partial reduction in TNF-α/CHX-induced ROS and cell death levels by cyanide and 
oligomycin implies that complex IV and V also participate in ROS production by TNF-α/CHX in 
MODE-K cells. As complex IV and V are not direct ROS production sites, the observed effect 
might probably be related to an indirect regulatory influence of complex IV and V on ROS 
production from the mitochondria. Similarly, the partial reduction of TNF-α/CHX-induced 
ROS and cell death levels by the proton ionophores CCCP and FCCP underlines the 
significance of the “uncoupling to survive” theory where “mild mitochondrial uncoupling” 
has been proposed to induce a protective antioxidant defense mechanism preventing cell 
death (Skulachev, 1996; Brand, 2000; Mailloux & Harper, 2011). In contrast to other 
mitochondrial complex inhibitors, inhibition of the Qi site of complex III with antimycin failed 
to inhibit TNF-α/CHX-induced ROS generation and cell death, excluding that O2 released 
from the Qi site of complex III towards the matrix contributes to TNF-α/CHX-induced ROS 
production in MODE-K cells. 
To gain further insight, we have assessed the contribution of mitochondrial ROS with 
MitoSOX Red to directly measure the primary species of intra-mitochondrial ROS, O2. 
Indeed, TNF-α/CHX increased the levels of mitochondrial O2 anion in MODE-K cells in a 
concentration-dependent manner. The onset of mitochondrial O2 production also occurs at 
2 h after exposure to TNF-α/CHX, the same time at which apoptotic cell death starts. This is 
in agreement with the involvement of mitochondrial ROS during TNF-α-induced ROS 
production in rat IECs reported previously (Jin et al., 2008; Baregamian et al., 2009). The 
contribution of complexes I and II to TNF-α/CHX-induced mitochondrial ROS production was 
confirmed by the observation that amytal and TTFA also decreased TNF-α/CHX-induced 
mitochondrial O2 production. 
Mitochondria play a critical role in cell survival as they are the main cellular sites 
controlling metabolism, cell cycle and apoptosis. Moreover, generation of ROS during 
apoptosis leads to mitochondrial damage associated with decreased Ψm. Treatment of 
MODE-K cells with TNF-α/CHX induced an increase in cells with depolarized mitochondria 
and increased the amount of respiration-interrupted mitochondria in a concentration- and 
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time-dependent manner. Additionally, our findings that treatment of MODE-K cells with 
TNF-α/CHX causes a rapid decrease in cellular oxygen consumption creating a hypoxic state 
(within 5 min of addition) and a decrease in Ψm (occurring within 60 min) and mitochondrial 
dysregulation (starting at 60 min) at earlier time points than ROS production and cell death 
(starting at 2 h), suggests that there could be a sequential link between these events. 
Taken together, NOX and mitochondria are the major sources of TNF-α/CHX-induced 
oxidative stress in MODE-K cells. 
VI.3  Influence of HO-1-derived products and resveratrol on TNF-α-induced oxidative 
stress and apoptotic cell death 
HO-1 serves as a cytoprotective gene by virtue of its potent antioxidant, anti-
apoptotic and anti-inflammatory properties, all attributed to the catalytic by-products of 
heme metabolism, namely, CO, biliverdin/bilirubin and iron/ferritin. Although HO-1 does not 
have a direct antioxidant enzymatic function, HO-1 and its product CO are believed to have 
indirect cytoprotective effects against oxidative stress (Vile et al., 1994; Otterbein & Choi, 
2000). However, studies to understand HO-1’s potential in treating ROS-induced GI diseases 
are still in their infancy (Bhattacharyya et al., 2014). Accumulating evidence indicates that 
CO mediates many of the biological functions of HO-1. The use of water soluble CO-RMs, 
CORM-3 and CORM-A1, with different CO-release kinetics that enable delivery of CO in a 
controllable manner could be of potential clinical utility for treatment of acute GI disorders 
like POI (De Backer et al., 2009). So, the influence of the HO-1 related protective compounds 
(CORM-A1, CORM-3, biliverdin and bilirubin) was tested on the effects of the different 
concentrations of TNF-α plus CHX, on cell viability, oxidative stress (ROS and GSH levels) and 
apoptosis (caspase-3/7 activity and DNA hypoploidy). CORM-A1 seems to be the most 
promising protective agent among the tested compounds. The highest non-cytotoxic 
concentration of CORM-3 and CORM-A1 reduced the decrease of cell viability by TNF-α at all 
tested concentrations (0.1-1 ng TNF-α), while 100 µM bilirubin and 1 µM biliverdin had no 
influence. However, a lower concentration of 1 µM bilirubin partially prevented the decrease 
in cell viability by 0.1 and 0.25 ng/ml TNF-α plus CHX (10 µg/ml). Bilirubin (1 µM) partially 
reduced ROS production and caspase-3/7 activity by 1 ng/ml TNF-α plus 10 µg/ml CHX, but 
failed to prevent TNF-α/CHX-induced apoptosis. A similar effect of bilirubin with only mild 
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reduction in TNF-α/CHX-induced apoptosis despite having a pronounced effect on caspase-3 
expression was already reported in cerebral vascular endothelial cells (Basuroy et al., 2006). 
These results suggest that a caspase-independent pathway of apoptosis might also be 
involved during TNF-α/CHX-induced cell death of MODE-K cells. Correspondingly, caspase-
independent apoptosis signaling of TNF-α has been reported in many different cell types 
including colonic IECs (Jones et al., 2000; Wilson & Browning, 2002; Chen et al., 2005; 
Alvarez et al., 2011). 
Low levels of HO-1 are expressed in the normal GI tract (Coeffier et al., 2002; Barton 
et al., 2003). In the GI tract, expression of HO-1 is increased in an experimental model of POI 
with surgical intestinal manipulation (De Backer et al., 2009) and models of sepsis by an i.p. 
injection of LPS (Otani et al., 2000), implying induction of HO-1 during stress conditions. 
However, in MODE-K cells, the baseline HO-1 protein level was decreased by treatment with 
TNF-α/CHX; this could at least partially be due to the presence of the protein synthesis 
inhibitor CHX. None of the previous investigations, where combination of TNF-α with CHX 
was used to induce cell death, investigated HO-1 expression (Beyaert et al., 1993; 
Bhattacharya et al., 2003; Pajak et al., 2005; Minero et al., 2013). In studies where TNF-α 
was used alone as an inflammatory trigger and not an apoptotic trigger, opposite effects 
have been obtained. In human chondrocytes (Fernandez et al., 2003) and peripheral blood 
mononuclear cells (Kirino et al., 2007), the expression of HO-1 protein was also decreased by 
TNF-α, similar to what we observed in our study. However, in human endothelial and 
monocytic cell lines, such as U937 and THP-1 (Muraosa & Shibahara, 1993; Terry et al., 1998; 
Terry et al., 1999; Udono-Fujimori et al., 2004; Liang et al., 2013), upregulation of HO-1 
expression by TNF-α was reported. The reason for this difference is not clear. 
Resveratrol showed the highest degree of cytoprotection against all tested 
concentrations of TNF-α/CHX. Resveratrol fully abolished TNF-α/CHX-induced ROS 
production and caspase-3/7 activity while only halving of TNF-α/CHX-induced apoptosis; 
these results further corroborate that TNF-α/CHX-induced apoptosis of MODE-K cells can 
occur via a ROS- and caspase-independent pathway. Apoptosis inducing factor (AIF) is a 
mammalian, caspase-independent death effector which, upon apoptosis induction, 
translocates from the mitochondria to the nucleus, causing chromatin condensation and 
DNA fragmentation (Cregan et al., 2004). Treatment of rat RIE-6 cells with TNF-α was 
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reported to increase AIF expression (Baregamian et al., 2009); a similar involvement of 
caspase-independent apoptotic induction by TNF-α might also exist in MODE-K cells. 
Given the contribution of ROS production in TNF-α/CHX-induced apoptosis in  
MODE-K cells, with CORM-A1 and resveratrol reducing both these effects, the antioxidant 
mechanism of these two agents was subsequently studied. 
VI.4  Mechanism of action of CORM-A1 during TNF-α/CHX-induced oxidative stress in 
MODE-K cells 
Treatment of MODE-K cells with 100 µM CORM-A1 partially reduced TNF-α/CHX-
induced cell death. The heme-containing proteins in mitochondria (cytochromes) and the 
NOX enzymes are the major cellular targets of CO due to its higher affinity for heme (Foresti 
& Motterlini, 2010). CO can partially and/or reversely inhibit cytochrome c oxidase (complex 
IV), leading to electron accumulation at complex III level, which facilitates O2 generation. 
Such an induction of a mild transient burst of mitochondrial ROS by CO resulting in adaptive 
signaling (“ROS-induced preconditioning”) towards subsequent oxidative insults is one of the 
most unified mechanisms proposed for the cytoprotective effect of CO (Queiroga et al., 
2012). However, the lack of induction of mitochondrial O2 during the initial hours of 
incubation of MODE-K cells with 100 µM CORM-A1 implies that the antioxidant effect of 
CORM-A1 does not involve preconditioning through induction of a mitochondrial ROS burst. 
Still, there has been speculated that the cytoprotective effects of CO can be independent of 
mitochondrial ROS generation, but could be attributed to partial or temporal inhibition of 
mitochondrial respiration (Almeida et al., 2015). Correspondingly, 100 µM CORM-A1 
decreased cellular OCR in MODE-K cells with partial recuperation from this decrease from 90 
min after its administration. This observation is in agreement with a finding in HEK293 cells 
showing reduced cellular respiration upon exposure to exogenous CO, which was suggested 
to contribute to cytoprotective effects of CO (D'Amico et al., 2006). Moreover, one has 
recently speculated that CO can alter O2 sensing and exert a “pseudo-hypoxic” state, 
providing a powerful cellular impact towards regeneration and increasing the cellular energy 
supply, thus leading to improved survival in the presence of cell stress and injury (Schallner 
& Otterbein, 2015). A similar effect on mitochondrial respiration might also explain the 
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partial recovery by CORM-A1 of the decrease in Ψm and the increase in mitochondrial 
dysfunction by TNF-α/CHX in MODE-K cells. 
CORM-A1 partially reduced TNF-α/CHX-induced and H2O2-induced intracellular total 
ROS illustrating its antioxidant potential. Mitochondrial complexes I and II are identified to 
be the major mitochondrial ROS production sites during TNF-α/CHX-induced cell death in 
MODE-K cells. CORM-A1 did not affect the mitochondrial O2 production induced by 
rotenone, the complex I inhibitor, which could be attributed to the fact that rotenone-
induced mitochondrial ROS are released into the mitochondrial matrix (Chen et al., 2003; 
Rodriguez-Rocha et al., 2013). Still, CORM-A1 could partially reduce antimycin-A-induced 
mitochondrial O2, which are reported to either fully (St-Pierre et al., 2002) or at least 
partially (Han et al., 2003) be released into the mitochondrial intermembrane space. 
However, CORM-A1 failed to influence TNF-α/CHX-induced mitochondrial ROS or O2 level, 
excluding that modulation of mitochondrial ROS contributes to its partial protection from 
TNF-α/CHX-induced cytotoxicity. Inhibition of NOX is an additional and intriguing mechanism 
by which CO could modulate redox signaling (Boczkowski et al., 2006). Several studies 
indicate that CO may directly inhibit NOX activity, probably by binding to the heme-
containing gp91phox/Nox2 subunit, and thus can reduce ROS generation (Taille et al., 2005; 
Matsumoto et al., 2006; Nakahira et al., 2006; Wang et al., 2007). The partial reduction of 
TNF-α/CHX-induced intracellular total ROS by CORM-A1 is thus probably due to inhibition of 
NOX-derived ROS. Moreover, the full use of CORM-A1-derived CO in the cytoplasm to 
counteract NOX-derived ROS upon exposure to TNF-α might be the plausible reason for the 
lack of any effect of CORM-A1 against TNF-α/CHX-induced mitochondrial ROS production. As 
NOX enzymes are not involved in the ROS production by antimycin-A, sufficient CO derived 
from CORM-A1 might have reached the mitochondrial intermembrane space upon exposure 
of MODE-K cells to antimycin-A; this might explain why CORM-A1 could partially reduce 
antimycin-A-induced mitochondrial O2. 
Exogenous CO in the form of CORMs was reported to exert its protective effects 
through induction of HO-1 in many cell types like murine macrophages (Sawle et al., 2005), 
mouse kidney tissue (Vera et al., 2005), human and rat hepatocytes (Lee et al., 2006), and 
rat endothelial cells (Rodella et al., 2006). Moreover, the induction of HO-1 can provide a 
positive feedback loop (CO→ induction of HO-1→ more CO→ further induction of HO-1) 
resulting in the formation of biliverdin/bilirubin exerting ROS scavenging properties (Rodella 
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et al., 2006). However, in MODE-K cells, treatment with CORM-A1 did not induce HO-1 
expression excluding the possibility that endogenous HO-1 induction contributes to the anti-
apoptotic effect of CORM-A1 in MODE-K cells. 
VI.5  Mechanism of action of resveratrol during TNF-α/CHX-induced oxidative stress in 
MODE-K cells 
While resveratrol interacts with many important enzymes and receptor signaling 
pathways, the antioxidant properties of resveratrol are of particular interest because of the 
fundamental role that oxidative stress plays in numerous pathological conditions. In contrast 
to CORM-A1, the antioxidant potential of resveratrol in IECs has been previously identified in 
two studies but the mechanism remains unknown (Elamin et al., 2013; Serra et al., 2014). In 
the primary screening experiments using the fluorescence plate reader, resveratrol per se 
did not influence the basal ROS level while it abolished the TNF-α/CHX-induced increase in 
ROS production when measured after 3 h of apoptotic stimulus. However, in the 
experiments using the flow cytometer, resveratrol per se increased total ROS with only 
partial reduction of TNF-α/CHX-induced total ROS production measured after 6 h of 
apoptotic stimulus. This discrepancy could be attributed to the differences in technology, 
time point of measurement, contribution of dead cells to the ROS signal along with the type 
of ROS contributing to the fluorescence, and experimental steps involved (washing of the 
cells with HBSS before carboxy-H2DCFDA loading in the cell culture plate for the plate reader 
measurement versus co-incubation of the dye with the cells without washing the cell culture 
plate in the flow cytometric analysis). Based on the flow cytometric measurements, 
resveratrol abolished TNF-α/CHX-induced mitochondrial ROS/O2 production with a 
pronounced reduction of TNF-α/CHX-induced cell death; this suggests that inhibition of 
mitochondria-derived ROS contributes to the cytoprotective/anti-apoptotic effects of 
resveratrol in MODE-K cells. Additionally, resveratrol effectively prevented TNF-α/CHX-
induced mitochondrial dysfunction and drop in Ψm in MODE-K cells. Moreover, resveratrol 
abolished both rotenone- and antimycin-A-induced ROS showing the potential of resveratrol 
in mitigating both complex I and complex III-derived ROS. All these effects of resveratrol with 
regard to the mitochondrial parameters could be attributed to the lipophilic nature of 
resveratrol enabling it to traverse through the mitochondrial intermembrane space and 
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reach the matrix, allowing scavenging of O2 produced inside the matrix, immediately after 
its generation. Indeed, resveratrol was previously shown to suppress the formation of O2 
produced by murine resident peritoneal macrophages stimulated by LPS or phorbol esters 
(Martinez & Moreno, 2000). Even though resveratrol was known for its OH scavenging 
potential, it seems unlikely that resveratrol could act through this mechanism as we have 
previously identified that OH is not the ROS entity contributing to TNF-α/CHX-induced cell 
death in MODE-K cells. 
With regard to the antioxidant defense, resveratrol can decrease oxidative stress 
through induction of MnSOD and HO-1 (Ungvari et al., 2009; Ryan et al., 2010; Kairisalo et 
al., 2011). Resveratrol per se increased basal HO-1 protein expression in MODE-K cells, but it 
did not prevent the decrease by TNF-α/CHX, excluding HO-1 induction as the mechanism of 
action for its protective effect against TNF-α/CHX. 
In recent years, it became evident that ROS are not only byproducts of cellular 
metabolism but also can act as second messengers to activate signaling pathways and hence 
lead to alterations in gene expression to regulate cellular functions. Contrary to decreasing 
mitochondrial ROS, resveratrol increased intracellular total ROS production in MODE-K cells, 
but still could decrease TNF-α/CHX-induced cell death. NOX1 seems to be the sole ROS 
production site of resveratrol in MODE-K cells as demonstrated by the abolishment of ROS 
by pan-NOX and Rac1 inhibitors. NOX-derived ROS production has been identified to exert 
stress-induced preconditioning with induction of antioxidant enzyme levels (Bell et al., 2005; 
Jiang et al., 2011; Frasier et al., 2013); the increase in the NOX-derived ROS levels by 
pretreatment with resveratrol might have induced a similar “preconditioning” effect in 
MODE-K cells to protect themselves from the successive cell death trigger (TNF-α/CHX). 
Interestingly, the mitochondrial complex I and II inhibitors showed a more 
pronounced effect in decreasing total cellular ROS and cell death as compared to the 
moderate effect of the NOX inhibitor VAS-2870; this might suggest that early ROS signaling 
from mitochondria can induce a later phase of NOX-derived ROS. Notably, resveratrol 
showed a pronounced cytoprotective effect against TNF-α/CHX concomitant with the 
abolishment of mitochondrial ROS/O2, while the inhibitory effect of CORM-A1 on NOX only 
led to partial reduction of TNF-α/CHX-induced cell death. These results together reinforce 
the possibility of sequential communication from mitochondria to NOX for ROS production in 
MODE-K cells. 
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A schematic overview of the intracellular sources of ROS production induced by  
TNF-α along with the sites of ROS production influenced by CORM-A1 and resveratrol in 
MODE-K cells is shown in Fig. VI.1. 
 
 
Fig. VI.1   Schematic overview of the intracellular sources of ROS production induced by TNF-α along with the 
sites of ROS production influenced by CORM-A1 and resveratrol in MODE-K cells. Binding of TNF-α to its 
receptor TNFR1 results in formation of O2 from mitochondrial complexes I, II and III, and NOX. CORM-A1 
reduces TNF-α-induced total ROS production through inhibition of NOX with partial reduction of antimycin-A-
induced mitochondrial O2 (influence of antimycin-A is not shown for clarity). Resveratrol per se induced total 
ROS production, mediated through NOX activation. Resveratrol abolished TNF-α-induced mitochondrial O2 
production. Resveratrol also abolished mitochondrial O2 production from complexes I and III induced by 
rotenone and antimycin-A, respectively (not shown for clarity). 
VI.6  Future perspectives 
Although primary IECs can be prepared with high purity from intestinal tissue, their 
short survival in culture precludes their use in functional ex vivo studies (Bjerknes & Cheng, 
1981; Cano-Gauci et al., 1993; Lotz et al., 2006). MODE-K is the most widely used mouse 
small IEC line in several research investigations in the literature to understand small 
intestinal mucosal pathophysiology, however, this cell line still suffers with the limitation 
that it does not develop measurable transepithelial resistance when grown in cultures (Iliev 
et al., 2009). So, our findings with TNF-α toxicity and ROS generation in MODE-K cells should 
be ideally reassessed in another cell line like IEC-1, a recently established murine IEC line 
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bearing many functional features of the intestinal epithelium including the generation of 
increasing transepithelial electrical resistance during in vitro culture (Schwerk et al., 2013). 
Following this, the effect of TNF-α/CHX in increasing the epithelial barrier permeability 
should be evaluated in IEC-1 cells both in the absence and presence of specific ROS inhibitors 
to strengthen the hypothesis that TNF-α-induced ROS production contributes to epithelial 
barrier dysfunction. The participation of mitochondrial ROS in TNF-α-induced cell death can 
be confirmed at the genetic level by using mtDNA-depleted ρ° cells generated from IEC-1 
cells. In the present study, the involvement of mitochondrial complex I, the primary site of 
electron entry in the ETC, in TNF-α-induced mitochondrial ROS generation, has been 
identified based on pharmacological intervention. This finding should be investigated by a 
genetic approach with silencing of NADH dehydrogenase [ubiquinone] 1 beta subcomplex 
subunit 8 (NDUFB8), a mitochondrial complex I subunit, using siRNA; this should prevent the 
induction of ROS from mitochondria upon TNF-α exposure in MODE-K cells. The involvement 
of NOX in TNF-α-induced ROS production can also be assessed by performing studies with 
siRNA for NOX1 along with measurement of NOX activity. The ROS assessments after each of 
the above silencing experiments also would help to understand the proposed crosstalk 
between mitochondria and NOX. The mechanism of action of CORM-A1 through inhibition of 
NOX could be reevaluated in NOX1 silenced cells. Since induction of antioxidant enzymes is 
proposed to be a possible mechanism of action for the cytoprotective effect of resveratrol, 
gene/protein expression studies of MnSOD will further strengthen the role of antioxidant 
defense mechanism by resveratrol. 
VI.7  General conclusion 
In this thesis, a murine in vitro model of TNF-α-induced IEC death was established 
using MODE-K cells and the involvement of oxidative stress during cell death signaling by 
TNF-α was identified. The data indicate that MODE-K cells are highly sensitive to TNF-α-
induced apoptosis involving caspase-3/7 activation when co-treated with CHX. Moreover, 
TNF-α/CHX-induced apoptosis of MODE-K cells corresponds with the production of ROS. 
Mitochondria and NOX are the two major sources of ROS overproduction during TNF-α/CHX-
induced cell death in MODE-K cells with O2 being the predominant ROS entity. From the 
results with mitochondrial complex inhibitors, the quinone-binding sites of mitochondrial 
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ETC complexes I (site IQ) and II (site QP) seem to be the major ROS production sites of 
mitochondria. Resveratrol shows pronounced protection against TNF-α/CHX-induced cell 
death involving the abolishment of mitochondrial ROS/O2; the moderate cytoprotection 
observed with CORM-A1 is NOX-dependent. This suggests a possible crosstalk of ROS 
signaling from mitochondria to NOX in MODE-K cells. Targeting ROS generation with agents 
like CORM-A1 and resveratrol interfering with particular intracellular ROS production sites 
should be further investigated for the treatment of acute GI inflammatory conditions. 
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Chapter VII   Summary 
 
A single layer of intestinal epithelial cells (IECs) in the gut provides a physical barrier 
between the organism and the luminal content. It allows the passage of nutrients and 
electrolytes but also forms the intestinal epithelial barrier preventing the passage of 
pathogens. The maintenance of its homeostasis is of prime importance for the survival of the 
organism. Apoptosis in the intestinal epithelium is an important regulator of mucosal 
homeostasis. Even though apoptotic cell death of IECs in the crypts and villi is continuously 
present during the physiological state, excessive apoptotic cell death has been implicated  in 
gastrointestinal (GI) disorders. Disturbance of the intestinal epithelial barrier occurs during 
acute GI inflammatory disease conditions such as necrotizing enterocolitis (NEC), and can 
have a triggering role during sepsis. Sepsis is driven by a complex cascade initiated by 
bacteria-derived molecules with subsequent inflammation, oxidative stress and 
mitochondrial dysfunction. The disruption of the intestinal epithelial barrier results in 
invasion of commensal bacteria and the excessive production of inflammatory cytokines by 
mucosal immune cells, eventually leading to pathological inflammation during sepsis. This 
can be accompanied by sepsis-induced ileus, facilitating the passage of luminal content. 
Postoperative ileus (POI), occurring after abdominal surgery, is related to the occurrence of 
an inflammatory process in the muscular layer, induced by surgical handling of the intestine. 
In a mouse model of POI, our laboratory has shown the occurrence of an early ‘oxidative 
burst’ in the mucosa following intestinal manipulation. This might possibly lead to increased 
intestinal permeability, which then can contribute to or trigger the muscular inflammation. 
Tumor necrosis factor-α (TNF-α) is one of the early inflammatory cytokines known to play an 
important role during epithelial barrier dysfunction by induction of IEC apoptosis; it is also 
known to be one of the early inflammatory agents in the pathogenesis of POI. In addition to 
its pro-inflammatory effects, exposure to TNF-α has been shown to be associated with an 
increase in oxidative stress in many cell lines and thus could be expected to cause the same 
effect in IECs. Among the intracellular antioxidant pathways, heme oxygenase-1 (HO-1) is a 
stress-responsive protein known to be upregulated by oxidative stress and inflammatory 
signals; it is known to exert cytoprotection. The beneficial effect of HO-1 is mainly attributed 
to the products of HO-1 activity, namely biliverdin/bilirubin and still more to carbon 
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monoxide (CO). Emerging evidence reveals that CO can exert diverse biological and 
cytoprotective effects. The recent discovery of CO-releasing molecules (CO-RMs) which allow 
controlled CO delivery in biological systems highlights the potential use of this class of 
compounds to deliver CO for therapeutic purposes. In the GI tract, CO/CO-RMs protect 
against the development of POI and decrease inflammation and associated tissue damage 
during sepsis. In addition, CO has been shown to reduce ischemia/reperfusion injury of 
intestinal grafts and development of NEC. Another strategy to obtain the beneficial effects of 
HO-1 is to induce it by pharmacological means. A frequently studied cytoprotective 
compound, that at least in some models acts through induction of HO-1, is the plant 
polyphenol resveratrol. 
The aim of this thesis was to establish an in vitro IEC model to assess TNF-α-induced 
oxidative stress, inflammation and cell death, and to investigate the protective effects of  
CO-RMs and resveratrol versus the TNF-α-induced dysfunction concentrating on their anti-
oxidative effect. 
The murine MODE-K IEC line was established as an in vitro model to assess TNF-α-
induced oxidative stress and apoptotic cell death (chapter III). Similar to many other cell 
types, TNF-α required a combination with the protein synthesis inhibitor cycloheximide 
(CHX) to induce cell death in MODE-K cells. TNF-α (0.1-1 ng)/CHX decreased cell viability, 
increased caspase-3/7 activity, induced apoptosis, decreased the level of reduced 
glutathione (GSH) and increased  production of reactive oxygen species (ROS) in a 
concentration-dependent manner in MODE-K cells. TNF-α/CHX-induced apoptosis occurred 
in parallel with ROS production from 2 h after the start of exposure. CORM-A1 and 
resveratrol were the most effective cytoprotective agents tested among the set of HO-1-
related products and antioxidant compounds, that was investigated; resveratrol abolished 
and CORM-A1 reduced TNF-α/CHX-induced ROS production. Treatment of MODE-K cells with 
TNF-α/CHX caused attenuation of basal HO-1 expression. None of the tested agents induced 
HO-1 in the presence of TNF-α/CHX in MODE-K cells; this suggests that the cytoprotection by 
CORM-A1 and resveratrol involves a HO-1 independent mechanism. 
As TNF-α/CHX-induced ROS production occurred in parallel with cell death, the 
relation between TNF-α/CHX-induced cell death and ROS production was further 
investigated, assessing the sources of ROS production (chapter IV). Using flow cytometry, 
simultaneous determination of the production of total ROS or mitochondrial superoxide 
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anion (O2) and of cell death was assessed. Exposure to TNF-α/CHX time-dependently 
increased intracellular total ROS and mitochondrial O2 production in MODE-K cells, starting 
from 2 h, which corresponds with the onset of apoptotic cell death. The significant reduction 
of TNF-α/CHX-induced ROS production and cell death by the antioxidants butylated 
hydroxytoluene, butylated hydroxyanisole, N-acetylcysteine and tiron underlines the 
important role of ROS production in cell death of MODE-K cells. By use of a set of inhibitors, 
it was shown that mitochondria and nicotinamide adenine dinucleotide phosphate oxidases 
(NOX) are the two major sources of ROS overproduction during TNF-α/CHX-induced cell 
death in MODE-K cells, with O2 being the major type of ROS. Particularly, the quinone-
binding sites of mitochondrial complex I (site IQ) and complex II (site QP) seem to be the 
major sites of mitochondrial ROS production. TNF-α/CHX treatment caused an immediate 
decrease in mitochondrial respiration, and a loss of mitochondrial membrane potential and 
increase in mitochondrial dysfunction from 1 h of exposure on; this was followed by ROS 
production and cell death from 2 h on suggesting a possible sequential link between these 
cellular events. 
Reducing oxidative stress in IECs may be a therapeutic approach to treat acute GI 
disorders. As ROS production corresponds to TNF-α/CHX-induced cell death in MODE-K cells, 
with CORM-A1 and resveratrol decreasing both these effects, the antioxidant mechanisms of 
these cytoprotective agents were investigated (chapter V). While CORM-A1 did not 
influence basal levels of intracellular total or mitochondrial ROS, resveratrol increased total 
cellular ROS but decreased mitochondrial ROS production. Both CORM-A1 and resveratrol 
reduced total ROS production induced by TNF-α/CHX, but only resveratrol abolished the 
TNF-α/CHX-induced increase in mitochondrial ROS level. Resveratrol greatly reduced and 
abolished TNF-α/CHX-induced mitochondrial depolarization and mitochondrial dysfunction 
respectively, but CORM-A1 only mildly influenced these parameters. The cytoprotective 
effect of resveratrol versus TNF-α/CHX in MODE-K cells is thus predominantly due to 
mitigation of mitochondrial ROS production, while CORM-A1 acts solely on NOX-derived ROS 
to protect MODE-K cells. As the cytoprotective effect of resveratrol was clearly more 
pronounced than that of CORM-A1, this might correlate with a sequential communication 
from mitochondria to NOX for TNF-α/CHX-induced ROS production in MODE-K cells. 
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Conclusions 
A murine in vitro model of TNF-α/CHX-induced oxidative stress and apoptosis was 
established using MODE-K cells, with ROS production corresponding to cell death. 
Mitochondria and NOX are the two major sources of ROS overproduction during TNF-α/CHX-
induced cell death in MODE-K cells; O2 was identified to be the predominant ROS. The 
quinone-binding sites of mitochondrial complexes I (site IQ) and II (site Qp) seem to be the 
major ROS production sites in the mitochondria. The pronounced cytoprotective effect of 
resveratrol against TNF-α/CHX-induced cell death involves the abolishment of mitochondrial 
ROS/O2 while a NOX-dependent mechanism contributes to the moderate cytoprotection by 
CORM-A1. Taken together, these results imply that the antioxidant effects of CORM-A1 and 
resveratrol in IECs could be of potential therapeutic benefit to offer a solution for acute GI 
inflammatory conditions involving oxidative stress of the IEC layer. 
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Chapter VIII   Samenvatting 
 
Een enkele laag van intestinale epitheliale cellen (IECs) in de darm vormt een fysieke 
barrière tussen het organisme en de darminhoud. Ze laat de passage van 
voedingsbestanddelen en electrolieten toe maar vormt ook de intestinale epitheliale 
barrière welke de passage van pathogenen voorkomt. Het behoud van de homeostase van 
de intestinale epitheliale cellaag is van primair belang voor de overleving van het organisme. 
Apoptose in het intestinal epitheel is een belangrijke regulator van de mucosale 
homeostase. Weliswaar is celdood van IECs door apoptose in de krypten en villi continu 
aanwezig in fysiologische condities, maar overmatige celdood door apoptose kan betrokken 
zijn in gastro-intestinale (GI) aandoeningen. Verstoring van de intestinale epitheliale barrière 
treedt op tijdens acute GI inflammatoire aandoeningen zoals  necrotizerende enterocolitis 
(NEC); dit kan ook een uitlokkende rol spelen tijdens sepsis. Sepsis wordt gedreven door een 
complexe cascade, in gang gestoken door van bacteriën afkomstige moleculen, met daarop 
volgend inflammatie, oxidatieve stress en mitochondriale dysfunctie. Het doorbreken van de 
intestinale epitheliale barrière leidt tot invasie van commensale bacteriën en overmatige 
productie van inflammatoire cytokinen door immuuncellen in de mucosa, wat uiteindelijk 
leidt tot pathologische inflammatie tijdens sepsis. Sepsis kan ook gepaard gaan met ileus, 
wat de passage van darminhoud doorheen de darmwand bevordert. Postoperatieve ileus 
(POI), die optreedt na abdominale chirurgie, wordt veroorzaakt door een inflammatoir 
proces in de spierlaag, uitgelokt door de manipulatie van de darm tijdens de operatie. In een 
model van POI bij de muis, werd in ons laboratorium voorheen aangetoond dat zich een 
vroege  ‘oxidatieve opstoot’ voordoet in de mucosa na intestinale manipulatie. Dit kan 
mogelijk leiden tot verhoogde intestinale permeabiliteit, wat kan bijdragen aan de 
inflammatie in de spierlaag of deze zelfs kan uitlokken. Tumor necrosis factor-α (TNF-α) is 
één van de inflammatoire cytokinen, die een rol speelt in de dysfunctie van de epitheliale 
barrière door inductie van apoptose van de IECs; het is ook één van de vroege inflammatoire 
agentia in de pathogenese van POI. Naast zijn pro-inflammatoire effecten, is blootstelling 
aan TNF-α geassocieerd met een toename in oxidatieve stress in verschillende cellijnen 
zodat een gelijkaardig effect kan verwacht worden in IECs. Onder de intracellulaire anti-
oxiderende signaalwegen, is heem oxygenase-1 (HO-1) een proteïne dat opgeregeld wordt 
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door oxidatieve stress en inflammatoire signalen; het heeft een cytoprotectief effect. Dit 
gunstig effect van HO-1 wordt hoofdzakelijk toegeschreven aan de producten bekomen door 
de enzymatische activiteit van HO-1, namelijk biliverdine/bilirubine en nog meer 
koolstofmonoxide (CO). Meer en meer evidentie ondersteunt dat CO talrijke biologische en 
cytoprotectieve effecten heeft. De recente ontwikkeling van CO-vrijstellende moleculen (CO-
RMs) met gecontroleerde afgifte van CO in biologische systemen maakt toediening van CO 
voor therapeutische doeleinden mogelijk. In de GI tractus, beschermen CO/CO-RMs tegen de 
ontwikkeling van POI en zij verminderen de inflammatie en de geassocieerde 
weefselbeschadiging tijdens sepsis. Verder gaat CO letsels door ischemie/reperfusie van 
intestinale transplanten en de ontwikkeling van NEC tegen. Een andere strategie om de 
gunstige effecten van HO-1 te bekomen is het te induceren op farmacologische wijze. Een 
cytoprotectieve stof die reeds frequent werd bestudeerd, en althans in sommige modellen 
werkzaam is door inductie van HO-1, is het polyfenol resveratrol, dat aanwezig is in diverse 
planten. 
De bedoeling van dit proefschrift was om een in vitro model van IECs te ontwikkelen 
ten einde de oxidatieve stress en celdood door TNF-α te onderzoeken. Verder werden de 
beschermende effecten van CO-RMs en resveratrol op deze door TNF-α uitgelokte 
dysfuncties onderzocht, hierbij concentrerend op hun anti-oxidatief effect. 
The  MODE-K IEC lijn, afkomstig van de muis, werd ontwikkeld als in vitro model voor 
onderzoek van oxidatieve stress en apoptotische celdood door TNF-α (chapter III). Zoals 
voor vele andere celtypes, was het nodig om TNF-α te combineren met de proteïnesynthese-
inhibitor cycloheximide (CHX) om celdood in MODE-K cellen uit te lokken. TNF-α (0.1-1 
ng)/CHX verminderde de leefbaarheid van de cellen, verhoogde de caspase-3/7 activiteit, 
lokte apoptose uit, verminderde het gehalte aan gereduceerd glutathion (GSH) en 
verhoogde de productie van reactieve zuurstofspecies (ROS) op concentratie-afhankelijke 
manier. De door TNF-α/CHX-uitgelokte apoptose trad op in parallel met de productie van 
ROS vanaf 2 u na de start van de blootstelling. CORM-A1 en resveratrol waren de meest 
effectieve cytoprotectieve agentia onder de bestudeerde set van HO-1-afhankelijke 
producten en anti-oxiderende substanties; CORM-A1 veminderde de door TNF-α/CHX 
uitgelokte productie van ROS terwijl resveratrol ze ophief. Behandeling van MODE-K cellen 
met TNF-α/CHX veroorzaakte een daling van de basale expressie van HO-1. Geen enkele van 
de geteste substanties verhoogde de expressie van HO-1 in aanwezigheid van TNF-α/CHX in 
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de MODE-K cellen; dit suggereert dat de cytoprotectie door CORM-A1 en resveratrol plaats 
grijpt via een mechanisme dat onafhankelijk is van HO-1 . 
Vermits de productie van ROS door TNF-α/CHX in parallel optreedt met de celdood, 
werd het verband tussen de door TNF-α/CHX uitgelokte celdood en productie van ROS 
verder bestudeerd, om de bronnen van de ROS te detecteren (chapter IV). Door gebruik van 
“flow cytometry” werd simultaan de productie van totaal ROS of van mitochondriale 
superoxide anionen (O2), en van celdood bestudeerd. Blootstelling aan TNF-α/CHX 
verhoogde tijdsafhankelijk de productie van intracellulair totaal ROS en van mitochondriale 
O2 in MODE-K cellen, startende vanaf 2 u, wat overeenkomt met de start van de 
apoptotische celdood. De significante vermindering van de door TNF-α/CHX uitgelokte 
productie van ROS en celdood door de anti-oxiderende substanties gebutyleerd 
hydroxytolueen, gebutyleerd hydroxyanisol, N-acetylcysteïne en tiron bevestigt de 
belangrijke rol van ROS in de celdood van MODE-K cellen. Door studie van het effect van een 
set inhibitoren, werd aangetoond dat mitochondria en nicotinamide adenine dinucleotide 
fosfaat oxidasen (NOX) de 2 belangrijkste bronnen zijn van ROS tijdens de door TNF-α/CHX 
uitgelokte celdood in MODE-K cellen, met O2 als belangrijkste ROS-type. De 
bindingsplaatsen van quinone in het mitochondriale complex I (site IQ) en complex II (site QP) 
blijken de majeure mitochondriale productieplaatsen te zijn van mitochondriale ROS. 
Behandeling met TNF-α/CHX veroorzaakte een onmiddellijke daling in de mitochondriale 
respiratie, en vanaf 1 u een daling van de mitochondriale membraanpotentiaal en een 
toename in mitochondriale dysfunctie; dit werd gevolgd door productie van ROS en celdood 
vanaf 2 u wat een sequentieel verband tussen deze cellulaire fenomenen suggereert. 
Vermindering van de oxidatieve stress in IECs zou een therapeutische benadering van  
acute GI aandoeningen kunnen vormen. Vermits de productie van ROS door TNF-α/CHX 
overeenkomt met de uitgelokte celdood in MODE-K cellen, en CORM-A1 en resveratrol beide 
effecten verminderen, werden de anti-oxiderende mechanismen van deze cytoprotectieve 
agentia verder onderzocht (chapter V). Terwijl CORM-A1 de basale spiegels van intracellulair 
totaal ROS en mitochondriaal ROS niet beïnvloedde, verhoogde resveratrol totaal cellulair 
ROS maar verminderde het de basale spiegel van mitochondriaal ROS. Zowel CORM-A1 als 
resveratrol verminderde de productie van totaal ROS door TNF-α/CHX, maar alleen 
resveratrol hief de toename van mitochondriale ROS en O2 door TNF-α/CHX op. 
Resveratrol verminderde uitgesproken de mitochondriale depolarizatie door TNF-α/CHX en 
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hief de mitochondriale dysfunctie op, terwijl CORM-A1 slechts een mild effect had op beide 
parameters. Het cytoprotectief effect van resveratrol versus TNF-α/CHX in MODE-K cellen 
berust dus hoofdzakelijk op onderdrukking van de mitochondriale productie van ROS, terwijl 
CORM-A1 enkel aangrijpt op NOX om de MODE-K cellen te beschermen. Vermits het 
cytoprotectief effect van resveratrol duidelijk meer uitgesproken was dan dit van CORM-A1, 
kan dit wijzen op een sequentiële communicatie van de mitochondria naar NOX toe tijdens 
de productie van ROS uitgelokt door TNF-α/CHX in MODE-K cellen. 
 
Besluiten 
Een in vitro model om oxidatieve stress en apoptose uitgelokt door TNF-α/CHX in 
IECs te bestuderen werd ontwikkeld door gebruik te maken van MODE-K cellen, afkomstig 
van de muis. De productie van ROS correleerde met het optreden van celdood. Mitochondria 
en NOX zijn de 2 majeure bronnen van overproductie van ROS tijdens door TNF-α/CHX 
uitgelokte celdood in MODE-K cellen; O2 is het belangrijkste betrokken ROS. De 
bindingsplaatsen voor quinone van mitochondriaal complex I (site IQ) en complex II (site Qp) 
lijken de majeure productieplaatsen van ROS in de mitochondria. Het uitgesproken 
cytoprotectief effect van resveratrol versus TNF-α/CHX berust op de opheffing van de 
productie van mitochondriaal ROS/O2 terwijl een NOX-afhankelijk mechanisme bijdraagt 
aan de matige cytoprotectie door CORM-A1. De anti-oxiderende effecten van CORM-A1 en 
resveratrol in IECs kunnen mogelijk therapeutisch nuttig zijn voor acute GI inflammatoire 
condities, waarin oxidatieve stress van de IEC-laag betrokken is. 
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